Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3005229	s-alfa-2	g/l (g/l)	11258	25726	0.00%
3005229	s-alfa-2	— (—)	1977	2605	100.00%	Distribution not available
3005229	s-alfa-2-fraktio	g/l (g/l)	1153	2351	0.00%
3005229	s-alfa2	g/l (g/l)	1011	1768	0.00%
3005229	alfa2-glob	g/l (g/l)	707	2811	0.00%
3005229	s-alfa-2	g/l_______ (g/l)	619	1918	0.00%
3005229	alfa-2	g/l (g/l)	438	907	0.00%
3005229	s-a2glob	g/l (g/l)	411	877	0.00%
3005229	s-alfa-2-fraktio	g/l_______ (g/l)	312	693	0.00%
3005229	alfa-2-glo	g/l (g/l)	85	96	0.00%
3005229	s-alfa2-globuliini(valetietues-prot-fr)	g/l (g/l)	60	82	0.00%
3005229	s-alfa-2-fraktio	— (—)	5	7	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of lipoprotein metabolism and other lipidaemias

3257

9378

2.19

319.23

2.3

7.58

7.26

g/l

19.10

3006

8518

Explicit Sepsis, including avohilmo

2132

7971

2.55

319.17

3.2

2.2

7.57

7.35

g/l

6.38

1950

7227

Septicaemia

2044

7582

2.59

315.96

3.2

2.1

7.55

7.29

g/l

9.29

1868

6797

Codeine

3168

7967

2.21

312.11

2.2

1.9

7.43

7.19

g/l

10.14

2925

7263

Other heart diseases

1449

3036

3.21

310.84

2.4

2.1

7.36

6.99

g/l

10.99

1366

2810

Explicit Sepsis

2088

7874

2.54

310.32

3.2

2.1

7.56

7.35

g/l

5.67

1910

7136

Infections, IBD-co-morbidities

700

712

7.40

307.65

4.3

2.2

7.38

7.03

g/l

3.83

652

654

Primary_lymphoid and hematopoietic malignant neoplasms

2190

4604

5.64

307.65

8.5

1.4

7.03

7.46

g/l

24.29

2119

4124

Polyneuropathies and other disorders of the peripheral nervous system

1855

4281

5.07

307.65

2.5

2.3

7.09

7.44

g/l

15.15

1709

3879

Unspecified kidney failure

846

1806

5.46

307.65

2.7

2.2

7.61

7.36

g/l

3.35

795

1602

L04AX Other immunosuppressants

2804

9915

3.01

307.65

5.4

1.7

7.45

7.32

g/l

3.25

2653

9061

Renal failure

3946

8180

4.67

307.65

2.5

2.2

7.66

7.35

g/l

20.51

3700

7281

Second line medication for Crohn's disease

2839

10127

2.97

307.65

5.3

1.7

7.44

7.33

g/l

3.00

2686

9254

ILD medications

4936

9610

2.89

307.65

3.1

1.7

7.42

7.25

g/l

8.19

4588

8683

General symptoms and signs

3887

8188

2.45

307.65

2.5

2.1

7.37

7.29

g/l

1.83

3603

7478

Gout

1638

4643

3.28

307.65

3.2

2.4

7.64

7.29

g/l

11.67

1529

4200

Pneumonia, organism unspecified

3743

11319

2.35

307.65

3.1

2.0

7.60

7.24

g/l

26.28

3452

10318

Condition for Implicit Sepsis (Organ dysfunction codes)

3719

10766

2.50

307.65

2.4

2.2

7.45

7.32

g/l

4.03

3394

9851

Bacterial Sepsis

2675

8025

2.95

307.65

3.1

2.2

7.64

7.37

g/l

11.42

2436

7264

Heart failure, not strict

3770

9284

2.90

307.65

2.6

2.3

7.62

7.28

g/l

22.67

3486

8433

ILD medications: prednisolone, methylprednisolone, prednisone

4711

9581

2.85

307.65

2.2

1.7

7.48

7.25

g/l

12.95

4362

8654

Heart failure and antihypertensive medication

1193

2048

4.06

307.65

2.3

2.6

7.60

7.04

g/l

16.97

1115

1861

Anaemias

1132

642

12.21

307.65

2.4

1.2

7.24

6.98

g/l

2.72

1080

597

Inflammatory bowel disease treatment related agents

4717

11028

2.46

307.65

2.1

2.4

7.51

7.24

g/l

17.96

4378

10002

Other and unspecified iron deficiency

1782

6705

2.83

307.65

2.0

2.4

7.62

7.41

g/l

5.37

1611

6034

ILD medications: immunosuppressive drugs

3529

8668

3.95

307.65

4.6

1.7

7.43

7.24

g/l

7.86

3352

7863

Persons encountering health services for specific procedures and health care

3898

11217

2.11

307.65

2.7

2.1

7.41

7.30

g/l

3.08

3643

10185

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

610

464

27.59

307.65

19.6

1.5

7.01

7.63

g/l

9.97

601

403

Implicit bacterial Sepsis

2390

7482

2.94

307.65

2.9

2.1

7.67

7.37

g/l

11.96

2175

6751

Multiple myeloma and malignant plasma cell neoplasms

930

866

20.12

307.65

16.3

1.6

6.97

7.50

g/l

12.27

915

774

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1097

798

29.93

307.65

7.5

1.2

6.92

7.53

g/l

15.11

1033

706

Heart failure,strict

2603

7353

2.62

307.65

2.3

2.4

7.59

7.33

g/l

10.11

2400

6622

Liquid cancers, including Hilmo

2760

6143

4.47

307.65

7.1

1.4

7.01

7.49

g/l

37.86

2642

5501

Metabolic disorders

3777

9869

2.38

307.65

2.4

2.2

7.50

7.24

g/l

14.48

3493

8982

Other systemic involvement of connective tissue (FG)

1569

3944

4.28

307.65

1.9

2.6

7.72

7.27

g/l

16.69

1438

3531

Glomerular disorders in diseases classified elsewhere

863

1995

5.00

307.65

2.8

2.3

7.91

7.35

g/l

14.81

819

1830

Multiple myeloma, including Hilmo

922

746

23.88

307.65

16.5

1.4

6.98

7.50

g/l

11.32

908

659

First line medication for Crohn's disease

4515

9482

2.66

307.65

3.1

1.6

7.42

7.23

g/l

8.67

4215

8567

Systemic connective tissue disorders

2105

6575

3.49

307.65

2.0

2.4

7.76

7.40

g/l

14.38

1939

5914

Fever of other and unknown origin

2698

7457

3.31

307.65

3.9

2.1

7.53

7.30

g/l

7.19

2515

6784

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3944

11957

2.27

307.65

3.1

2.0

7.58

7.24

g/l

23.78

3650

10909

Examination and observation for other reasons

2477

4774

3.06

307.65

2.4

2.2

7.24

7.37

g/l

2.86

2301

4393

Osteopathies and chondropathies

2694

10121

2.56

307.65

3.0

2.2

7.53

7.37

g/l

4.54

2411

9218

Liquid cancers

2587

5401

5.26

307.65

7.5

1.4

6.99

7.48

g/l

35.43

2482

4829

Bacterial infection, other or unspecified

3200

8850

3.29

307.65

3.4

2.1

7.81

7.28

g/l

43.10

2963

7948

Autoimmune diseases excluding thyroid diseases

4134

10102

2.29

307.65

2.0

2.5

7.39

7.31

g/l

2.32

3860

9174

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3569

9265

2.33

307.65

3.1

1.9

7.57

7.27

g/l

17.55

3315

8432

Influenza and pneumonia

4084

11546

2.26

307.65

3.1

2.0

7.55

7.24

g/l

22.41

3789

10536

Iron deficiency anaemia

2127

8547

2.58

307.65

2.1

2.3

7.58

7.41

g/l

4.17

1917

7714

Other and unspecified anaemias

3442

8041

4.54

307.65

2.6

2.3

7.36

7.48

g/l

3.07

3173

7185

Other bacterial diseases

4474

11245

2.77

307.65

3.0

2.0

7.63

7.22

g/l

37.88

4161

10204

Autoimmune diseases excluding thyroid diseases, strict definition

3992

9756

2.30

307.65

2.0

2.5

7.39

7.31

g/l

2.08

3729

8853

Abnormal findings on examination of blood, without diagnosis

2346

8936

2.52

307.65

2.7

2.4

7.65

7.31

g/l

14.93

2185

8156

Renal tubulo-interstitial diseases

4779

10961

3.41

307.65

2.4

2.3

7.61

7.25

g/l

32.88

4429

9949

Implicit Sepsis

3673

10593

2.69

307.65

2.5

2.2

7.51

7.33

g/l

7.28

3340

9659

Oedema, not elsewhere classified

1573

5276

3.09

307.65

2.3

2.1

7.55

7.36

g/l

3.70

1430

4765

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6045

10366

4.24

307.65

2.5

2.2

7.30

7.40

g/l

3.66

5619

9386

Other soft tissue disorders, not elsewhere classified

3643

9249

2.32

307.65

2.3

2.4

7.35

7.33

g/l

0.26

3379

8412

Other bacterial diseases, including avohilmo

4479

10811

2.70

307.65

2.9

2.0

7.59

7.20

g/l

34.56

4173

9804

Oral corticosteroids

4613

10965

2.57

307.65

2.2

2.4

7.56

7.24

g/l

24.06

4290

9943

Other and unspecified polyneuropathies, also in other diseases

1719

3780

5.40

307.65

2.1

2.3

7.09

7.44

g/l

13.88

1580

3421

Tramadol

3320

7808

2.66

307.65

2.4

2.0

7.50

7.20

g/l

15.57

3055

7111

Implicit bacterial Sepsis, including avohilmo

2593

7916

2.92

307.65

2.8

2.2

7.65

7.37

g/l

11.57

2358

7160

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

772

1408

6.81

307.65

3.4

2.2

8.34

7.41

g/l

30.56

718

1260

Multiple myeloma

610

464

27.59

307.65

19.6

1.5

7.01

7.63

g/l

9.97

601

403

Polyarthropathies

3265

7089

3.12

307.65

2.5

2.4

7.65

7.24

g/l

27.00

3052

6481

All pneumoniae

4008

11829

2.28

307.65

3.1

2.0

7.57

7.24

g/l

23.79

3720

10789

Pneumonias (Asthma/COPD co-morbidities)

3998

11813

2.29

307.65

3.1

2.0

7.57

7.24

g/l

23.17

3708

10773

Implicit Sepsis, including avohilmo

3793

10818

2.62

307.65

2.5

2.2

7.48

7.32

g/l

5.93

3448

9897

All chronic kidney diseases

3990

7734

4.56

307.65

2.4

2.3

7.67

7.28

g/l

30.63

3755

6952

Nutritional anaemias

2429

9861

2.47

307.65

2.1

2.4

7.55

7.40

g/l

3.78

2198

8900

Other systemic involvement of connective tissue

1599

5082

3.43

307.65

1.9

2.4

7.72

7.42

g/l

8.16

1467

4581

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3771

10447

2.54

307.65

2.4

2.2

7.43

7.30

g/l

4.12

3452

9579

Bacterial infection, other or unspecified, including avohilmo

3413

9204

3.26

307.65

3.3

2.1

7.79

7.27

g/l

45.01

3166

8279

Erysipelas, including avohilmo

2989

10073

2.28

307.65

2.3

2.0

7.60

7.23

g/l

23.93

2764

9107

All kidney diseases

4892

10684

3.24

307.65

2.4

2.2

7.57

7.22

g/l

31.55

4556

9701

Other anaemias

3458

8097

4.51

307.65

2.5

2.3

7.36

7.48

g/l

3.08

3188

7239

Finngen Rheumatological endpoints

3363

8574

2.29

307.65

2.2

2.4

7.44

7.16

g/l

16.16

3116

7845

Malaise and fatigue

2568

6782

3.15

307.65

2.2

2.1

7.47

7.33

g/l

3.28

2331

6149

Aplastic and other anaemias

3615

8462

4.39

307.65

2.5

2.3

7.36

7.47

g/l

3.02

3332

7576

Pain in limb

3389

9160

2.44

307.65

2.2

2.4

7.37

7.33

g/l

0.44

3132

8333

Dialysis, with operation codes

928

1907

5.64

307.65

3.8

2.2

7.49

7.25

g/l

3.39

883

1736

Asthma, unspecified (mode), excluding more controls

1956

5297

2.74

307.65

2.1

1.9

7.55

7.20

g/l

14.19

1813

4824

Chronic kidney disease

2924

6035

5.44

307.65

2.3

7.66

7.36

g/l

14.73

2757

5343

3569

9265

2.33

307.65

3.1

1.9

7.57

7.27

g/l

17.55

3315

8432

Glomerular diseases

1239

3186

4.39

307.65

2.8

2.3

7.87

7.32

g/l

20.52

1176

2921

Acute renal failure

1577

4138

4.28

307.65

2.8

2.2

7.72

7.33

g/l

12.83

1476

3686

Heart failure, strict

2840

9163

2.27

306.79

2.3

2.4

7.59

7.40

g/l

6.13

2612

8241

Nephropathy related operations

833

2087

4.56

306.43

3.9

2.3

7.48

7.34

g/l

1.26

797

1911

Medical observation and evaluation for suspected diseases and conditions

2322

4822

2.54

304.36

2.3

2.1

7.36

7.37

g/l

0.11

2102

4431

Gout, FINNGEN

1638

6178

2.84

300.71

3.2

2.3

7.64

7.31

g/l

11.16

1529

5566

Care involving dialysis

618

1251

5.81

298.09

2.5

2.1

7.54

7.28

g/l

2.73

587

1146

Autoimmune diseases related-to ILD

3241

13483

2.07

297.58

2.1

2.4

7.53

7.30

g/l

11.06

3017

12258

Pure hypercholesterolaemia

3021

9115

2.18

297.27

2.3

7.62

7.26

g/l

22.00

2789

8266

Hypertension, essential

2574

6396

2.35

294.01

2.2

2.3

7.51

7.05

g/l

29.57

2404

5829

All-cause Heart Failure

2775

9052

2.24

292.33

2.3

2.4

7.60

7.41

g/l

6.47

2553

8134

Osteoporosis

1519

5138

2.94

291.58

2.3

2.2

7.53

7.54

g/l

0.03

1316

4582

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4063

11377

1.95

286.47

2.2

2.4

7.36

g/l

0.01

3809

10275

Hypertensive diseases (excluding secondary)

1536

3072

3.00

285.61

2.2

2.1

7.45

6.97

g/l

18.80

1448

2837

Asthma, unspecified (mode)

2031

6064

2.50

283.61

2.1

1.9

7.55

7.23

g/l

13.24

1877

5514

Implicit viral Sepsis, including avohilmo

1523

5756

2.81

278.98

2.8

2.1

7.47

7.37

g/l

1.26

1391

5199

Dental caries

1220

3858

3.17

276.10

3.9

2.1

7.35

7.38

g/l

0.14

1134

3550

Diseases of oesophagus, stomach and duodenum

3829

11976

1.94

272.87

2.2

2.3

7.36

7.34

g/l

0.37

3490

10970

Reimbursement for rheumatic diseases

2348

10796

2.25

272.75

1.8

2.4

7.67

7.33

g/l

16.70

2197

9784

Provisional assignment of new diseases of uncertain etiology

2232

10060

2.29

270.64

2.9

2.1

7.49

7.34

g/l

3.73

2056

9144

Codes for special purposes

2234

10077

2.29

270.29

2.9

2.1

7.49

7.34

g/l

3.71

2057

9160

Diseases of arteries, arterioles and capillaries (FINNGEN)

1005

1977

3.72

268.00

2.4

2.3

7.74

7.06

g/l

21.26

943

1804

Other septicaemia, including avohilmo

1822

7140

2.52

267.97

2.9

2.0

7.57

7.29

g/l

9.37

1664

6386

Transplanted organ and tissue status

636

1431

5.05

267.92

5.8

2.2

7.05

7.35

g/l

3.84

616

1314

Opioids

3154

8001

2.09

267.15

2.5

1.9

7.39

7.19

g/l

7.56

2918

7295

Diverticular disease of intestine

2963

9063

2.11

266.60

2.5

2.3

7.42

7.39

g/l

0.40

2720

8241

Other arthritis (FG)

1327

4786

2.92

265.70

2.3

2.5

7.75

7.19

g/l

23.86

1237

4361

Other septicaemia

1787

7012

2.53

265.05

2.9

2.0

7.56

7.29

g/l

8.31

1630

6261

Certain infectious and parasitic diseases

3172

7864

2.07

261.28

2.5

1.9

7.44

7.21

g/l

10.06

2947

7115

Caries of dentine

1102

3482

3.25

260.96

3.8

2.1

7.36

g/l

0.01

1023

3212

Pain in joint

2140

5679

2.39

260.58

2.1

2.3

7.45

7.33

g/l

2.28

1953

5164

Dyspnoea

3437

13110

1.95

258.85

2.4

2.3

7.49

7.33

g/l

5.95

3153

11957

Acute tubulo-interstitial nephritis

2373

9387

2.21

257.25

2.4

2.3

7.66

7.30

g/l

18.41

2147

8450

Hypertensive diseases

2491

6446

2.24

257.15

2.1

2.3

7.48

7.04

g/l

25.85

2325

5874

Codeine or tramadol medication

3967

11700

1.89

256.83

2.2

2.3

7.49

7.29

g/l

9.09

3658

10656

Hypertension

2486

6446

2.24

255.29

2.1

2.3

7.48

7.04

g/l

26.20

2320

5874

Any gastric operation

2319

5116

2.33

253.98

2.3

1.9

7.37

7.25

g/l

2.17

2133

4687

GASTRO-related operations

2319

5116

2.33

253.98

2.3

1.9

7.37

7.25

g/l

2.17

2133

4687

Abnormalities of breathing

2948

8373

2.07

249.68

2.3

2.2

7.37

7.33

g/l

0.60

2719

7649

Other specific joint derangements/joint disorders

2447

7144

2.19

246.51

2.1

2.4

7.39

7.22

g/l

4.68

2242

6562

Polymyalgia rheumatica

900

2765

3.65

245.02

1.9

2.4

8.14

7.46

g/l

20.78

810

2467

Autoimmune diseases

3721

10142

1.91

244.38

2.1

2.5

7.35

7.31

g/l

0.86

3458

9210

Covid-19 confirmed case

1761

7595

2.44

243.67

3.0

2.2

7.56

7.38

g/l

4.23

1610

6880

Erysipelas

2289

9346

2.19

243.56

2.3

2.1

7.62

7.26

g/l

17.92

2117

8431

Other diseases of blood and blood-forming organs, wide

1149

4054

3.06

242.96

3.4

2.3

6.98

7.43

g/l

14.33

1083

3694

Pain, not elsewhere classified

1141

3985

3.01

241.80

2.7

2.1

7.38

7.28

g/l

1.10

1058

3627

Used for control exclusion in common control thyroid runs

3481

9286

1.93

238.57

2.2

2.5

7.33

7.31

g/l

0.40

3226

8439

Other heart diseases, wide

2912

8926

2.02

236.91

2.3

7.38

7.29

g/l

1.77

2720

8175

Asthma, excluding more controls

2318

5426

2.25

236.06

2.1

1.9

7.47

7.19

g/l

10.42

2158

4949

Persons encountering health services in other circumstances, wide

3993

11427

1.84

235.45

2.2

2.4

7.35

7.36

g/l

0.14

3724

10313

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

476

567

6.33

233.69

2.4

7.72

7.07

g/l

8.72

455

514

Low back pain

2732

9295

2.04

231.89

2.6

2.2

7.44

7.34

g/l

1.99

2521

8467

Oxycodone

1727

6386

2.42

229.56

4.7

2.0

7.79

7.27

g/l

22.66

1560

5771

Other specified/unspecified arthritis

1180

4333

2.87

228.69

2.2

2.4

7.76

7.25

g/l

17.47

1096

3957

Other diseases of intestines

3399

10246

1.89

223.16

2.3

2.2

7.32

7.33

g/l

0.17

3128

9373

L04AA Selective immunosuppressants

1028

3568

3.08

222.69

1.8

2.3

7.42

7.37

g/l

0.35

989

3284

Complications of surgical and medical care, not elsewhere classified

3594

13419

1.83

221.91

2.3

7.47

7.33

g/l

4.59

3300

12229

Pain in throat and chest

2748

8332

2.00

215.56

2.3

2.2

7.30

7.33

g/l

0.45

2546

7608

Cardiovascular diseases (excluding rheumatic etc)

1511

3418

2.59

215.16

2.2

2.0

7.29

6.97

g/l

8.70

1435

3168

Other disorders of fluid, electrolyte and acid-base balance

1456

5724

2.53

214.80

2.5

2.3

7.62

7.35

g/l

6.70

1322

5129

Asthma (only as main-diagnosis), excluding more controls

2123

5426

2.22

213.73

2.1

1.9

7.47

7.19

g/l

10.14

1976

4949

Type 2 diabetes, wide definition

3003

10145

1.92

211.41

2.0

2.5

7.89

7.16

g/l

86.82

2769

9219

L04AD Calcineurin inhibitors

587

1486

4.37

210.74

2.5

7.19

7.30

g/l

0.67

572

1384

Headache

2040

7470

2.16

209.46

2.1

7.32

7.29

g/l

0.33

1886

6828

Continuous positive airway pressure

836

2155

3.43

209.32

2.3

2.4

7.62

7.12

g/l

11.12

760

1974

Hypertensive heart and/or renal disease

1237

3434

2.79

209.08

2.0

2.5

7.61

7.18

g/l

12.67

1143

3046

Diabetic nephropathy, excluding more controls

844

2158

3.50

208.93

1.8

2.2

8.17

7.58

g/l

16.53

796

1953

Viral Sepsis

1050

3818

2.94

208.92

3.2

2.1

7.50

7.39

g/l

1.19

963

3449

Spondylopathies

2872

8951

1.95

208.58

2.6

2.2

7.42

7.36

g/l

0.88

2657

8131

Implicit viral Sepsis

1047

3813

2.93

207.71

3.2

2.1

7.50

7.39

g/l

1.16

960

3444

Cerebrovascular diseases (FINNGEN)

1025

2439

3.06

207.48

2.1

2.3

7.45

7.03

g/l

9.29

941

2237

Non-Hodgkin lymphoma, all, including Hilmo

765

2350

3.59

206.79

3.0

1.4

7.15

7.46

g/l

4.69

729

2105

Asthma

2445

6206

2.08

206.33

2.1

1.9

7.47

7.21

g/l

9.73

2278

5650

Symptoms and signs involving the skin and subcutaneous tissue

2689

13568

1.93

206.15

2.4

2.3

7.15

7.40

g/l

12.84

2468

12375

Asthma (mode)

2419

6256

2.08

204.99

2.1

1.9

7.45

7.22

g/l

8.16

2256

5697

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2711

12630

1.93

204.80

2.5

2.3

7.47

7.38

g/l

1.97

2496

11455

Disorders of calcium metabolism

458

988

5.34

204.18

3.9

2.4

7.47

7.30

g/l

1.02

414

904

Disorders of mineral metabolism

534

1299

4.61

203.22

3.5

2.3

7.49

7.31

g/l

1.25

484

1185

Gout, idiopatic and unspecified

1336

5572

2.57

202.58

2.1

2.4

7.73

7.35

g/l

12.06

1241

5059

Other disorders of skin and subcutaneous tissue

2828

12994

1.89

201.07

2.3

2.4

7.50

7.36

g/l

3.84

2598

11803

Enlarged lymph nodes

716

2135

3.58

199.74

2.1

2.2

7.32

7.27

g/l

0.29

681

1949

Symptoms and signs involving cognition, perception, emotional state and behaviour

3370

12791

1.80

197.86

2.1

2.4

7.30

7.36

g/l

1.15

3073

11734

Coagulation defects, purpura and other haemorrhagic conditions

948

3363

3.02

197.79

2.5

2.3

6.95

7.45

g/l

15.26

888

3063

Rheumatoid arthritis

1324

4834

2.54

197.09

1.9

2.5

7.74

7.28

g/l

15.87

1237

4377

Exposure to unspecified factor

3510

13753

1.78

196.87

2.3

7.37

7.35

g/l

0.16

3178

12601

Syncope and collapse

1675

6340

2.28

196.81

2.3

2.2

7.34

7.35

g/l

0.07

1490

5738

Follow-up examination after treatment for conditions other than malignant neoplasms

1479

4160

2.44

193.36

2.4

2.1

7.38

7.37

g/l

0.03

1365

3824

Symptoms and signs involving the urinary system

2891

12028

1.87

192.74

2.2

2.4

7.37

7.39

g/l

0.37

2613

10953

Ulcer of lower limb, not elsewhere classified

864

2987

3.17

191.24

2.4

2.2

7.91

7.44

g/l

11.25

797

2683

Disorders resulting from impaired renal tubular function

320

538

7.38

190.49

2.3

2.5

7.54

7.31

g/l

1.25

311

497

Diseases of arteries, arterioles and capillaries

2744

10976

1.90

189.92

2.2

2.4

7.69

7.36

g/l

16.63

2517

9918

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3243

11617

1.80

189.07

2.8

2.2

7.34

g/l

0.03

2995

10663

Dorsalgia

3171

9384

1.83

186.21

2.4

2.2

7.36

7.34

g/l

0.25

2923

8547

Asthma (only as main-diagnosis)

2227

6206

2.05

185.63

2.1

1.9

7.47

7.21

g/l

9.50

2068

5650

Heart failure and bmi 25plus

1506

4392

2.41

185.58

2.2

2.5

7.72

7.51

g/l

4.26

1377

3903

Preparatory care for dialysis

364

710

6.27

185.13

2.3

2.7

7.60

7.28

g/l

2.53

348

658

Small fibre neuropathy

294

471

8.03

184.84

2.6

2.3

7.05

7.32

g/l

1.63

269

430

Disturbances of skin sensation

1073

4181

2.69

184.51

2.0

2.3

6.93

7.37

g/l

15.61

995

3853

Disorders of thyroid, IBD co-morbidities

492

729

4.79

184.39

2.1

2.3

7.44

7.01

g/l

4.30

459

667

Cardiovascular diseases

1304

2721

2.59

183.22

2.1

1.9

7.25

6.99

g/l

5.40

1234

2528

Atrial fibrillation and flutter

1007

2315

2.91

182.92

2.6

2.3

7.36

7.04

g/l

5.94

946

2118

Gout, unspecified

1106

4439

2.69

182.50

2.2

2.3

7.71

7.35

g/l

9.35

1035

4019

Glomerulonephritis

564

1556

4.03

180.04

2.9

2.4

7.82

7.38

g/l

6.33

541

1432

Other CVD (FINNGEN)

565

1131

4.11

176.54

2.8

2.2

7.41

7.14

g/l

2.63

507

1011

Certain infectious and parasitic diseases, including avohilmo

2202

5522

2.04

176.07

2.4

1.9

7.44

7.21

g/l

6.84

2054

4982

Symptoms and signs concerning food and fluid intake

551

1514

3.94

174.55

2.0

2.2

7.22

7.41

g/l

1.69

509

1369

Gout, strict definition

1011

3982

2.75

173.99

2.2

2.5

7.78

7.35

g/l

11.44

941

3612

Lower back pain or/and sciatica

3629

13525

1.70

172.88

2.5

2.3

7.43

7.33

g/l

2.89

3337

12334

Non-ischemic cardiomyopathy

1472

5331

2.31

171.26

2.3

2.4

7.45

7.37

g/l

0.97

1343

4744

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1165

2928

2.57

168.59

2.4

2.2

7.21

6.98

g/l

4.16

1091

2703

Cardiac arrhythmias

1676

5059

2.17

167.59

2.4

7.26

7.06

g/l

4.72

1568

4665

Fall on same level

3575

11383

1.71

166.52

2.2

2.3

7.36

7.31

g/l

0.99

3198

10601

Other necrotizing vasculopathies (FG)

383

853

5.11

163.85

1.6

2.9

8.38

7.19

g/l

22.45

352

767

Neurological diseases, wide definition

624

820

3.91

163.22

2.1

7.22

7.01

g/l

1.67

587

755

Other pulmonary diagnosis

2367

6260

1.94

163.05

2.6

1.9

7.43

7.21

g/l

7.06

2200

5699

Osteoporosis with pathological fracture (FG)

451

1144

4.43

162.67

2.1

2.6

7.63

7.37

g/l

2.24

380

999

Extracorporeal dialysis

409

970

4.87

162.59

2.5

2.4

7.51

7.32

g/l

1.14

388

898

Secondary hypertension

375

802

5.00

162.10

2.1

2.3

7.41

7.12

g/l

2.15

358

724

Excluding asthma or asthma-COPD overlap

2362

6260

1.93

161.70

2.6

1.9

7.44

7.21

g/l

7.44

2197

5699

Endocrine, nutritional and metabolic diseases

2089

5363

2.00

159.75

2.2

2.4

7.45

7.03

g/l

20.99

1946

4925

Hyperlipidaemia, other/unspecified

1601

7023

2.14

159.75

2.3

7.61

7.33

g/l

7.88

1460

6321

Benign neoplasm of colon, rectum, anus and anal canal

2552

12263

1.82

158.35

2.4

7.41

g/l

0.05

2294

11149

Other special examinations and investigations of persons without complaint or reported diagnosis

1921

4822

2.06

158.26

2.4

2.1

7.28

7.37

g/l

1.38

1776

4431

Other dorsopathies, not elsewhere classified

3107

9391

1.75

158.02

2.3

2.2

7.31

7.34

g/l

0.48

2864

8554

Bleeding

2999

12385

1.74

157.39

2.3

2.4

7.45

7.39

g/l

1.19

2736

11267

Purpura and other haemorrhagic conditions

684

2308

3.21

156.98

2.5

2.4

6.84

7.45

g/l

15.85

641

2098

Care involving use of rehabilitation procedures

2165

10560

1.89

156.78

2.4

2.2

7.44

7.32

g/l

2.41

2077

9568

Seropositive rheumatoid arthritis

981

3940

2.60

156.77

1.9

2.6

7.69

7.25

g/l

11.72

916

3532

Complications of medical and surgical care

2641

13674

1.78

156.66

2.5

2.3

7.49

7.35

g/l

4.09

2431

12440

Diseases of the skin and subcutaneous tissue

3053

8877

1.76

156.20

2.4

2.2

7.35

7.33

g/l

0.23

2809

8075

Malignant neoplasm, including Hilmo

2713

8957

1.80

155.58

3.5

1.4

7.29

7.37

g/l

1.47

2539

8154

COPD/asthma/ILD related infections

3155

9265

1.74

155.06

2.9

1.9

7.44

7.27

g/l

6.17

2908

8432

COPD/asthma related infections

3155

9265

1.74

155.06

2.9

1.9

7.44

7.27

g/l

6.17

2908

8432

COPD differential diagnosis

2334

6258

1.91

154.40

2.6

1.9

7.44

7.22

g/l

7.05

2173

5699

ILD differential diagnosis

2332

6256

1.91

153.98

2.6

1.9

7.44

7.22

g/l

7.02

2171

5697

Other and unspecified dermatitis

1926

10197

1.95

153.90

2.2

2.3

7.34

7.38

g/l

0.53

1780

9276

Symptoms and signs involving the nervous and musculoskeletal systems

2157

11878

1.87

152.27

2.2

2.4

7.22

7.40

g/l

6.05

1990

10791

Asthma (diagnoses ohter than nonallergic)

2927

14064

1.72

151.17

2.0

2.4

7.51

7.33

g/l

6.91

2700

12814

Dermatitis

2232

12154

1.85

150.97

2.2

2.4

7.36

7.37

g/l

0.20

2060

11065

Malignant neoplasm, wide definition

2708

9011

1.79

150.92

3.6

1.4

7.29

7.37

g/l

1.26

2538

8202

Valvular heart disease excluding rheumatic fever

1745

6290

2.05

150.85

2.5

2.4

7.21

7.40

g/l

4.21

1596

5679

Constipation

3116

12681

1.70

150.64

2.7

2.3

7.31

7.39

g/l

1.53

2815

11615

Pain (limb, back, neck, head abdominally)

2219

5905

1.92

150.21

2.3

7.35

7.33

g/l

0.22

2046

5347

Malignant neoplasm

2672

8933

1.79

149.96

3.8

1.4

7.28

7.37

g/l

1.60

2503

8127

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

846

1457

2.97

149.26

2.2

1.9

7.33

7.25

g/l

0.49

792

1333

Dermatitis and eczema

3662

13497

1.64

149.10

2.2

2.3

7.33

7.36

g/l

0.61

3388

12288

Malignant neoplasm

2671

8947

1.79

148.95

3.8

1.4

7.29

7.37

g/l

1.48

2504

8139

Atrial fibrillation and flutter with reimbursement

863

1993

2.84

148.46

2.6

2.3

7.46

7.08

g/l

6.92

808

1813

Non-rheumatic valve diseases

1736

6277

2.04

148.46

2.5

2.4

7.21

7.40

g/l

4.30

1587

5667

Nephrotic syndrome

241

389

7.47

148.43

2.8

2.5

8.23

7.26

g/l

9.43

235

361

Diabetic nephropathy

851

3312

2.76

146.36

1.8

2.1

8.17

7.67

g/l

13.33

802

3026

Symptoms and signs involving the circulatory and respiratory systems

2881

8379

1.75

146.33

2.2

7.31

7.33

g/l

0.26

2674

7655

Asthma-related infections

2071

11126

1.86

144.68

2.3

7.57

7.35

g/l

7.42

1915

10086

Asthma, hospital admission 2, infections

2071

11126

1.86

144.68

2.3

7.57

7.35

g/l

7.42

1915

10086

Other necrotizing vasculopathies

447

1235

4.08

143.47

1.7

2.6

8.35

7.35

g/l

18.44

413

1122

Hypothyroidism (congenital or acquired)

482

663

4.16

142.78

2.5

1.2

7.18

6.98

g/l

1.26

459

617

Myelodysplastic syndrome, including Hilmo

262

481

6.65

142.24

2.3

1.4

6.42

7.52

g/l

17.94

245

423

Complications of procedures, not elsewhere classified

2750

13187

1.72

141.92

2.2

2.3

7.46

7.33

g/l

3.14

2530

12012

Dizziness and giddiness

2612

11922

1.75

141.34

2.1

2.4

7.32

7.38

g/l

1.00

2377

10908

Abnormalities of gait and mobility

677

2419

3.06

141.26

1.9

2.3

7.38

7.46

g/l

0.65

627

2202

Hypothyroidism, levothyroxine purchases

478

661

4.14

140.93

2.4

1.2

7.21

6.99

g/l

1.51

455

615

Hypothyroidism and >3 levothyroxin purchases

478

661

4.14

140.93

2.4

1.2

7.21

6.99

g/l

1.51

455

615

Spinal stenosis

1986

7922

1.91

140.92

2.3

7.47

7.41

g/l

0.64

1799

7155

Any reimbursement code in KELA

1299

2876

2.31

140.67

2.5

1.5

7.35

6.90

g/l

14.32

1232

2593

Soft tissue disorders

3038

9287

1.71

140.46

2.3

2.4

7.31

7.33

g/l

0.23

2807

8446

Other disorders of urethra and urinary system

2381

9455

1.79

139.03

2.2

2.3

7.51

7.34

g/l

5.00

2188

8619

Amyloidosis

220

353

7.91

137.85

7.4

2.2

7.30

7.26

g/l

0.11

212

322

Intestinal infectious diseases

3072

14035

1.66

137.83

2.9

2.2

7.47

7.33

g/l

4.31

2833

12790

Parasetamol

1947

5147

1.95

137.75

2.4

2.0

7.39

7.09

g/l

9.75

1792

4767

Amyloidosis, other/unspecified

201

296

9.00

137.48

7.8

2.2

7.31

7.23

g/l

0.24

195

269

Haemorrhage from respiratory passages

1368

5908

2.13

135.77

2.2

2.3

7.36

7.43

g/l

0.71

1257

5310

Diabetes, varying definitions

3129

11105

1.66

135.55

2.0

2.5

7.76

7.13

g/l

69.81

2877

10117

Diabetes mellitus

3139

11106

1.66

135.40

2.0

2.5

7.77

7.13

g/l

71.76

2886

10119

Heart failure and coronary heart disease

1872

7060

1.94

134.93

2.1

2.5

7.57

7.41

g/l

3.38

1731

6299

Spondylosis

1974

8489

1.87

133.86

2.2

7.42

7.38

g/l

0.49

1813

7713

Intestinal infectious diseases, including avohilmo, including avohilmo

3707

13199

1.59

133.30

2.8

2.2

7.40

7.35

g/l

1.06

3419

12021

Diseases of the musculoskeletal system and connective tissue

1325

3034

2.23

133.16

2.2

7.35

7.15

g/l

3.18

1233

2775

Gastro-oesophageal reflux disease

2318

11339

1.77

132.83

2.1

2.4

7.35

7.36

g/l

0.09

2076

10388

Disorders of other endocrine glands

1532

7774

2.00

132.19

2.3

7.35

7.39

g/l

0.42

1401

7053

Depression medications

510

676

3.87

132.11

1.7

1.2

7.22

6.96

g/l

2.10

493

630

Persons encountering health services for examination and investigation

1842

4822

1.95

131.10

2.2

2.1

7.32

7.37

g/l

0.53

1692

4431

Diarrhoea and gastroenteritis of presumed infectious origin

2294

11920

1.76

130.59

2.8

2.1

7.48

7.32

g/l

4.13

2115

10854

Type 2 diabetes

3080

10977

1.66

130.58

2.0

2.5

7.79

7.13

g/l

74.54

2830

9994

Disorders of parathyroid gland

952

4099

2.43

129.79

2.3

7.39

7.54

g/l

1.99

862

3670

Hypertensive Heart Disease

1003

3299

2.42

129.69

2.0

2.5

7.69

7.19

g/l

13.50

915

2924

Speech therapy

1094

5051

2.28

129.49

2.2

2.3

7.54

7.41

g/l

1.76

1059

4567

Chronic gastritis

1165

5522

2.21

128.85

2.2

2.4

7.40

7.45

g/l

0.43

1051

4989

ILD medications: azathioprine

507

1602

3.33

128.26

1.8

1.6

7.43

7.19

g/l

2.21

478

1469

Kidney transplant status

297

656

5.10

128.10

1.7

2.4

7.29

7.16

g/l

0.52

291

615

Rheumatoid arthritis, including avohilmo

1460

7518

2.02

127.90

1.9

2.4

7.72

7.40

g/l

9.95

1362

6774

Neoplasms

1877

5237

1.91

127.51

2.7

1.2

7.19

7.34

g/l

2.66

1762

4794

Genitourinary diseases

1538

3810

2.07

127.44

2.1

2.3

7.32

7.20

g/l

1.46

1441

3501

Hypercalcemia

325

785

4.87

127.14

4.0

2.5

7.44

7.43

g/l

0.03

298

709

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

250

488

6.23

127.08

2.5

1.4

6.72

7.55

g/l

11.29

236

428

Chronic lymphocytic leukaemia

250

488

6.23

127.08

2.5

1.4

6.72

7.55

g/l

11.29

236

428

Chronic lymphocytic leukaemia, helper endpoint

250

488

6.23

127.08

2.5

1.4

6.72

7.55

g/l

11.29

236

428

Certain disorders involving the immune mechanism

792

3211

2.61

126.66

2.7

2.2

7.25

7.37

g/l

1.14

748

2948

Other functional intestinal disorders

1600

7682

1.95

126.26

2.6

2.3

7.31

7.42

g/l

1.60

1457

6946

Myalgia

847

3534

2.49

125.76

2.2

2.3

7.26

7.33

g/l

0.67

778

3220

Bacterial pneumoniae

1524

6997

1.98

123.98

3.6

2.0

7.60

7.29

g/l

9.62

1448

6316

Other/unspecified dorsalgia

1294

6355

2.07

123.79

2.7

2.2

7.47

7.37

g/l

1.09

1182

5762

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2186

9977

1.77

123.60

2.2

2.5

7.95

7.22

g/l

67.32

1996

9007

Cardiomyopathy

751

3013

2.64

122.55

2.5

2.3

7.23

7.38

g/l

1.36

706

2713

Bacterial pneumonia, not elsewhere classified

1460

6644

2.00

122.08

3.6

2.0

7.61

7.29

g/l

9.72

1393

5995

Non-follicular lymphoma

535

1824

3.23

122.05

2.6

2.5

7.17

7.42

g/l

2.42

509

1656

Acquired haemolytic anaemia

213

373

7.09

121.96

3.3

2.2

5.88

7.45

g/l

26.28

203

339

Other diseases of urinary system

3096

10891

1.63

121.44

2.3

7.43

7.31

g/l

3.48

2853

9983

Diseases of liver

1327

6742

2.05

120.85

1.8

2.5

7.32

7.35

g/l

0.33

1190

6200

Diaphragmatic hernia

1459

7669

1.98

120.61

2.3

7.47

g/l

0.03

1317

6919

Hypertensive Renal Disease

262

551

5.47

120.54

1.9

2.7

7.41

7.23

g/l

0.88

253

493

Fracture of lumbar spine and pelvis

1028

4756

2.27

120.52

2.3

2.2

7.44

7.49

g/l

0.34

873

4250

Adjustment and management of implanted device

864

3738

2.45

120.21

2.6

2.1

7.32

7.43

g/l

1.17

804

3319

Asthma-related pneumonia

1432

7454

1.98

119.93

2.3

7.70

7.40

g/l

8.51

1337

6673

STROKE

1804

6660

1.87

119.78

2.4

2.5

7.41

7.21

g/l

5.21

1641

6057

Neurological diseases

2338

6804

1.75

119.46

2.2

2.4

7.28

7.41

g/l

3.06

2149

6249

Other antidepressants

3235

10447

1.61

119.41

2.1

2.4

7.33

7.34

g/l

0.11

2928

9603

Asthma-related pneumonia or sepsis

1432

7466

1.98

119.34

2.3

7.70

7.40

g/l

8.53

1337

6683

Asthma, hospital admissions 3, pneumonia

1432

7466

1.98

119.34

2.3

7.70

7.40

g/l

8.53

1337

6683

Nerve, nerve root and plexus disorders

3432

13350

1.57

118.71

2.2

2.3

7.39

7.35

g/l

0.64

3160

12165

Arthropathies

2468

7359

1.72

118.50

2.2

2.4

7.38

7.23

g/l

3.89

2285

6743

Benign neoplasm: Colon

2131

11810

1.75

117.78

2.4

7.42

7.43

g/l

0.09

1908

10733

Antihypertensive medication - note that there are other indications

1249

3080

2.15

117.09

2.0

2.3

7.31

6.94

g/l

9.94

1178

2847

Haemolytic anaemias

243

493

5.76

117.06

3.1

2.2

5.95

7.47

g/l

28.96

232

447

Hypothyroidism, drug reimbursement

325

512

4.57

117.03

2.3

1.2

7.31

7.01

g/l

1.97

309

471

Disorders of lens

2284

8381

1.73

115.30

2.5

2.4

7.48

7.33

g/l

3.79

2088

7758

Other disorders involving the immune mechanism, not elsewhere classified

215

396

6.34

115.12

2.3

2.4

7.46

7.21

g/l

1.14

206

371

Insulin medication

2081

10115

1.75

115.01

2.1

2.5

7.98

7.17

g/l

74.84

1923

9165

Other disorders of kidney and ureter

642

2479

2.79

114.80

2.3

2.4

7.46

7.39

g/l

0.47

615

2263

Gastrointestinal diseases

1461

3690

2.02

114.49

2.4

1.9

7.29

7.36

g/l

0.63

1351

3400

Abnormal findings on diagnostic imaging of lung

1908

10456

1.79

113.83

2.5

2.4

7.57

7.41

g/l

3.70

1746

9450

Any event in cancer register

2677

9630

1.65

113.43

3.4

1.6

7.31

7.35

g/l

0.69

2502

8802

3576

11876

1.55

113.13

3.1

2.0

7.41

7.34

g/l

1.43

3290

10786

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2902

10854

1.61

112.39

2.0

2.5

7.90

7.14

g/l

89.07

2664

9880

Use of hypnotics and sedatives

3334

12389

1.56

112.20

2.7

2.2

7.31

7.35

g/l

0.59

3047

11355

Lymphoid leukaemia

348

962

4.10

111.96

2.8

2.6

6.85

7.41

g/l

7.35

332

875

Injuries to the abdomen, lower back, lumbar spine and pelvis

1508

8068

1.90

111.65

2.4

2.2

7.42

7.40

g/l

0.08

1314

7314

Intracranial trauma

1555

5603

1.91

111.58

2.2

2.4

7.29

7.40

g/l

1.54

1404

5168

Other arrhythmias

1913

8188

1.78

111.39

2.2

2.3

7.21

7.32

g/l

2.13

1759

7478

Dorsopathies

2946

9396

1.61

110.24

2.4

2.2

7.29

7.34

g/l

0.84

2714

8558

Thrombocytopenia, unspecified

397

1206

3.63

109.63

2.1

2.4

6.60

7.43

g/l

16.95

370

1110

Other intervertebral disc disorders

2516

9189

1.66

109.61

2.3

2.2

7.33

7.34

g/l

0.20

2307

8359

Chronic lower respiratory diseases

3617

12619

1.53

109.49

2.1

2.4

7.52

7.29

g/l

11.96

3351

11507

Other joint disorders

2360

7357

1.70

108.92

2.1

2.4

7.36

7.23

g/l

3.01

2171

6741

1427

7634

1.90

107.31

2.3

7.49

7.32

g/l

3.60

1319

6944

Disorders of choroid and retina

2808

12560

1.60

106.88

2.3

2.4

7.47

7.38

g/l

1.84

2526

11468

Sicca syndrome [Sjögren]

417

1331

3.41

105.82

1.8

2.5

7.21

7.43

g/l

1.83

388

1209

Other disorders of white blood cells

317

852

4.17

105.77

2.2

2.4

7.09

7.40

g/l

2.33

293

783

Azathioprine

507

1803

2.95

104.40

1.8

2.5

7.43

7.20

g/l

2.19

478

1659

Other and unspecified diseases of blood and blood-forming organs

205

400

6.15

103.97

5.3

2.5

6.75

7.43

g/l

5.86

197

375

Abnormal weight loss

487

1718

3.08

103.95

2.0

2.4

7.21

7.43

g/l

2.03

448

1565

All influenza

938

4429

2.20

103.87

4.6

2.0

7.46

7.26

g/l

2.81

863

4006

Weight loss

508

1839

2.99

103.09

2.1

2.4

7.23

7.43

g/l

1.80

468

1672

Disorders of eyelid, lacrimal system and orbit

2833

13429

1.58

102.57

2.4

2.3

7.31

7.38

g/l

1.37

2570

12267

Gonarthrosis [arthrosis of knee](FG)

2256

7856

1.68

102.37

2.2

2.5

7.50

7.19

g/l

14.37

2081

7161

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2097

12541

1.68

102.33

2.3

7.48

7.37

g/l

2.29

1935

11381

Chronic periodontitis, including avohilmo

3173

13374

1.54

101.76

2.5

2.3

7.47

7.33

g/l

4.50

2861

12263

Presence of cardiac and vascular implants and grafts

1751

7419

1.79

101.68

1.8

2.4

7.38

7.44

g/l

0.65

1557

6731

Chronic apical periodontitis

3411

12762

1.52

101.41

2.4

2.2

7.37

7.35

g/l

0.32

3097

11685

Coxarthrosis [arthrosis of hip](FG)

1797

7133

1.78

101.32

2.2

2.6

7.47

7.21

g/l

7.93

1640

6481

Venous thromboembolism

1989

11562

1.70

101.29

2.7

2.3

7.50

7.41

g/l

1.35

1832

10435

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

194

367

6.14

100.86

2.1

2.4

7.42

7.19

g/l

0.94

186

343

Periodontitis

3170

13370

1.54

100.79

2.5

2.3

7.47

7.33

g/l

4.56

2861

12257

Cough

1333

6681

1.91

100.59

2.5

2.2

7.38

7.39

g/l

0.03

1226

6057

Other arthrosis

1712

6540

1.80

99.97

2.1

2.5

7.42

7.25

g/l

3.25

1578

5974

Unspecified haematuria

1604

7408

1.82

99.85

2.2

2.5

7.33

7.39

g/l

0.67

1467

6747

Other autoimmune haemolytic anaemias

136

187

9.90

99.30

2.6

2.3

5.67

7.49

g/l

25.18

131

170

Injuries to the head

3389

13491

1.51

99.08

2.3

7.34

7.35

g/l

0.09

3066

12380

Injuries to the hip and thigh

1821

9658

1.74

98.94

2.2

2.3

7.45

7.42

g/l

0.31

1534

8808

Dialysis

221

474

5.26

98.88

2.4

2.0

7.45

7.25

g/l

0.76

214

442

Infections of the skin and subcutaneous tissue

1844

10794

1.72

98.69

2.6

2.3

7.46

7.30

g/l

3.53

1713

9913

Hyperparathyroidism

799

3591

2.32

98.59

2.4

2.2

7.40

7.55

g/l

1.78

726

3201

Paroxysmal tachycardia

615

2013

2.62

98.58

2.0

2.2

7.19

7.05

g/l

1.12

570

1834

Bacterial pneumonia (organism specified)

1634

8505

1.79

98.58

3.8

2.1

7.60

7.36

g/l

6.40

1551

7635

Isolated proteinuria

190

361

6.14

98.47

3.0

2.6

7.70

7.26

g/l

2.20

182

333

Type 2 diabetes, definitions combined

2872

10837

1.57

98.18

2.1

2.5

7.77

7.14

g/l

63.93

2624

9859

Other medical care

1720

8395

1.77

98.16

3.4

2.2

7.64

7.40

g/l

5.70

1583

7531

Type 2 diabetes, strict (exclude DM1)

2887

10915

1.57

97.86

2.1

2.5

7.77

7.14

g/l

64.80

2639

9931

Sulfasalazine

905

4309

2.17

97.81

1.8

2.5

7.59

7.25

g/l

7.32

848

3914

General examination and investigation of persons without complaint and reported diagnosis

1662

4813

1.82

97.56

2.3

2.2

7.27

7.37

g/l

1.58

1499

4424

Viral pneumonia

544

2091

2.75

97.15

4.0

1.9

7.55

7.27

g/l

2.96

510

1893

Senile cataract

2127

7860

1.69

96.95

2.6

2.4

7.49

7.35

g/l

2.87

1938

7264

COPD (mode)

1107

4384

2.04

96.21

1.8

2.0

7.97

7.29

g/l

27.68

1001

3948

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3055

12810

1.53

95.85

2.4

2.3

7.32

7.36

g/l

0.68

2806

11709

Diabetes, insulin treatment (Kela reimbursement)

3124

12381

1.53

95.02

2.0

2.4

7.90

7.17

g/l

89.54

2876

11264

Seronegative rheumatoid arthritis

456

1619

2.98

94.87

2.2

2.8

7.72

7.24

g/l

6.07

427

1472

Benign neoplasms

2798

9855

1.57

94.85

2.3

2.2

7.23

7.35

g/l

2.84

2574

9052

Hernia of abdominal wall, postoperative

621

2539

2.52

94.84

2.4

2.1

7.43

7.29

g/l

1.24

574

2336

484

1775

2.85

94.05

2.3

7.26

7.31

g/l

0.26

448

1625

Hernia

2882

12631

1.54

93.73

2.4

2.3

7.31

7.39

g/l

1.62

2627

11515

Bronchitis

3349

13608

1.50

93.73

3.2

2.1

7.38

7.35

g/l

0.38

3091

12386

Cerebrovascular diseases

2597

11663

1.58

93.44

2.3

2.4

7.50

7.39

g/l

2.40

2323

10649

Sciatica+with lumbago

1609

8256

1.76

93.28

2.2

7.42

7.35

g/l

0.79

1483

7529

Falls/tendency to fall

2983

9808

1.55

93.15

2.2

2.4

7.33

7.31

g/l

0.21

2694

9148

Streptococcal septicaemia, including avohilmo

429

1497

3.08

92.82

4.5

2.1

7.49

7.27

g/l

1.84

391

1344

Other bacterial intestinal infections, including avohilmo

891

4321

2.15

92.45

3.5

2.1

7.44

7.39

g/l

0.28

817

3909

Symptoms and signs involving the digestive system and abdomen

2963

9758

1.54

92.21

2.2

2.3

7.30

7.37

g/l

1.36

2733

8869

Hyperkalaemia

326

977

3.67

91.92

2.4

2.2

7.73

7.35

g/l

2.95

300

870

Explicit bacterial Sepsis, including avohilmo

483

1807

2.84

91.28

4.6

2.1

7.50

7.38

g/l

0.72

441

1645

Other nutritional deficiencies

2003

11315

1.65

90.96

1.9

2.4

7.74

7.26

g/l

30.15

1850

10422

Other cataract

1581

6794

1.78

90.41

2.6

2.4

7.44

7.37

g/l

0.96

1439

6259

Hard cardiovascular diseases

2572

9818

1.58

90.12

2.3

2.4

7.45

7.32

g/l

3.08

2382

8956

Insulin, combination of fast acting with intermediate-acting or long-acting

2081

11829

1.63

89.92

2.1

2.4

7.98

7.29

g/l

56.59

1923

10748

Insulin, intermediate and long-acting

1883

11162

1.67

89.32

2.0

2.4

7.99

7.28

g/l

55.04

1738

10155

DVT of lower extremities and pulmonary embolism

1567

9169

1.75

89.13

2.8

2.3

7.48

7.43

g/l

0.55

1440

8264

Type 2 diabetes, definitions combined, including avohilmo

2821

10760

1.54

89.12

2.0

2.5

7.75

7.13

g/l

61.95

2581

9797

Other diseases of intestine

639

2757

2.44

89.11

2.4

2.3

7.46

7.39

g/l

0.45

605

2512

Arthrosis

2073

6952

1.66

89.08

2.1

2.4

7.41

7.25

g/l

4.17

1915

6352

Viral hepatitis, IBD co-morbidity

150

243

6.47

89.06

2.0

7.51

6.89

g/l

2.89

138

231

Other external causes of accidental injury

2253

7019

1.63

88.77

2.3

7.36

7.33

g/l

0.29

2039

6543

Hypo-osmolality and hyponatraemia

721

3256

2.30

88.34

2.7

2.2

7.48

7.41

g/l

0.48

648

2891

Other bacterial intestinal infections

734

3373

2.28

87.93

3.6

2.1

7.48

7.43

g/l

0.34

673

3044

Diabetes medication

3069

12094

1.50

87.20

1.9

2.4

7.87

7.15

g/l

86.86

2813

11007

Diseases of the digestive system

1650

9813

1.71

86.88

2.3

7.42

7.41

g/l

0.10

1519

8874

Other and unspecified disorders of white blood cells

241

615

4.44

86.78

2.1

2.5

7.01

7.42

g/l

3.03

226

566

SLE (Finngen)

191

404

5.30

86.77

1.7

2.4

7.21

7.35

g/l

0.49

180

371

Diseases of the respiratory system

1804

5339

1.72

86.62

2.5

1.9

7.47

7.26

g/l

4.67

1666

4840

Streptococcal septicaemia

411

1456

3.03

86.50

4.6

2.1

7.48

7.26

g/l

1.71

375

1304

Diseases of the eye and adnexa

1951

5901

1.68

86.04

2.2

2.1

7.22

7.29

g/l

0.96

1822

5486

Non-Hodgkin lymphoma, all

267

737

4.06

85.86

3.7

1.4

7.09

7.50

g/l

3.15

257

643

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3052

13295

1.49

85.40

2.6

2.2

7.39

7.34

g/l

0.85

2813

12110

Factors influencing health status and contact with health services

784

1740

2.31

85.37

2.4

1.9

7.35

7.38

g/l

0.13

724

1585

IgA nephropathy (IgA glomerulonephritis)

161

300

6.29

85.37

1.9

2.5

7.38

7.19

g/l

0.64

153

279

Pruritus

474

1816

2.76

85.30

2.1

2.3

7.25

7.47

g/l

2.28

441

1657

Peripheral artery disease

1711

8154

1.71

85.26

2.1

2.4

7.96

7.37

g/l

32.84

1566

7321

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2738

14274

1.52

85.10

2.8

2.2

7.31

7.36

g/l

0.89

2513

13050

Vasculitis limited to skin, not elsewhere classified

184

388

5.55

85.01

2.2

2.5

7.31

7.46

g/l

0.54

179

357

Other diseases of blood and blood-forming organs

348

1139

3.34

84.94

4.2

2.5

6.80

7.38

g/l

8.66

324

1050

Explicit bacterial Sepsis

463

1767

2.78

84.14

4.7

2.1

7.49

7.39

g/l

0.60

423

1610

Other retinal disorders

2265

11106

1.58

84.11

2.3

2.4

7.56

7.42

g/l

3.44

2024

10087

Concussion

1289

5572

1.82

82.82

2.1

2.4

7.28

7.40

g/l

1.70

1164

5138

Polyarthrosis

777

3337

2.18

82.76

2.3

2.6

7.65

7.37

g/l

3.88

691

3004

Accidents

2220

7019

1.61

82.39

2.2

2.3

7.36

7.33

g/l

0.25

2009

6543

Vocal cord dysfunction

372

1095

3.09

82.38

2.5

7.38

6.99

g/l

3.32

337

1020

Obesity related asthma

1161

6397

1.87

82.34

1.9

2.4

7.55

7.30

g/l

5.56

1071

5864

Other diseases of pleura

1720

9157

1.68

81.87

2.4

2.3

7.64

7.39

g/l

6.91

1576

8267

Other acute lower respiratory infections

1721

10048

1.67

81.81

3.2

2.2

7.50

7.36

g/l

2.91

1599

9114

Giant cell arteritis

264

754

3.98

81.32

1.7

2.6

8.71

7.45

g/l

16.16

238

676

Polyuria

895

4566

2.05

81.22

2.0

2.5

7.27

7.40

g/l

1.43

810

4156

Need for other prophylactic measures

285

848

3.68

81.19

2.6

2.4

7.55

7.39

g/l

0.87

280

778

Abdominal and pelvic pain

2889

9758

1.51

80.68

2.3

7.33

7.37

g/l

0.61

2671

8869

Abnormalities of heart beat

1133

6025

1.87

80.67

2.2

7.22

7.39

g/l

2.98

1029

5420

Fracture of rib(s), sternum and thoracic spine

1177

6570

1.85

80.49

2.6

2.3

7.38

7.39

g/l

0.09

1051

5979

Disorders of gallbladder, biliary tract and pancreas

3065

13122

1.48

80.21

2.3

7.45

7.34

g/l

2.68

2793

11983

Benzodiazepine use

3034

14102

1.47

79.97

2.2

2.3

7.43

7.34

g/l

2.00

2721

12939

Cystitis

2503

9819

1.54

79.73

2.3

7.43

7.33

g/l

2.11

2271

8958

Urinary track infection

1462

4172

1.79

79.55

2.2

7.51

7.35

g/l

3.01

1341

3794

Acute myeloid leukaemia and myelodysplastic syndromes

171

359

5.57

79.44

1.9

1.4

6.51

7.62

g/l

12.21

160

318

Myelodysplastic syndrome

124

195

8.10

79.41

2.1

1.3

6.25

7.68

g/l

12.68

114

171

Seropositive rheumatoid arthritis, wide

981

5203

1.96

79.16

1.9

2.4

7.69

7.44

g/l

4.37

916

4699

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1911

12127

1.61

78.82

2.2

2.4

7.47

7.38

g/l

1.54

1759

11018

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

957

5044

1.97

78.74

1.9

2.4

7.68

7.44

g/l

3.95

894

4558

Obesity and other hyperalimentation

1853

10969

1.62

78.57

1.8

2.4

7.79

7.25

g/l

34.46

1713

10103

Fibromyalgia

324

1054

3.24

78.47

2.1

7.42

7.33

g/l

0.39

305

980

Obesity

1842

10912

1.62

78.36

1.8

2.4

7.79

7.25

g/l

34.17

1704

10053

Injuries to the thorax

1610

9842

1.68

78.32

2.4

2.3

7.41

7.39

g/l

0.19

1446

8983

Other/unspecified seropositive rheumatoid arthritis

970

5155

1.96

77.81

1.9

2.4

7.69

7.45

g/l

4.21

905

4653

Sleep apnoea

2916

12608

1.48

77.77

2.0

2.4

7.40

7.34

g/l

1.27

2689

11556

Nausea and vomiting

930

4735

1.97

77.56

2.9

2.3

7.50

7.46

g/l

0.31

858

4238

Pulmonary heart disease, diseases of pulmonary circulation

1224

6989

1.81

77.53

2.5

2.3

7.51

7.42

g/l

0.93

1130

6291

Mood disorders, excluding more controls

2756

10980

1.50

76.73

2.1

2.4

7.34

7.35

g/l

0.09

2513

10113

Undetermined asthma, excluding more controls

435

1675

2.70

76.66

2.1

1.7

7.52

7.26

g/l

2.32

403

1506

Implicit fungal Sepsis, including avohilmo

344

1184

3.14

76.66

3.0

2.2

7.58

7.40

g/l

1.08

311

1080

Bacterial intestinal infections, IBD co-morbidities

729

3529

2.16

76.50

3.7

2.1

7.48

7.44

g/l

0.25

669

3192

Statin medication

1675

5687

1.68

76.42

2.1

2.5

7.47

7.02

g/l

21.03

1559

5191

Other and unspecified vasculitis limited to skin

164

344

5.57

76.27

2.3

2.4

7.30

7.47

g/l

0.56

159

313

Irritable bowel syndrome

828

4182

2.04

76.22

2.3

2.2

7.08

7.37

g/l

5.62

754

3813

Abnormal findings on examination of urine, without diagnosis

237

653

4.03

76.21

3.2

2.5

7.68

7.33

g/l

1.99

226

602

Sleep disorders (combined)

3257

11876

1.45

76.04

2.0

2.4

7.36

7.37

g/l

0.08

2971

10840

Secondary and unspecified malignant neoplasm of lymph nodes

383

1404

2.93

75.83

1.7

1.4

7.37

7.47

g/l

0.48

363

1252

Other disorders of lacrimal gland

1232

7083

1.79

75.73

2.7

2.3

7.24

7.45

g/l

4.30

1112

6447

Idiopathic gout

455

1825

2.68

75.64

2.1

2.3

7.83

7.36

g/l

6.21

417

1660

Dysphagia

940

4992

1.95

75.30

2.3

2.5

7.35

7.45

g/l

0.99

854

4517

Asthma, hospital admissions , main diagnosis only

2410

14081

1.51

75.14

2.0

2.3

7.49

7.34

g/l

4.41

2223

12837

Episodal and paroxysmal disorders

3061

10721

1.47

75.08

2.0

2.4

7.29

7.36

g/l

1.34

2797

9801

Coxarthrosis

1613

6311

1.69

75.02

2.2

2.5

7.47

7.29

g/l

3.73

1468

5743

Shoulder lesions

2239

8775

1.55

74.40

2.2

2.4

7.45

7.35

g/l

2.09

2052

7972

Gonarthrosis

1896

6725

1.62

74.35

2.1

2.5

7.50

7.26

g/l

6.96

1753

6136

Other specified/unspecified systemic involvement of connective tissue

265

798

3.61

73.97

1.8

2.7

7.39

7.37

g/l

0.04

253

725

Fracture of femur

1099

5533

1.85

73.81

2.3

2.2

7.53

7.51

g/l

0.12

878

4975

Fibrosis and cirrhosis of liver

372

1369

2.94

73.47

1.6

2.5

7.09

7.37

g/l

2.43

345

1264

Asthma, including avohilmo

3440

13463

1.42

73.43

2.1

2.4

7.45

7.33

g/l

4.10

3183

12261

Conduction disorders

1043

4568

1.89

73.19

2.2

2.3

7.40

7.43

g/l

0.15

936

4091

Ischemic heart diseases

2541

10210

1.51

72.92

2.3

2.5

7.49

7.33

g/l

4.65

2365

9263

Other disorders of veins

1368

8042

1.72

72.84

2.2

2.3

7.30

7.42

g/l

1.94

1228

7308

Postmenopausal osteoporosis with pathological fracture

356

1293

3.03

72.76

2.1

2.3

7.57

7.72

g/l

0.84

296

1157

Systemic lupus erythematosus

191

467

4.56

72.50

1.7

2.3

7.21

7.41

g/l

0.81

180

431

Depression or dysthymia

2021

7065

1.59

72.49

2.3

2.5

7.35

7.36

g/l

0.04

1822

6553

Percutaneous Coronary Intervention

2453

10031

1.51

72.08

2.1

2.5

7.48

7.33

g/l

3.66

2300

9094

Other symptoms and signs involving cognitive functions and awareness

1666

9267

1.63

71.85

2.2

2.4

7.36

7.44

g/l

1.24

1463

8397

Persons encountering health services for specific procedures, not carried out

326

1125

3.06

71.45

2.2

2.0

7.33

7.25

g/l

0.36

310

1036

Acute bronchitis

1351

7951

1.71

70.48

3.2

2.2

7.53

7.39

g/l

2.51

1254

7170

Other gastritis (incl. Duodenitis)

815

4231

2.00

70.08

2.3

2.4

7.50

7.40

g/l

0.90

737

3849

Atherosclerosis, excluding cerebral and coronary sclerosis

1584

7751

1.65

69.63

2.0

2.4

7.96

7.38

g/l

30.32

1453

6954

Emergency coronary revascularization (for ACS)

2700

11249

1.47

69.51

2.1

2.5

7.48

7.36

g/l

2.82

2523

10168

Chronic rhinitis, nasopharyngitis and pharyngitis

997

5518

1.85

69.45

2.1

2.3

7.20

7.36

g/l

2.27

911

5055

Biological medication for rheuma

522

2289

2.36

69.44

1.6

2.3

7.59

7.22

g/l

5.02

502

2146

Enterocolitis due to Clostridium difficile

470

1990

2.50

68.92

4.2

2.2

7.55

7.48

g/l

0.37

437

1797

Marginal zone B-cell lymphoma, including Hilmo

128

238

6.55

68.78

2.6

1.4

6.89

7.58

g/l

3.96

123

207

Pulmonary embolism

1101

6315

1.80

68.72

2.6

2.3

7.55

7.44

g/l

1.25

1016

5702

Osteonecrosis

302

1031

3.18

68.56

7.6

2.1

7.68

7.38

g/l

2.01

284

956

Soft tissue disorders related to use, overuse and pressure

920

4996

1.90

68.50

2.4

2.5

7.34

7.38

g/l

0.32

847

4543

Pulmonary heart disease

1101

6322

1.80

68.46

2.6

2.3

7.55

7.44

g/l

1.26

1016

5709

Diseases of oral cavity, salivary glands and jaws

1819

5921

1.61

68.21

2.3

2.1

7.36

7.44

g/l

1.23

1634

5396

Immunodeficiency with predominantly antibody defects

154

335

5.23

68.12

4.9

2.1

7.04

7.32

g/l

1.14

145

319

Solid cancers, including Hilmo

2296

8961

1.51

67.72

2.3

1.4

7.42

7.37

g/l

0.63

2132

8153

Cardiomyopathy in other diseases

14.04

67.69

7.5

2.0

7.12

7.56

g/l

0.87

Other diseases of anus and rectum

1017

5691

1.83

67.66

2.3

7.43

7.44

g/l

0.08

895

5130

Immunodeficiencies

223

638

3.82

67.51

4.4

2.3

7.09

7.31

g/l

1.05

209

594

Diffuse large B-cell lymphoma, including Hilmo

257

809

3.50

67.37

1.8

1.4

7.50

7.51

g/l

0.03

240

720

Diffuse large B-cell lymphoma

257

809

3.50

67.37

1.8

1.4

7.50

7.51

g/l

0.03

240

720

Diffuse large B-cell lymphoma, helper endpoint

257

809

3.50

67.37

1.8

1.4

7.50

7.51

g/l

0.03

240

720

Retention of urine

1266

6079

1.73

67.17

2.1

2.5

7.46

7.40

g/l

0.61

1145

5525

Coronary revascularization (ANGIO or CABG)

2427

10035

1.49

67.13

2.1

2.5

7.48

7.33

g/l

3.72

2276

9097

Disorders of lacrimal system

1427

8655

1.66

67.08

2.6

2.3

7.26

7.44

g/l

3.85

1282

7858

Temporal arteritis

223

648

3.90

66.98

1.6

2.7

8.70

7.45

g/l

14.21

200

576

Other CVD

849

4547

1.95

66.94

2.5

2.3

7.43

7.49

g/l

0.37

744

4056

Hypokalaemia

471

2018

2.45

66.86

2.6

2.2

7.62

7.36

g/l

2.41

433

1808

Asthma/COPD (KELA code 203)

2706

12617

1.45

66.41

2.1

2.4

7.50

7.29

g/l

8.54

2476

11506

Visual disturbances and blindness

1687

10845

1.59

66.30

2.3

7.29

7.41

g/l

2.39

1524

9835

Unspecified privation

421

1724

2.58

66.24

2.0

2.3

7.53

7.40

g/l

0.71

394

1581

Obesity, other/unspecified

950

5255

1.85

66.21

1.7

2.3

7.76

7.22

g/l

18.43

888

4861

Other diseases of pericardium

219

628

3.81

66.05

1.7

2.4

7.75

7.36

g/l

2.03

200

560

Chronic nephritic syndrome

201

546

4.09

66.05

2.6

7.54

7.24

g/l

1.53

193

507

Obesity due to excess calories

1328

8072

1.68

65.92

1.8

2.4

7.79

7.23

g/l

27.21

1227

7452

Lumbar disc prolapse

1822

8750

1.57

65.55

2.4

2.2

7.35

7.34

g/l

0.10

1686

7996

Insulin, fast-acting

1151

6756

1.75

65.51

1.9

2.4

7.93

7.24

g/l

32.76

1072

6167

Undetermined asthma

435

1807

2.50

65.47

2.1

1.7

7.52

7.27

g/l

2.12

403

1634

Hypotension

759

3960

2.01

64.96

2.6

2.3

7.41

7.51

g/l

0.94

658

3532

Type 1 diabetes

720

3659

2.02

64.91

1.7

2.4

7.81

7.09

g/l

20.85

680

3365

Zoster [herpes zoster], including avohilmo

1747

10990

1.57

64.59

3.0

2.3

7.37

7.42

g/l

0.53

1580

9950

Major coronary heart disease event

2592

10769

1.46

64.44

2.2

2.5

7.51

7.34

g/l

4.94

2416

9762

Other (not insulin) diabetes medications

2862

11868

1.43

64.21

1.9

2.5

7.88

7.16

g/l

82.01

2615

10793

Other diseases of liver

640

3149

2.11

64.17

2.0

2.4

7.27

7.37

g/l

0.77

583

2906

ILD, hospital admission 2, with pulmonary infections

426

1785

2.53

64.02

2.4

1.9

7.89

7.32

g/l

7.59

402

1605

Any mental disorder

3135

11218

1.42

63.85

2.1

2.4

7.36

7.35

g/l

0.10

2841

10326

Primary hyperparathyroidism

479

2123

2.40

63.59

2.6

2.4

7.31

7.54

g/l

2.32

432

1914

Sleep apnoea, including avohilmo

2948

12714

1.42

63.12

2.0

2.4

7.39

7.33

g/l

0.93

2717

11652

GI-bleeding

1179

7052

1.72

63.05

2.3

7.47

7.42

g/l

0.44

1084

6354

Viral infections characterized by skin and mucous membrane lesions

1287

7860

1.67

62.73

3.4

2.2

7.30

7.36

g/l

0.60

1195

7179

Other (seronegative) rheumatoid arthritis, wide

695

3561

2.03

62.43

2.0

2.3

7.81

7.46

g/l

5.00

644

3214

Other diseases of the digestive system

1175

7042

1.72

62.43

2.3

7.46

7.42

g/l

0.34

1076

6352

Other diseases of hard tissues of teeth

1766

5865

1.59

62.42

2.3

2.1

7.30

7.44

g/l

2.59

1582

5348

Cutaneous abscess, furuncle and carbuncle

811

4357

1.92

62.41

2.2

2.3

7.47

7.30

g/l

1.91

757

4017

SLE, strict definition

179

467

4.27

62.35

1.7

2.0

7.16

7.46

g/l

1.44

169

433

SLE, ICD10

179

467

4.27

62.35

1.7

2.0

7.16

7.46

g/l

1.44

169

433

Visual disturbances

1549

9928

1.59

62.08

2.3

7.27

7.41

g/l

2.73

1419

9039

Endocarditis

181

476

4.18

62.05

2.2

2.4

7.38

7.40

g/l

0.04

171

429

External causes of morbidity and mortality

1716

5466

1.60

61.99

2.3

7.37

7.32

g/l

0.53

1564

5083

Other abnormal findings of blood chemistry

223

680

3.56

61.13

3.0

2.4

7.24

7.34

g/l

0.35

214

628

Urticaria and erythema

1021

5905

1.77

61.12

2.2

7.31

7.36

g/l

0.45

944

5413

Cardiomyopathy, other and unspecified

319

1189

2.86

61.07

2.3

7.31

7.44

g/l

0.57

301

1068

Other dialysis

170

438

4.38

60.53

2.5

2.7

7.45

7.27

g/l

0.62

165

408

Malignant neoplasm of skin, including Hilmo

1663

7192

1.58

60.36

2.6

1.4

7.24

7.47

g/l

6.16

1508

6483

Idiopathic thrombocytopenic purpura

164

412

4.45

60.22

2.4

6.79

7.48

g/l

5.54

155

375

AV-block

686

3009

2.02

59.32

2.3

7.43

7.48

g/l

0.34

614

2657

Giant cell arteritis with polymyalgia rheumatica

223

702

3.58

59.17

1.6

2.5

8.70

7.51

g/l

13.26

200

629

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1560

6749

1.59

58.65

2.6

1.4

7.26

7.49

g/l

5.74

1409

6055

Systemic lupus erythematosus, unspecified

158

394

4.49

58.63

1.8

2.0

7.13

7.46

g/l

1.48

150

367

Anxiety disorders, excluding more controls

2258

9952

1.47

58.55

2.3

2.4

7.23

7.34

g/l

2.51

2074

9188

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

575

2823

2.14

58.54

1.5

2.4

7.05

7.34

g/l

3.42

517

2609

Cirrhosis of liver, NAS

274

971

3.08

58.50

1.6

2.6

6.90

7.38

g/l

4.53

257

894

Early onset COPD, excluding more controls

619

3102

2.06

58.45

2.1

1.9

7.87

7.17

g/l

16.47

573

2834

Chronic periodontitis, complicated

1820

11928

1.52

58.16

2.5

2.4

7.59

7.34

g/l

7.64

1658

10953

Anaemia in chronic diseases classified elsewhere

148

356

4.74

57.93

1.8

2.5

7.44

7.45

g/l

0.02

139

325

Noninfective enteritis and colitis

1338

8414

1.62

57.64

2.4

2.3

7.34

7.35

g/l

0.05

1232

7691

Other headache syndromes

1164

7069

1.67

57.20

1.9

2.5

7.19

7.37

g/l

3.30

1065

6474

Insulin, fast-acting or short human

1155

7044

1.68

56.91

1.9

2.3

7.93

7.30

g/l

28.27

1076

6426

Biguanides

2803

12182

1.41

56.91

1.9

2.4

7.90

7.17

g/l

82.06

2570

11086

Solid cancers

2199

8876

1.47

56.71

2.2

1.4

7.43

7.37

g/l

0.81

2037

8069

Unspecified fall

1608

10396

1.55

56.63

2.2

2.3

7.42

7.39

g/l

0.29

1405

9472

Volume depletion

383

1614

2.50

56.58

1.9

2.2

7.59

7.37

g/l

1.68

334

1433

Agranulocytosis

423

1865

2.39

56.50

4.1

2.3

7.05

7.47

g/l

4.75

410

1708

Iron deficiency anaemia secondary to blood loss (chronic)

602

3045

2.06

56.14

2.1

2.3

7.37

7.43

g/l

0.32

535

2743

Convulsions, not elsewhere classified

596

2954

2.04

55.65

1.8

2.2

7.51

7.22

g/l

3.28

550

2707

Ischaemic heart disease, wide definition

2408

10453

1.44

55.64

2.4

2.5

7.59

7.33

g/l

10.14

2243

9472

Mood disorders

2861

13288

1.39

55.46

2.1

2.4

7.33

7.36

g/l

0.43

2614

12159

Abnormal findings on diagnostic imaging of other body structures

542

2655

2.13

55.36

2.8

2.4

7.34

7.45

g/l

0.79

506

2412

Methotrexate

445

2014

2.30

55.26

1.9

2.5

7.62

7.30

g/l

3.43

419

1824

Mood [affective] disorders

2853

13279

1.39

55.20

2.1

2.4

7.32

7.36

g/l

0.48

2606

12151

Calcific aortic valvular stenosis, including rheumatic fever

1161

6893

1.67

54.96

2.4

2.3

7.47

g/l

0.05

1056

6144

Later onset COPD, excluding more controls

786

3282

1.89

54.91

1.7

2.0

7.92

7.34

g/l

14.91

707

2899

Calcific aortic valvular stenosis

1157

6877

1.67

54.79

2.4

2.3

7.47

7.48

g/l

0.03

1052

6130

Calcific aortic valvular stenosis, operated

1157

6877

1.67

54.79

2.4

2.3

7.47

7.48

g/l

0.03

1052

6130

Arthropathies in other diseases classified elsewhere

166

448

4.04

54.78

2.4

2.7

7.76

7.18

g/l

3.47

153

411

Operations 2 for CAVS

1156

6873

1.67

54.67

2.4

2.3

7.47

7.48

g/l

0.03

1051

6126

Calcific aortic valvular stenosis, diagnosis (helper)

1156

6873

1.67

54.67

2.4

2.3

7.47

7.48

g/l

0.03

1051

6126

Chronic ulcer of skin, not elsewhere classified

310

1210

2.74

54.48

2.1

2.2

7.74

7.40

g/l

2.66

286

1092

Gingivitis and periodontal diseases

2857

10688

1.40

54.20

2.4

2.2

7.36

7.37

g/l

0.11

2577

9763

Other and unspecified coagulation defects

205

640

3.44

53.87

2.6

2.5

7.13

7.34

g/l

0.97

195

592

Malignant neoplasm of skin

1576

6988

1.56

53.81

2.6

1.4

7.23

7.48

g/l

6.73

1425

6284

COPD

1558

8349

1.55

53.44

1.9

2.5

7.86

7.35

g/l

22.95

1418

7551

Type 1 diabetes, wide definition, subgroup 1

559

2787

2.06

53.38

1.7

2.3

7.83

7.07

g/l

18.30

523

2584

Cardiomyopathies, Primary/intrinsic

438

2008

2.28

53.05

1.9

2.3

7.26

7.38

g/l

0.68

408

1802

Symptoms and signs involving speech and voice

1089

6676

1.67

52.95

2.5

2.3

7.17

7.43

g/l

5.90

990

6060

Anxiety (asthma-related co-morbidities)

1465

7218

1.56

52.91

1.9

2.3

7.23

7.27

g/l

0.42

1352

6708

Non-allergic asthma (mode), excluding more controls

513

2465

2.12

52.85

2.0

1.8

7.49

7.27

g/l

2.33

476

2225

Other neurological diseases

2302

12693

1.43

52.80

2.2

2.4

7.30

7.42

g/l

2.72

2064

11550

Other anxiety disorders

1088

5628

1.67

52.37

1.9

2.2

7.24

7.29

g/l

0.37

1003

5225

Secondary uncertain malignant neoplasm

493

2380

2.16

52.33

1.9

1.4

7.54

7.46

g/l

0.38

460

2124

Rotator cuff syndrome

1813

8468

1.50

52.32

2.3

2.4

7.45

7.35

g/l

1.45

1658

7701

Injuries to the shoulder and upper arm

2538

14166

1.40

52.21

2.5

2.3

7.40

7.36

g/l

0.44

2274

12968

Motor neuron disease ALS

117

253

5.23

52.14

1.4

2.2

6.68

7.38

g/l

5.03

111

235

Other respiratory diseases principally affecting the interstitium

710

3895

1.90

52.09

2.4

2.3

7.83

7.42

g/l

7.94

671

3505

Diseases of pulp and periapical tissues and dental caries

2011

7069

1.48

51.92

2.2

2.3

7.41

7.40

g/l

0.14

1811

6429

Prurigo nodularis

145

373

4.40

51.88

1.7

2.8

7.42

7.45

g/l

0.06

133

340

Benign neoplasm: Colon, unspecified

937

5569

1.74

51.87

2.4

7.40

g/l

0.03

818

5055

Isolated proteinuria with specified morphological lesion

150

7.12

51.72

4.3

2.6

7.83

7.37

g/l

1.23

138

Motor neuron disease (with DMD)

117

256

5.14

51.33

1.4

2.1

6.68

7.37

g/l

4.87

111

238

Cardiomyopathy (excluding other)

448

2102

2.23

51.19

1.9

2.3

7.25

7.38

g/l

0.74

418

1889

Basal cell carcinoma, including Hilmo

1490

6612

1.56

50.94

2.6

1.4

7.28

7.50

g/l

5.01

1333

5928

Persons with potential health hazards related to communicable diseases

816

4614

1.78

50.91

2.3

2.1

7.25

7.23

g/l

0.11

788

4304

Diabetic retinopathy, excluding more controls

848

2668

1.84

50.83

1.8

2.1

7.92

7.59

g/l

5.57

778

2423

Amputation

431

2004

2.27

50.81

2.3

8.09

7.40

g/l

11.97

396

1791

Dental caries, including avohilmo

2209

7924

1.45

50.80

2.2

2.3

7.37

7.40

g/l

0.26

1991

7223

ILD, hospital admissions 3, with pneumonia sepsis

365

1587

2.44

50.68

2.3

1.9

7.94

7.29

g/l

8.36

344

1431

Mycoses, including avohilmo

2592

14406

1.39

50.24

2.3

7.33

7.35

g/l

0.23

2350

13205

Seropositive rheumatoid arthritis, strict definition

529

2665

2.07

50.03

1.7

2.3

7.81

7.43

g/l

4.83

494

2431

Nonalcoholic fatty liver disease

353

1517

2.44

49.90

1.9

2.5

7.40

7.30

g/l

0.50

326

1411

Selective serotonin reuptake inhibitors

2753

10448

1.38

49.84

2.2

2.4

7.38

7.34

g/l

0.65

2521

9604

Other coagulation defects

275

1056

2.75

49.55

2.5

2.4

7.16

7.40

g/l

1.41

258

966

Other reaction to severe stress, and adjustment disorders

845

4910

1.75

49.44

2.5

2.2

7.14

7.29

g/l

1.95

795

4562

Depression

2583

12606

1.39

49.04

2.1

2.4

7.32

7.35

g/l

0.49

2360

11567

Other disorders of skin and subcutaneous tissue, not elsewhere classified

516

2595

2.07

48.99

2.1

2.2

7.60

7.45

g/l

1.06

464

2348

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1468

6572

1.55

48.76

2.6

1.4

7.24

7.50

g/l

6.59

1324

5892

Amputation of toe

322

1351

2.55

48.75

2.2

2.4

8.04

7.40

g/l

8.26

296

1228

All anxiety disorders

1478

7593

1.53

48.65

1.9

2.3

7.23

7.30

g/l

0.87

1365

7030

Other diseases of arteries and capillaries

354

1544

2.42

48.61

2.3

2.4

7.69

7.38

g/l

2.27

323

1408

Open wound of head

1673

10753

1.49

48.55

2.2

2.3

7.40

7.38

g/l

0.19

1492

9832

Exposure to other specified factors

2206

13583

1.41

48.48

2.1

2.3

7.38

7.34

g/l

0.56

1992

12502

Other and unspecified immunodeficiencies with predominantly antibody defects

145

6.85

48.46

5.2

2.3

7.17

7.29

g/l

0.22

137

Candidiasis, including avohilmo

889

5288

1.72

48.39

2.5

2.2

7.43

7.40

g/l

0.24

799

4816

Diseases of pulp and periapical tissues, including avohilmo

2916

11168

1.37

48.23

2.2

2.3

7.41

7.35

g/l

0.95

2646

10190

Functional dyspepsia

795

4593

1.77

48.15

2.4

2.3

7.27

7.40

g/l

1.44

737

4211

Zoster [herpes zoster]

680

3769

1.87

48.05

4.0

2.3

7.29

7.46

g/l

1.94

614

3390

Fungal Sepsis

202

674

3.25

47.90

3.5

2.2

7.68

7.34

g/l

1.87

187

620

Tumor necrosis factor alpha inhibitors

426

2003

2.19

47.90

1.5

2.3

7.55

7.24

g/l

3.30

407

1879

Other noninfective gastroenteritis and colitis

755

4307

1.80

47.75

2.7

2.3

7.41

7.43

g/l

0.11

695

3907

Pericarditis

161

467

3.74

47.75

1.9

2.2

7.94

7.38

g/l

3.13

148

421

Other diseases of upper respiratory tract

3136

12257

1.35

47.71

2.3

7.30

7.40

g/l

2.78

2873

11158

Trochanteric bursitis

487

2421

2.09

47.56

2.2

2.4

7.46

7.47

g/l

0.04

442

2194

Covid-19 suspected case

562

2928

1.97

47.48

2.5

2.2

7.28

7.26

g/l

0.07

533

2711

Abnormal involuntary movements

472

2327

2.11

47.35

2.2

2.3

7.15

7.42

g/l

3.27

428

2129

Disorder of lipoprotein metabolism, unspecified

478

2370

2.10

47.31

1.9

2.3

7.75

7.36

g/l

5.03

439

2124

Subjective visual disturbances

803

4681

1.76

47.30

2.4

2.3

7.20

7.42

g/l

3.20

738

4273

Sequelae of external causes of morbidity and mortality

856

5091

1.73

46.99

2.3

2.4

7.55

7.40

g/l

1.84

809

4636

Pleural effusion

612

3312

1.93

46.98

2.6

2.3

7.72

7.41

g/l

3.79

575

2986

Osteomyelitis

267

1043

2.73

46.82

2.4

2.2

7.99

7.35

g/l

5.97

247

968

Urticaria

779

4506

1.77

46.76

2.2

7.26

7.36

g/l

0.95

717

4145

Peripheral artery operations in Hilmo

504

2567

2.05

46.30

2.4

2.3

7.98

7.35

g/l

12.29

460

2305

Caries of dentine, including avohilmo

2314

8497

1.41

46.25

2.2

2.3

7.37

7.39

g/l

0.19

2087

7753

Deforming dorsopathies

782

4548

1.76

46.09

2.4

2.2

7.35

7.41

g/l

0.52

711

4131

Neurotic, stress-related and somatoform disorders

2322

11606

1.39

45.99

2.2

2.3

7.21

7.35

g/l

4.20

2136

10665

Stroke, including SAH

2067

10594

1.42

45.96

2.3

2.4

7.49

7.42

g/l

1.11

1853

9642

Psychiatric diseases

2708

9998

1.37

45.91

2.2

2.4

7.37

7.35

g/l

0.22

2455

9236

Type 1 diabetes, wide definition

574

3043

1.93

45.85

1.7

2.3

7.82

7.10

g/l

17.12

537

2807

Non-invasive ventilation

582

2652

1.93

45.80

3.1

2.4

7.56

7.11

g/l

8.03

542

2434

Conjunctivitis

1984

11347

1.42

45.65

2.3

7.21

7.38

g/l

4.40

1815

10383

Other and unspecified types of non-Hodgkin lymphoma, hilmo

206

718

3.14

45.51

3.0

2.6

7.10

7.43

g/l

1.82

193

652

Coronary atherosclerosis

2010

8992

1.43

45.39

2.4

2.5

7.66

7.37

g/l

10.72

1866

8107

Anxiety disorders

2346

11730

1.39

45.19

2.2

2.3

7.21

7.36

g/l

4.16

2156

10773

ILD, hospital admissions

601

3280

1.91

45.07

2.4

2.3

7.83

7.42

g/l

6.74

570

2964

Disorders of continuity of bone

319

1370

2.43

45.02

3.9

2.1

7.36

7.34

g/l

0.07

294

1273

Stroke, excluding SAH

1995

10265

1.43

44.94

2.3

2.4

7.49

7.42

g/l

0.92

1785

9333

Substance abuse, excluding more controls

1522

8644

1.49

44.87

1.6

2.4

7.54

7.29

g/l

6.49

1361

8025

Presence of other functional implants

1892

9133

1.44

44.82

2.3

7.50

7.44

g/l

0.91

1699

8300

Lichen simplex chronicus and prurigo

256

1001

2.72

44.77

1.9

2.6

7.48

7.37

g/l

0.46

236

912

Injury, poisoning and certain other consequences of external causes

1338

4346

1.56

44.68

2.3

7.40

7.28

g/l

1.58

1225

4027

Acute upper respiratory infections of multiple and unspecified sites

2075

10865

1.41

44.33

3.4

2.1

7.28

7.36

g/l

1.43

1922

9932

Acute upper respiratory infections

2972

13458

1.34

44.25

3.1

2.1

7.33

7.38

g/l

1.10

2735

12239

Implicit fungal Sepsis

186

620

3.26

44.24

3.7

2.2

7.66

7.31

g/l

1.80

171

570

Injuries to the knee and lower leg

3285

13572

1.32

44.18

2.0

2.4

7.41

7.34

g/l

1.34

2988

12425

Other interstitial pulmonary diseases

605

3329

1.90

44.17

2.4

2.3

7.84

7.42

g/l

7.06

574

3004

Disorders of conjunctiva

2242

12657

1.39

44.16

2.3

7.23

7.37

g/l

3.89

2052

11579

Other chronic obstructive pulmonary disease

1464

8132

1.51

43.98

1.8

2.5

7.88

7.35

g/l

22.91

1332

7358

Spondylopathies (FG)

347

1555

2.30

43.97

1.8

2.6

7.42

7.10

g/l

2.82

332

1433

Dental operations

1884

6779

1.45

43.89

2.3

2.1

7.37

7.41

g/l

0.33

1697

6175

Other inflammation of eyelid, including avohilmo

1136

7337

1.57

43.84

2.6

2.3

7.11

7.35

g/l

5.40

1029

6760

Interstitial lung disease endpoints

605

3337

1.89

43.83

2.4

2.3

7.84

7.42

g/l

6.96

574

3012

Interstitial lung disease

605

3337

1.89

43.83

2.4

2.3

7.84

7.42

g/l

6.96

574

3012

Fitting and adjustment of other devices

1216

7014

1.56

43.73

2.4

2.2

7.43

g/l

0.02

1075

6255

Chronic sinusitis

1179

7681

1.56

43.64

2.5

2.3

7.29

7.36

g/l

0.80

1097

7045

Rare circulating lymphoid malignancy, including Hilmo

138

385

3.93

43.59

4.6

1.4

7.15

7.46

g/l

1.41

132

342

Major coronary heart disease event excluding revascularizations

1932

9066

1.43

43.45

2.2

2.5

7.68

7.38

g/l

11.15

1769

8163

Artrosis, including avohilmo

2243

8887

1.40

43.43

2.1

2.5

7.36

7.28

g/l

1.32

2049

8177

L01XX Other antineoplastic agents

273

1124

2.62

43.37

3.4

2.5

6.69

7.45

g/l

13.35

255

1028

Meniscus derangement

1479

6629

1.50

43.36

2.2

2.5

7.34

7.26

g/l

1.16

1357

6061

Secondary right heart disease

207

744

3.03

43.21

1.9

2.4

7.13

7.51

g/l

2.71

194

678

Basal cell carcinoma

1409

6449

1.52

43.18

2.6

1.4

7.28

7.50

g/l

5.02

1266

5777

Diabetic neuropathy

467

2374

2.07

43.11

2.0

2.1

7.85

7.72

g/l

0.92

436

2168

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1365

8800

1.51

43.00

2.1

2.2

7.21

7.39

g/l

3.77

1242

8059

Gastroduodenal ulcer

879

5370

1.68

42.96

2.1

2.4

7.45

7.42

g/l

0.22

803

4859

Ischaemic Stroke, excluding all haemorrhages

1896

9949

1.43

42.92

2.3

2.4

7.51

7.44

g/l

1.04

1695

9023

Cholelithiasis, broad definition with cholecystitis

2530

12522

1.36

42.90

2.4

7.45

7.36

g/l

1.92

2304

11409

Pacemaker

1313

8185

1.53

42.85

2.1

2.3

7.26

7.48

g/l

4.65

1170

7336

Psoriatic and enteropathic arthropathies

325

1437

2.34

42.70

1.8

2.6

7.62

7.10

g/l

5.91

307

1327

Drug-induced osteoporosis with pathological fracture

115

291

4.63

42.69

1.7

2.6

7.76

7.58

g/l

0.43

264

Cellulitis

689

3968

1.78

42.44

3.0

2.3

7.53

7.35

g/l

2.00

644

3636

Fracture of shoulder and upper arm

1118

7254

1.57

42.40

2.7

2.3

7.46

7.42

g/l

0.32

979

6584

L04AC Interleukin inhibitors

211

766

2.89

42.33

1.6

2.3

7.57

7.23

g/l

1.84

203

718

Rash and other nonspecific skin eruption

336

1519

2.31

42.28

2.4

2.3

7.22

7.46

g/l

1.88

317

1385

Other symptoms and signs involving the nervous and musculoskeletal systems

1179

7758

1.55

42.04

2.2

2.4

7.13

7.39

g/l

6.45

1093

7079

Special screening examination for infectious and parasitic diseases

457

1647

2.05

41.87

2.4

2.2

6.94

7.11

g/l

1.35

416

1570

Asthma and allergy, excluding more controls

257

1013

2.56

41.82

2.0

1.5

7.12

g/l

0.01

237

934

Missing teeth due to accident, extraction or parodontitis

1956

12631

1.41

41.79

2.3

2.4

7.48

7.39

g/l

1.40

1697

11605

Spondyloarthritis

518

2747

1.94

41.71

2.2

2.3

7.65

7.34

g/l

3.59

493

2502

Adverse effects, not elsewhere classified

534

2863

1.91

41.54

2.3

7.24

7.38

g/l

1.12

509

2646

Voice disturbances

829

5054

1.68

41.38

2.7

2.3

7.10

7.42

g/l

7.63

764

4611

Overexertion and strenuous or repetitive movements

325

1462

2.32

41.31

2.6

2.4

7.52

7.30

g/l

1.22

296

1358

Non-allergic asthma (mode)

513

2694

1.93

41.17

2.0

1.9

7.49

7.29

g/l

2.13

476

2433

Eosinophilic disease (BM)

149

5.94

41.04

2.5

1.6

7.31

7.12

g/l

0.36

138

Allergic conjunctivitis

1409

9284

1.48

40.72

2.0

2.3

7.21

7.37

g/l

3.34

1283

8517

Viral pneumonia (unknown virus, not influenza)

243

969

2.64

40.63

3.4

2.4

7.57

7.36

g/l

1.05

230

893

Other disorders of bone

528

2842

1.91

40.59

3.7

2.0

7.38

7.30

g/l

0.44

486

2648

Open wound of lower leg

494

2608

1.96

40.59

2.0

2.3

7.51

7.41

g/l

0.59

446

2374

Rheumatism, unspecified

411

2038

2.09

40.49

2.2

2.5

7.44

7.47

g/l

0.14

384

1837

Allergic asthma (mode), excluding more controls

471

2375

1.97

40.33

1.9

1.7

7.32

7.15

g/l

1.20

440

2179

Superficial injury of head

758

4540

1.71

40.22

2.1

2.3

7.57

7.43

g/l

1.26

677

4113

Reactive arthropathies, FINNGEN

213

798

2.79

40.15

2.3

2.7

7.32

7.05

g/l

1.49

193

731

Other infectious diseases, including avohilmo

334

1541

2.27

40.11

2.5

2.3

7.76

7.41

g/l

2.98

316

1411

Other abnormalities of plasma proteins

230

4.89

39.81

5.1

2.7

7.42

7.33

g/l

0.16

208

Complications of internal orthopaedic prosthetic devices, implants and grafts

797

4869

1.69

39.76

2.1

2.3

7.59

7.46

g/l

1.32

718

4355

Need for immunization against other single viral diseases

100

238

4.71

39.60

3.1

2.4

7.37

7.21

g/l

0.41

221

Diseases of the myoneural junction and muscle

441

2273

2.02

39.27

1.7

2.3

7.34

7.43

g/l

0.49

383

2063

Cholelithiasis

2418

12370

1.35

39.13

2.4

2.3

7.44

7.36

g/l

1.43

2199

11260

ILD, hospital admissions 1, main diag only

534

2941

1.90

39.03

2.4

7.85

7.43

g/l

5.93

505

2659

Myeloproliferative diseases

328

1531

2.26

38.55

2.7

2.4

6.80

7.46

g/l

11.57

300

1393

Somatoform disorder

462

2431

1.96

38.21

2.4

2.3

7.21

7.40

g/l

1.92

421

2245

Hypothyroidism, strict autoimmune

1825

8604

1.41

38.19

2.1

2.5

7.39

7.33

g/l

0.85

1663

7774

All influenza (not pneumonia)

415

2106

2.03

38.13

4.6

1.9

7.34

7.21

g/l

0.83

382

1929

Other pulmonary heart/vessel disease

214

837

2.76

37.86

1.9

2.4

7.14

7.50

g/l

2.55

199

763

Migraine without aura

401

2009

2.03

37.78

2.2

7.11

7.23

g/l

0.81

379

1878

Hypoparathyroidism

172

602

3.11

37.74

1.8

2.3

7.45

7.55

g/l

0.29

151

548

Paralytic ileus and intestinal obstruction

797

4920

1.66

37.65

2.9

2.3

7.47

7.44

g/l

0.25

733

4445

Acute sinusitis

1291

8022

1.48

37.45

3.4

2.1

7.30

7.32

g/l

0.15

1192

7375

Phlebitis and thrombophlebitis (not including DVT)

698

4183

1.71

37.31

2.9

2.3

7.35

7.43

g/l

0.57

643

3812

Pain in thoracic spine

424

2184

1.99

37.31

2.8

2.2

7.21

7.38

g/l

1.26

398

1985

DVT of lower extremities

627

3655

1.77

37.27

3.1

2.3

7.36

7.42

g/l

0.41

570

3317

Injuries to the elbow and forearm

1935

12170

1.38

37.21

2.1

2.3

7.39

7.36

g/l

0.26

1729

11141

Asthma and allergy

257

1071

2.42

37.11

2.0

1.5

7.12

7.15

g/l

0.09

237

982

Other degenerative diseases of the nervous system

847

3839

1.64

36.97

1.9

2.4

7.31

7.51

g/l

2.67

744

3496

Diseases of spleen

243

4.53

36.86

2.0

2.1

6.79

7.36

g/l

2.21

224

Papulosquamous disorders

1149

7742

1.51

36.81

2.2

2.4

7.49

7.36

g/l

1.94

1064

7091

In situ neoplasms

1253

8595

1.49

36.76

2.4

2.3

7.38

7.45

g/l

0.75

1137

7746

Gastric ulcer

603

3492

1.78

36.70

2.1

2.4

7.45

7.43

g/l

0.14

545

3154

Hypocalcemia

123

359

3.81

36.67

4.6

2.6

7.50

7.44

g/l

0.12

109

336

Myocardial infarction

1559

7708

1.44

36.64

2.1

2.5

7.71

7.38

g/l

10.76

1417

6924

Coxibs

768

2402

1.71

36.58

2.1

2.3

7.42

7.28

g/l

1.20

700

2197

Other chronic obstructive pulmonary disease, including avohilmo

1757

10476

1.40

36.39

1.8

2.5

7.83

7.36

g/l

22.01

1595

9528

Haemorrhage, not elsewhere classified

162

557

3.11

36.33

2.8

2.4

7.19

7.52

g/l

1.76

152

502

Benign neoplasm of other and ill-defined parts of digestive system

610

3566

1.77

36.09

2.2

2.4

7.32

7.46

g/l

1.26

561

3240

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

501

2763

1.87

36.08

1.9

1.4

7.42

7.44

g/l

0.05

474

2494

Nonorganic sleeping disorders, excluding more controls

496

2714

1.87

36.06

1.7

2.3

7.14

7.30

g/l

1.42

460

2533

Other inflammation of eyelid

468

2528

1.91

35.99

3.0

2.3

7.19

7.45

g/l

2.61

409

2313

Other general symptoms and signs

149

482

3.19

35.95

1.4

2.5

7.29

7.35

g/l

0.15

138

445

Abnormal serum enzyme levels

987

6257

1.56

35.79

2.2

2.4

7.32

7.28

g/l

0.35

922

5734

Charcot foot

231

4.54

35.72

2.3

2.9

7.93

7.09

g/l

3.67

209

Myeloproliferative diseases (CML excluded)

299

1388

2.28

35.71

2.8

2.4

6.82

7.44

g/l

9.49

273

1265

Personality disorders, excluding more controls

531

2967

1.82

35.59

1.7

2.3

7.23

7.21

g/l

0.08

494

2793

Other diseases of lip and oral mucosa

1199

8202

1.49

35.55

2.6

2.4

7.29

7.39

g/l

1.17

1083

7517

Disorders of synovium and tendon

1360

8031

1.45

35.53

1.9

2.4

7.41

7.33

g/l

0.95

1243

7325

Other symptoms and signs involving the urinary system

367

1847

2.07

35.03

2.5

2.4

7.36

7.34

g/l

0.07

351

1678

Atopic dermatitis

1329

7343

1.46

34.89

1.8

2.3

7.23

7.30

g/l

0.78

1218

6777

Adalimumab

264

1168

2.34

34.76

1.4

2.4

7.50

7.25

g/l

1.53

253

1097

Superficial injury of lower leg

708

4333

1.67

34.65

1.9

2.3

7.41

7.37

g/l

0.21

634

3958

Other viral diseases, including avohilmo

841

5302

1.59

34.59

3.3

2.1

7.24

7.28

g/l

0.21

809

4921

Systemic atrophies primarily affecting the central nervous system

186

710

2.82

34.54

1.6

2.6

6.97

7.36

g/l

2.78

175

648

Intracranial injury

1637

11061

1.40

34.41

2.2

2.3

7.30

7.38

g/l

1.31

1461

10088

Polyarthritis, unspecified

142

468

3.24

34.28

2.6

2.5

7.93

7.22

g/l

3.98

136

428

Budesonide

374

1902

2.02

34.19

2.0

2.4

7.30

7.23

g/l

0.28

342

1740

Other extrapyramidal and movement disorders in other diseases

788

4979

1.62

34.19

2.2

2.3

7.18

7.44

g/l

4.50

712

4536

Phobic anxiety disorders

263

1162

2.31

34.17

2.1

7.22

7.20

g/l

0.06

250

1095

Acetic acid derivatives and related substances

763

2390

1.68

34.12

2.1

2.3

7.44

7.28

g/l

1.64

696

2185

Reactive arthropathies

253

1110

2.36

34.08

2.1

2.5

7.36

7.23

g/l

0.57

228

1026

Allergic asthma (mode)

471

2514

1.86

33.98

1.9

1.7

7.32

7.19

g/l

0.85

440

2309

Disorders of sclera, cornea, iris and ciliary body

1511

10861

1.41

33.97

2.3

7.41

7.36

g/l

0.57

1402

9920

Valvular operations

451

2454

1.90

33.87

1.6

2.3

6.91

7.41

g/l

7.78

412

2195

Recurrent or chronic depression

936

4203

1.57

33.82

2.1

2.4

7.20

7.29

g/l

0.83

859

3953

Other peripheral vascular diseases

281

1296

2.27

33.81

1.9

2.3

7.20

7.36

g/l

0.73

259

1191

Bipolar affective disorders

422

2240

1.92

33.80

1.9

2.3

7.27

7.25

g/l

0.08

396

2096

Peripheral arterial reconstruction

634

3817

1.72

33.77

2.1

2.3

8.11

7.40

g/l

17.96

583

3421

Other disorders of eye and adnexa

416

2214

1.94

33.40

1.9

2.3

7.31

7.40

g/l

0.46

392

2037

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

292

1374

2.21

33.31

3.5

2.3

7.56

7.38

g/l

1.14

273

1259

Other and unspecified effects of external causes

671

4090

1.67

33.30

2.2

7.23

7.33

g/l

0.91

632

3777

Stomatitis and related lesions

566

3310

1.75

33.11

2.6

2.3

7.37

7.39

g/l

0.10

525

3032

Other enthesopathies

771

4870

1.61

33.06

2.0

2.4

7.29

7.33

g/l

0.27

703

4463

Etanercept

199

796

2.61

33.02

1.5

2.3

7.65

7.30

g/l

1.92

193

746

1579

10237

1.40

32.83

1.6

2.4

7.43

7.29

g/l

2.71

1423

9472

Cervicalgia

581

3433

1.73

32.66

2.2

2.3

7.27

7.42

g/l

1.23

528

3122

Mycoses

811

5210

1.59

32.59

2.9

2.4

7.47

7.36

g/l

1.09

748

4759

Alcohol use disorder, Swedish definition

1506

9880

1.40

32.56

1.7

2.4

7.42

7.29

g/l

2.36

1356

9145

Persons encountering health services in other circumstances

1026

6844

1.50

32.48

2.3

7.29

7.36

g/l

0.65

959

6178

Other viral diseases

665

4054

1.66

32.44

3.6

2.1

7.27

7.28

g/l

0.06

641

3759

Localized swelling, mass and lump of skin and subcutaneous tissue

898

5914

1.55

32.17

2.3

2.4

7.26

7.41

g/l

1.80

824

5388

1638

10437

1.38

32.09

1.6

2.4

7.42

7.29

g/l

2.49

1478

9662

Any death

1992

10498

1.35

31.76

3.0

2.3

7.69

7.35

g/l

12.57

1800

9577

Other metabolic disorders

348

1775

2.01

31.62

3.5

2.2

7.28

7.27

g/l

0.05

333

1626

Degeneration of macula and posterior pole

1639

9285

1.39

31.61

2.3

2.4

7.50

7.47

g/l

0.30

1442

8364

Extrapyramidal and movement disorders

1216

8540

1.45

31.59

2.1

2.4

7.18

7.45

g/l

7.36

1090

7749

Psoriasis

801

5174

1.58

31.43

1.9

2.4

7.61

7.32

g/l

5.30

745

4756

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

919

6115

1.53

31.36

2.3

7.31

7.41

g/l

0.96

846

5585

Pyogenic arthritis

222

957

2.42

31.36

2.9

2.5

7.65

7.25

g/l

2.23

209

873

Disease of hard tissues of teeth, NOS

1512

5666

1.42

31.30

2.2

2.1

7.32

7.43

g/l

1.47

1369

5176

Raynaud syndrome

270

1265

2.22

31.14

1.6

2.5

6.80

7.36

g/l

6.14

251

1167

Fracture of lower leg, including ankle

1510

10809

1.39

31.01

2.0

2.4

7.53

7.36

g/l

3.42

1363

9883

Metatarsalgia

282

1346

2.17

30.89

2.3

7.24

7.36

g/l

0.54

258

1238

Superficial injury of hip and thigh

493

2836

1.79

30.74

2.0

2.3

7.45

7.49

g/l

0.17

430

2579

Viral pneumonia (known virus, not influenza)

129

431

3.25

30.74

6.6

2.6

7.24

7.38

g/l

0.37

120

390

Noninfectious colitis NAS

405

2199

1.90

30.62

2.6

2.2

7.45

g/l

0.02

378

2009

Sequelae with surgical and medical care as external cause

655

4070

1.65

30.62

2.1

2.3

7.58

7.44

g/l

1.30

616

3695

Sequelae of cerebrovascular disease

1227

7394

1.45

30.50

2.1

2.3

7.50

7.41

g/l

1.04

1060

6694

Hypertrophic cardiomyopathy

174

687

2.71

30.23

2.6

2.7

7.18

7.39

g/l

0.72

164

633

Systemic sclerosis (FG)

279

3.81

30.08

1.9

3.0

7.14

7.04

g/l

0.24

255

Sub-endpoint used in defining T1D endpoints

760

4813

1.58

30.06

1.7

2.2

7.82

7.31

g/l

12.16

714

4392

Disorders of muscles

298

1467

2.10

30.05

1.7

2.2

7.31

7.32

g/l

0.01

279

1352

Non-selective monoamine reuptake inhibitors

1046

6904

1.48

30.02

2.3

2.5

7.50

7.38

g/l

1.52

954

6288

Postprocedural endocrine and metabolic disorders, not elsewhere classified

322

1629

2.03

30.00

3.5

2.2

7.30

7.27

g/l

0.07

307

1490

Gonarthrosis,primary

2662

12623

1.29

29.84

2.1

2.4

7.49

7.36

g/l

3.85

2419

11502

Myocardial infarction, strict

1438

7367

1.41

29.82

2.1

2.5

7.74

7.38

g/l

12.36

1310

6617

Other complications of surgical and medical care, not elsewhere classified

305

1525

2.07

29.61

2.4

2.3

7.47

7.37

g/l

0.46

281

1399

Decubitus ulcer and pressure area

246

1139

2.27

29.59

1.8

2.3

8.03

7.51

g/l

4.16

217

1023

Elevated blood glucose level

266

1267

2.18

29.48

2.0

2.2

7.81

7.35

g/l

3.70

238

1163

Enthesopathies of lower limb, excluding foot

584

3553

1.68

29.35

2.4

2.2

7.29

7.32

g/l

0.16

534

3250

Myocardial infarction, without ST-elevation

1358

8876

1.41

29.20

2.1

2.4

7.70

7.41

g/l

7.85

1225

7987

Essential (haemorrhagic) thrombocythaemia

153

576

2.84

29.19

2.5

1.4

6.77

7.50

g/l

6.24

137

512

Other pleural conditions

384

2094

1.91

29.07

2.9

2.3

7.60

7.38

g/l

1.59

354

1876

Vascular disorders of the intestines

261

1246

2.19

28.94

2.4

2.1

7.66

7.50

g/l

0.77

244

1110

Carpal tunnel syndrome

1683

10912

1.35

28.81

2.3

2.4

7.48

7.36

g/l

2.39

1567

9939

Other enthesopathy of foot (+metatarsalgia)

293

1457

2.07

28.75

2.3

7.24

7.36

g/l

0.61

267

1339

Nonischemic cardiomyopathy

344

1814

1.97

28.70

2.3

7.20

7.31

g/l

0.56

323

1634

Mental and behavioural disorders due to psychoactive substance use

1567

10640

1.36

28.69

1.7

2.4

7.53

7.27

g/l

7.71

1402

9827

Other infectious diseases

268

1297

2.16

28.66

2.6

2.3

7.82

7.42

g/l

3.08

253

1185

COPD, early/later onset

1480

9144

1.38

28.46

1.8

2.4

7.87

7.36

g/l

22.54

1345

8288

Other skin changes

628

3936

1.64

28.33

3.2

2.3

7.27

7.47

g/l

2.34

562

3573

Neuromuscular dysfunction of bladder

298

1505

2.06

28.25

2.1

2.5

7.16

7.29

g/l

0.76

277

1374

Progressive vascular leukoencephalopathy

191

816

2.52

28.23

2.2

2.4

7.56

7.62

g/l

0.18

165

731

Cervical disc disorders

972

6682

1.48

28.21

2.4

2.2

7.31

7.38

g/l

0.61

884

6107

Other hammer toe(s) (acquired)

510

2749

1.73

28.17

2.0

2.6

7.60

7.41

g/l

1.57

443

2459

Migraine with aura

507

2999

1.72

28.13

1.7

2.4

6.98

7.30

g/l

4.40

471

2781

Disorders of the thyroid gland

2515

12842

1.28

28.12

2.2

2.4

7.38

7.35

g/l

0.25

2301

11734

Other and unspecified acquired haemolytic anaemias

142

5.26

28.12

3.0

1.7

5.61

7.32

g/l

11.31

132

Substance abuse

1522

10473

1.37

28.10

1.6

2.4

7.54

7.27

g/l

7.81

1361

9680

Diseases of external ear

1016

7056

1.47

28.02

2.3

7.39

7.37

g/l

0.09

869

6463

Other or unspecified ileus, impaction or obstruction

561

3425

1.68

28.00

2.8

2.2

7.45

7.41

g/l

0.22

519

3092

Recurrent aphthous stomatitis , including avohilmo

422

2386

1.82

28.00

2.6

2.3

7.34

7.46

g/l

0.77

391

2180

Migraine

1071

5791

1.45

27.94

2.0

2.4

7.12

7.33

g/l

4.41

994

5357

Psoriatic arthropathies

273

1338

2.10

27.89

1.9

2.5

7.71

7.19

g/l

5.03

255

1239

COPD related to multimorbidity

1321

8103

1.40

27.87

1.8

2.4

7.88

7.36

g/l

20.73

1194

7336

Generalized anxiety disorder

318

1636

1.98

27.86

1.8

2.2

7.13

7.24

g/l

0.54

295

1527

Special screening examination for other diseases and disorders

300

1517

2.02

27.85

2.6

2.3

7.57

7.36

g/l

1.27

283

1400

Oxicams

655

2306

1.64

27.62

2.4

7.22

7.29

g/l

0.44

589

2104

Substance use, excluding alcohol

480

2822

1.74

27.51

1.6

2.3

7.70

7.24

g/l

7.51

417

2649

Conjunctivitis (acute, non atopic), including avohilmo

2668

12788

1.27

27.50

2.3

7.26

7.39

g/l

3.27

2459

11697

Panic disorder

300

1523

2.01

27.49

1.7

2.3

7.39

7.27

g/l

0.62

278

1425

5-aminosalicylic acid

464

2710

1.74

27.15

1.9

2.4

7.24

7.18

g/l

0.32

433

2493

COPD, hospital admissions

1456

9077

1.37

27.11

1.8

2.4

7.87

7.36

g/l

22.51

1324

8229

Diabetic maculopathy, excluding more controls

322

1693

1.96

27.03

1.5

2.4

8.14

7.15

g/l

18.82

299

1547

Angina pectoris

1691

8446

1.35

26.92

2.4

2.5

7.56

7.38

g/l

4.24

1574

7605

Injuries to unspecified part of trunk, limb or body region

321

1690

1.97

26.90

2.1

2.4

7.42

7.39

g/l

0.11

290

1548

Inflammatory bowel disease

781

5188

1.53

26.88

2.1

2.3

7.28

7.30

g/l

0.08

723

4791

Diseases of salivary glands

874

5944

1.50

26.88

2.3

7.31

7.38

g/l

0.61

794

5444

Injuries to the ankle and foot

1731

11209

1.33

26.83

2.2

2.3

7.36

7.30

g/l

0.81

1599

10345

Other disorders of ear

2539

13010

1.27

26.81

2.3

7.28

7.39

g/l

2.50

2288

11937

Spondylolisthesis/Spondylolysis

500

2999

1.71

26.75

2.6

2.3

7.37

7.42

g/l

0.29

459

2731

Protozoal diseases

130

473

2.97

26.66

6.3

2.6

7.48

7.34

g/l

0.40

124

436

Oter anti-inflammatory and antirheumatic agents, non-steroids

652

2237

1.63

26.61

2.4

7.50

7.30

g/l

1.99

587

2035

Hydronephrosis

338

1818

1.92

26.46

1.9

2.1

7.68

7.36

g/l

2.70

315

1646

Mixed connective tissue disease

223

3.98

26.30

1.9

2.5

7.09

7.38

g/l

0.94

206

Disorders of skin appendages

1183

8475

1.40

26.29

2.2

2.3

7.32

7.31

g/l

0.04

1104

7797

Paracetamol or NSAID medication

340

877

1.98

26.20

2.4

1.8

7.29

7.13

g/l

0.85

314

820

Unspecified acute lower respiratory infection

433

2513

1.77

26.20

3.2

2.2

7.43

7.33

g/l

0.59

408

2303

Sequelae of other external causes

195

862

2.37

26.17

2.8

2.6

7.39

7.36

g/l

0.10

188

791

Cerebral palsy and other paralytic syndromes

328

1755

1.93

26.11

2.2

2.3

7.30

7.39

g/l

0.44

303

1614

Heart failure and hypertrophic cardiomyopathy

304

3.55

26.08

3.0

2.6

7.35

7.36

g/l

0.01

276

Fracture of forearm

1474

9869

1.36

26.07

2.1

2.4

7.39

7.41

g/l

0.21

1306

8975

Restless leg syndrome

436

2549

1.76

25.86

2.0

2.3

7.15

7.46

g/l

3.51

392

2336

Caries of enamel

2452

12727

1.27

25.77

2.7

2.3

7.25

7.35

g/l

2.10

2244

11724

Use of pramipexole

685

4485

1.56

25.63

1.9

2.3

7.29

7.46

g/l

1.80

601

4061

Collagenous colitis

297

1551

1.99

25.62

2.9

2.4

7.49

7.42

g/l

0.24

273

1416

Disorders of adult personality and behaviour

572

3580

1.62

25.56

1.8

2.2

7.19

7.23

g/l

0.18

534

3359

Fissure and fistula of anal and rectal regions

614

3919

1.60

25.42

2.3

7.31

7.33

g/l

0.12

558

3590

Atopic dermatitis, strict definition with reimbursement

557

3324

1.63

25.42

1.9

2.1

7.07

7.27

g/l

2.20

512

3092

Eosinophilia

221

3.95

25.18

2.5

2.3

7.31

7.38

g/l

0.14

206

Crystal arthropathies, rheuma endpoint

289

3.52

25.17

1.6

3.1

8.11

7.18

g/l

3.89

257

Protozoal diseases, including avohilmo

131

494

2.85

25.08

6.2

2.7

7.48

7.34

g/l

0.43

125

456

Cardiodefibrillation

1159

8404

1.40

24.88

2.3

2.4

7.21

7.44

g/l

4.90

1075

7607

Other symptoms and signs involving the circulatory and respiratory systems

201

917

2.27

24.85

2.5

2.3

7.21

7.45

g/l

1.21

181

828

Conjunctivitis (acute, non atopic)

679

4434

1.55

24.81

2.8

2.2

7.26

7.38

g/l

1.10

629

4082

Other and unspecified urticaria

475

2870

1.69

24.66

2.2

7.30

7.38

g/l

0.53

433

2645

Other encephalitis

106

359

3.16

24.60

1.9

2.6

7.29

7.35

g/l

0.11

335

Coxarthrosis, primary

1873

12083

1.30

24.57

2.2

2.4

7.49

7.43

g/l

0.76

1686

10929

Hallux valgus (acquired)

822

3980

1.50

24.50

2.2

2.5

7.52

7.32

g/l

2.73

734

3607

Benign neoplasm: Transverse colon

385

2217

1.80

24.43

2.7

2.4

7.39

7.41

g/l

0.09

345

2022

Other embolism and thrombosis

391

2257

1.78

24.31

2.8

2.2

7.44

g/l

0.02

367

2045

Malignant neoplasm of urinary organs, including Hilmo

370

2105

1.82

24.29

2.0

1.4

7.87

7.47

g/l

3.44

341

1876

Other and unspecified drugs and medicaments

265

1357

2.03

24.22

3.4

2.4

7.54

7.39

g/l

0.79

248

1241

Faecal incontinence

305

1638

1.93

24.19

1.7

2.4

7.47

7.54

g/l

0.28

278

1462

Other disorders of glucose regulation and pancreatic internal secretion

248

1240

2.07

24.17

1.9

2.3

7.70

7.39

g/l

1.94

224

1134

Ankylosing spondylitis

232

1132

2.11

24.08

1.7

2.2

7.41

7.28

g/l

0.49

223

1046

Bullous disorders

216

1033

2.20

24.08

1.9

2.5

7.24

7.44

g/l

1.15

205

942

Amputation of foot

121

449

2.93

24.04

2.4

2.6

8.15

7.32

g/l

4.54

112

408

Other/unspecified reactive arthropathies

198

912

2.26

24.04

2.3

2.4

7.34

7.31

g/l

0.08

180

849

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

327

1804

1.88

23.84

1.9

1.4

7.91

7.49

g/l

3.11

301

1608

Other disorders of eyelid

1365

9650

1.35

23.76

2.1

2.4

7.45

7.46

g/l

0.15

1235

8726

Benign neoplasm of other and unspecified endocrine glands

403

2363

1.76

23.75

2.5

2.3

7.39

7.43

g/l

0.16

363

2176

Migraine without aura and triptan purchases

304

1630

1.90

23.72

1.6

2.0

7.09

7.27

g/l

1.31

288

1517

Open wound of ankle and foot

292

1556

1.93

23.57

2.4

2.3

7.77

7.34

g/l

3.76

268

1442

Other respiratory disorders and diseases

657

4343

1.55

23.56

2.0

2.3

7.63

7.41

g/l

2.38

589

3917

Other diseases of the respiratory system

657

4343

1.55

23.56

2.0

2.3

7.63

7.41

g/l

2.38

589

3917

Hyperplasia of prostate

1065

4268

1.43

23.54

2.5

7.14

7.34

g/l

3.14

982

3960

Mixed and other personality disorders

185

834

2.28

23.45

1.7

2.1

7.21

7.20

g/l

0.02

178

788

KRA_PSY_EATING, excluding more controls

119

430

2.79

23.42

1.8

7.14

7.18

g/l

0.08

113

406

Benign neoplasm: Sigmoid colon

620

4058

1.57

23.39

2.5

2.3

7.54

7.42

g/l

0.98

565

3687

Encephalitis

109

386

3.01

23.35

1.9

2.5

7.30

7.35

g/l

0.11

360

Thyroiditis, ILD-related definition

286

1517

1.93

23.33

2.3

2.4

7.43

7.38

g/l

0.15

261

1387

Sarcoidosis

385

2241

1.77

23.27

1.9

2.3

7.25

7.38

g/l

0.79

362

2067

Other specified and unspecified disorders of eye and adnexa

139

559

2.63

23.21

2.3

2.4

7.17

7.34

g/l

0.60

131

515

Chronic pancreatitis

388

2270

1.76

23.10

1.8

2.4

7.38

7.32

g/l

0.26

356

2090

Diabetic retinopathy

1093

4893

1.42

23.03

1.8

2.1

7.88

7.75

g/l

1.61

993

4496

Cramp and spasm

152

638

2.50

23.02

2.6

2.3

7.07

7.33

g/l

1.22

140

594

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1449

9994

1.33

22.99

2.0

2.3

7.18

7.32

g/l

2.47

1344

9213

Pneumonia derived septicemia

128

497

2.73

22.98

6.3

2.4

7.49

7.33

g/l

0.50

112

455

Fracture of foot, except ankle

595

3860

1.57

22.96

2.5

2.2

7.30

7.34

g/l

0.24

547

3575

Herpesviral [herpes simplex] infections, including avohilmo

590

3820

1.57

22.94

2.8

2.2

7.26

7.34

g/l

0.57

547

3509

Nonorganic sleeping disorders

496

3085

1.64

22.93

1.7

2.2

7.14

7.30

g/l

1.42

460

2861

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

531

3314

1.60

22.73

1.9

2.2

7.43

7.25

g/l

1.67

484

3106

Pneumococcal septicemia

123

471

2.77

22.72

6.2

2.5

7.49

7.30

g/l

0.58

108

432

Exclusions for E4_PCOS_BROAD

427

2564

1.70

22.72

2.9

2.3

7.29

7.33

g/l

0.17

398

2373

Ulcerative colitis

602

3927

1.56

22.70

2.2

2.3

7.31

7.32

g/l

0.07

556

3627

Radiculopathy

462

2841

1.66

22.59

2.5

2.2

7.29

7.44

g/l

1.20

425

2565

Haemorrhoids and perianal venous thrombosis

918

6467

1.43

22.50

2.4

2.3

7.31

7.43

g/l

1.32

834

5841

Diseases of inner ear

1569

11563

1.31

22.39

2.0

2.4

7.40

7.42

g/l

0.10

1412

10494

Transient ischemic attack

1615

9923

1.31

22.35

2.2

2.4

7.37

7.44

g/l

0.92

1444

8995

Ascites

253

1314

2.00

22.31

1.5

2.4

6.73

7.49

g/l

9.17

234

1197

Vitamin B12 deficiency anaemia

334

1893

1.82

22.24

2.1

2.4

7.39

7.44

g/l

0.17

305

1711

Idiopathic urticaria

238

3.54

22.22

1.3

2.0

7.08

7.36

g/l

0.78

227

Primary biliary cholangitis, wide definition

300

3.26

22.21

1.5

2.3

7.59

7.33

g/l

0.76

275

Carcinoma in situ of skin of other and unspecified parts of face

342

1964

1.82

22.11

2.2

2.4

7.52

7.56

g/l

0.17

316

1750

Other crystal arthropathies

313

3.24

22.10

1.6

2.4

8.11

7.26

g/l

3.34

278

Diagnoses used for exclusion with ILD

749

5147

1.48

22.09

2.3

7.44

7.38

g/l

0.50

683

4677

Chronic tubulo-interstitial nephritis

127

500

2.67

22.08

2.2

2.1

7.44

7.38

g/l

0.15

116

455

Disorders of vestibular function (Vertigo)

1366

10084

1.34

22.06

2.1

2.4

7.41

7.43

g/l

0.16

1225

9121

Abnormality of white blood cells, not elsewhere classified

115

5.04

21.86

2.2

2.1

6.99

7.33

g/l

0.59

108

Amiodarone users

350

2027

1.79

21.85

2.1

2.4

7.25

7.39

g/l

0.82

333

1843

Disorders of vitreous body and globe

1533

11172

1.31

21.85

2.4

7.30

7.43

g/l

2.44

1398

10169

Scoliosis

213

1044

2.10

21.84

2.4

2.2

7.22

7.46

g/l

1.35

190

944

Respiratory insufficiency

252

1310

1.98

21.82

1.7

7.51

7.27

g/l

1.47

221

1170

Vitreous haemorrhage

321

1811

1.83

21.77

2.1

2.4

7.66

7.46

g/l

1.24

300

1660

Retinal detachments and breaks

1076

7901

1.38

21.71

2.6

2.4

7.30

7.41

g/l

1.23

978

7191

Autoimmune hepatitis, wide definition

139

575

2.52

21.69

1.7

2.6

7.53

7.23

g/l

1.08

129

519

Systemic sclerosis

343

3.07

21.60

1.9

2.2

7.14

7.40

g/l

0.94

315

Cyst of kidney

256

1353

1.98

21.59

2.4

2.5

7.47

7.42

g/l

0.18

242

1238

Psoriasis vulgaris

507

3227

1.61

21.50

1.8

2.3

7.63

7.31

g/l

3.81

470

2986

Persistent mood disorders

485

3052

1.62

21.48

2.1

2.3

7.41

7.39

g/l

0.10

449

2796

Other and unspecified myopathies

296

1640

1.87

21.40

1.8

2.3

7.43

7.45

g/l

0.05

249

1487

Barrett oesophagus

180

841

2.25

21.34

2.3

2.7

7.52

7.40

g/l

0.40

164

776

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1317

9609

1.34

21.31

2.3

7.16

7.35

g/l

4.07

1211

8833

COPD, hospital admission 2, with asthma infections

1030

6467

1.40

21.30

1.9

2.4

7.94

7.35

g/l

20.34

933

5860

Cutaneous lupus erythematosus

100

358

3.01

21.19

2.1

7.27

7.46

g/l

0.50

328

Other diseases of pancreas

283

1553

1.89

21.13

2.2

2.4

7.37

7.38

g/l

0.03

259

1425

Congenital malformations, deformations and chromosomal abnormalities

1267

9040

1.34

21.11

2.0

2.3

7.18

7.30

g/l

1.77

1181

8338

Vasomotor and allergic rhinitis

802

5487

1.44

21.00

2.3

2.2

7.07

7.32

g/l

4.36

731

5055

1363

9360

1.33

20.90

2.8

2.3

7.33

7.50

g/l

2.99

1213

8395

Suppurative and necrotic conditions of lower respiratory tract

195

949

2.15

20.77

2.7

2.4

7.95

7.32

g/l

4.21

183

867

Iridocyclitis

601

4001

1.53

20.76

2.4

2.3

7.53

7.38

g/l

1.38

558

3657

Personality disorders

531

3436

1.57

20.69

1.7

2.1

7.23

g/l

0.02

494

3219

Special screening examination for neoplasms

186

887

2.17

20.63

2.8

2.2

7.26

7.32

g/l

0.16

168

821

Disorders of vitreous body

1487

10949

1.31

20.57

2.4

7.29

7.43

g/l

2.72

1356

9972

Misadventures to patients during surgical and medical care

420

2590

1.66

20.43

2.1

2.2

7.61

7.41

g/l

1.47

384

2354

Candidiasis

388

2343

1.70

20.43

3.1

2.2

7.57

7.42

g/l

0.91

353

2143

COPD, hospital admissions 3, with asthma pneumonia sepsis

894

5502

1.42

20.35

1.9

2.4

7.98

7.37

g/l

19.09

812

4958

Problems related to lifestyle

242

1272

1.95

20.30

1.5

2.4

7.51

7.24

g/l

1.45

226

1168

Agoraphobia

215

3.47

20.30

1.8

7.28

7.13

g/l

0.27

206

Demyelinating diseases of the central nervous system

200

986

2.09

20.24

1.6

2.1

6.90

7.29

g/l

2.99

188

921

Heartburn

307

1743

1.81

20.21

2.1

2.3

7.16

7.42

g/l

1.79

274

1585

Folate deficiency anaemia

168

4.10

20.12

2.7

1.9

7.18

7.41

g/l

0.43

152

Pyothorax

154

693

2.34

20.06

3.0

2.6

7.87

7.30

g/l

2.72

143

635

Abnormal results of function studies

252

1352

1.92

20.06

2.4

2.5

7.19

7.33

g/l

0.71

233

1252

Other viral diseases, not elsewhere classified, including avohilmo

562

3684

1.54

20.05

3.1

2.2

7.31

7.29

g/l

0.06

538

3408

Skin changes due to chronic exposure to nonionizing radiation

1306

9034

1.33

19.98

2.9

2.3

7.33

7.50

g/l

3.17

1164

8090

Other and unspecified local infections of skin and subcutaneous tissue

281

1562

1.85

19.97

3.2

2.4

7.46

7.35

g/l

0.48

258

1435

Actinic keratosis

1281

8883

1.33

19.96

2.9

2.3

7.32

7.51

g/l

3.34

1140

7952

Benign neoplasm: Stomach

321

1862

1.79

19.92

2.5

2.4

7.39

7.48

g/l

0.44

293

1697

Fall on and from stairs and steps

715

4967

1.46

19.92

2.2

2.3

7.51

7.41

g/l

0.81

638

4540

Lesion of ulnar nerve

382

2314

1.69

19.91

2.1

2.2

7.46

7.30

g/l

0.99

361

2146

Fibroblastic disorders

639

4345

1.50

19.90

2.3

2.4

7.33

7.36

g/l

0.22

584

3945

Dilated cardiomyopathy

380

2307

1.70

19.87

1.9

2.4

7.28

7.35

g/l

0.30

354

2111

Allergic urticaria

206

1034

2.05

19.87

2.2

2.4

7.31

7.33

g/l

0.07

191

954

Other local infections of skin and subcutaneous tissue

295

1666

1.82

19.87

3.1

2.4

7.44

7.35

g/l

0.38

267

1527

Intestinal stricture

925

6728

1.40

19.86

2.8

2.3

7.45

7.42

g/l

0.19

845

6084

Traumatic subdural haemorrhage

417

2412

1.66

19.84

2.3

7.18

7.57

g/l

5.21

362

2188

Other shoulder lesions

241

1277

1.94

19.82

1.5

2.3

7.40

7.31

g/l

0.33

224

1180

Diseases of the ear and mastoid process

2838

11748

1.22

19.71

2.3

7.28

7.36

g/l

1.48

2592

10809

Mixed hyperlipidaemia

135

579

2.45

19.61

1.5

2.2

8.00

7.20

g/l

5.44

124

530

Other diseases of stomach and duodenum

214

1099

2.02

19.58

2.2

2.5

7.68

7.51

g/l

0.74

201

1002

Herpesviral [herpes simplex] infections

312

1798

1.78

19.55

3.2

2.3

7.44

7.36

g/l

0.39

295

1650

Primary gonarthrosis, bilateral

1565

10260

1.29

19.49

2.0

2.5

7.61

7.39

g/l

5.80

1409

9292

Primary biliary cholangitis (PBC)

292

3.12

19.37

1.7

2.0

7.60

7.38

g/l

0.56

268

Bronchiectasis

274

1533

1.86

19.32

2.8

2.5

7.69

7.43

g/l

1.65

255

1374

Intestinal malabsorption

150

677

2.32

19.31

2.0

2.5

7.16

7.29

g/l

0.47

141

621

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

297

1698

1.80

19.29

2.9

2.5

7.52

7.40

g/l

0.56

280

1562

Memory loss

317

1851

1.78

19.29

2.1

2.4

7.23

7.48

g/l

1.92

278

1687

Congenital malformations of the urinary system

156

716

2.26

19.16

2.0

2.5

7.35

7.31

g/l

0.09

149

665

Delirium, not induced by alcohol and other psychoactive substances

431

2716

1.63

19.16

2.1

2.3

7.54

7.44

g/l

0.53

379

2440

Acute pancreatitis

554

3692

1.53

19.15

2.0

2.3

7.52

7.34

g/l

1.54

512

3374

Congenital malformations of the urinary system, including avohilmo

165

775

2.21

19.12

2.0

2.5

7.32

7.33

g/l

0.03

157

721

Mucosal proctocolitis

296

1692

1.79

19.00

2.2

2.4

7.30

7.25

g/l

0.17

285

1580

Diseases of male genital organs

1252

4748

1.34

18.97

2.2

2.4

7.15

7.30

g/l

2.07

1170

4421

Adhesive capsulitis of shoulder

441

2800

1.61

18.96

2.0

2.4

7.71

7.37

g/l

3.25

404

2555

Internal derangement of knee

847

6045

1.40

18.91

2.2

2.5

7.41

7.22

g/l

2.45

756

5545

Migraine with aura and triptan purchases

289

1639

1.79

18.91

1.6

2.0

7.01

7.30

g/l

2.31

275

1515

Other inflammatory liver diseases

198

1002

2.05

18.87

1.8

2.6

7.56

7.32

g/l

1.08

178

920

Juvenile arthritis (FINNGEN)

304

2.94

18.81

1.9

2.2

7.31

7.03

g/l

0.78

286

Oesophageal varices

145

655

2.33

18.76

1.6

2.4

6.95

7.37

g/l

2.01

133

601

Thyrotoxicosis, other and/or unspecified

506

3322

1.55

18.69

2.0

2.3

7.44

7.43

g/l

0.08

466

3036

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

413

2569

1.63

18.66

2.4

1.4

7.33

7.56

g/l

1.98

371

2259

Transport accidents

1018

6278

1.36

18.61

1.9

2.3

7.25

7.33

g/l

0.73

938

5866

Carcinoma in situ of skin of scalp and neck

131

574

2.46

18.55

2.1

2.6

7.37

7.47

g/l

0.31

120

516

Thoracic aortic aneurysm

457

2949

1.59

18.55

2.4

2.5

7.07

7.25

g/l

1.47

411

2718

Pain associated with micturition

337

2016

1.71

18.50

2.5

2.3

7.21

7.44

g/l

1.92

302

1839

Viral hepatitis, including avohilmo

175

850

2.12

18.49

2.3

2.1

7.52

7.21

g/l

1.35

161

799

Fracture of skull and facial bones

543

3630

1.52

18.40

2.9

2.3

7.23

7.32

g/l

0.62

489

3359

Injury of unspecified body region

230

1236

1.92

18.32

1.8

2.5

7.42

7.39

g/l

0.09

204

1129

Alcoholic liver disease

305

1784

1.76

18.32

1.3

2.4

7.12

7.33

g/l

1.13

258

1658

Other viral hepatitis, including avohilmo

148

676

2.25

18.30

2.4

2.1

7.53

7.18

g/l

1.37

138

643

Hypoglycaemia, other or unspecified

191

964

2.05

18.28

1.7

2.3

7.73

7.39

g/l

1.79

174

883

Familial hypercholesterolemia

439

2813

1.60

18.27

2.5

2.3

7.70

7.38

g/l

3.82

393

2506

Mental and behavioural disorders due to alcohol

1289

9475

1.31

18.15

1.6

2.4

7.49

7.28

g/l

4.41

1164

8778

Other/unspecified rheumatoid arthritis

380

2360

1.66

18.14

1.9

2.3

7.82

7.52

g/l

2.26

345

2121

Artificial joint operation, meniscal resection

2533

13412

1.22

18.12

2.2

2.4

7.50

7.35

g/l

4.39

2306

12238

Unspecified nephritic syndrome

315

2.96

18.09

2.1

2.4

7.75

7.33

g/l

1.31

292

Guillain-Barre syndrome

214

3.45

18.08

3.1

2.1

7.27

7.29

g/l

0.04

199

Thyrotoxicosis

646

4486

1.46

18.08

1.9

2.3

7.48

7.43

g/l

0.26

589

4082

Dermatitis due to substances taken internally

155

727

2.21

18.07

4.2

2.6

7.39

7.43

g/l

0.10

145

668

Atopic dermatitis, strict definition

517

3350

1.53

17.99

1.9

2.1

7.06

7.23

g/l

1.69

481

3139

Hypothyroidism, other/unspecified

2238

12046

1.23

17.91

2.2

2.4

7.36

g/l

0.07

2046

10991

Epilepsy

765

5461

1.41

17.91

2.0

2.5

7.33

7.38

g/l

0.32

684

4996

Personal history of malignant neoplasm

242

1331

1.87

17.88

2.5

2.0

7.67

7.50

g/l

0.68

222

1218

Chronic laryngitis and laryngotracheitis

395

2482

1.63

17.85

1.9

2.2

7.50

7.43

g/l

0.35

347

2262

Other viral hepatitis

142

645

2.27

17.82

2.3

2.0

7.52

7.16

g/l

1.41

132

612

Other viral diseases, not elsewhere classified

411

2594

1.61

17.78

3.4

2.2

7.39

7.31

g/l

0.35

395

2395

Acute posthaemorrhagic anaemia

117

493

2.49

17.72

3.0

2.6

7.40

7.54

g/l

0.40

102

443

Benign neoplasm: Ascending colon

463

3031

1.57

17.69

2.3

2.4

7.39

7.45

g/l

0.37

419

2748

Viral hepatitis

168

818

2.11

17.67

2.2

2.1

7.50

7.19

g/l

1.31

154

768

Fenamates

378

1576

1.66

17.64

2.2

2.3

7.41

7.28

g/l

0.78

344

1429

therapeutic use

124

541

2.44

17.57

2.0

2.5

7.44

7.42

g/l

0.03

103

491

Systemic sclerosis, icd10

378

2.75

17.54

2.0

2.1

7.16

7.45

g/l

1.10

350

Hypermobility syndrome

108

438

2.54

17.50

2.1

1.9

7.19

7.30

g/l

0.28

103

421

Exclusions for E4_PCOS_CONSORTIUM

1572

7739

1.28

17.45

2.2

7.45

7.39

g/l

0.67

1421

7056

Hernia of abdominal wall

1245

9641

1.31

17.38

2.4

7.46

7.35

g/l

1.49

1156

8814

Early onset COPD

619

4303

1.47

17.37

2.1

2.5

7.87

7.26

g/l

13.36

573

3945

Ocular pain

221

1193

1.90

17.29

1.6

2.5

7.34

g/l

0.02

208

1094

Insulin, fast-acting (human)

307

1822

1.72

17.23

1.7

2.1

7.81

7.20

g/l

7.38

288

1694

Poisoning by drugs, medicaments and biological substances

481

3177

1.53

17.20

2.0

2.2

7.58

7.25

g/l

3.94

440

2963

Diplopia

376

2359

1.63

17.16

2.1

2.3

7.32

7.42

g/l

0.59

346

2167

Alcohol induced polyneuropathy

143

4.05

17.16

1.4

2.0

7.02

7.25

g/l

0.43

130

COPD-related respiratory insufficiency

394

2506

1.62

17.12

2.0

2.5

7.96

7.35

g/l

8.48

352

2247

Neuralgia and neuritis, unspecified

148

698

2.20

17.05

2.4

7.25

7.36

g/l

0.34

133

646

Spirochaetal infections, other/unspecified

268

1544

1.79

17.05

2.4

7.01

7.37

g/l

3.07

228

1419

Ankylosing spondylitis, ICD10

221

1199

1.90

17.04

1.7

2.4

7.42

7.28

g/l

0.53

212

1119

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

392

2409

1.61

17.00

1.8

2.3

7.15

7.34

g/l

1.35

365

2225

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

364

2194

1.64

16.99

1.8

2.4

7.11

7.34

g/l

1.62

340

2031

Other and unspecified visual disturbances

301

1790

1.73

16.98

2.4

2.3

7.35

7.42

g/l

0.29

281

1645

Allergic rhinitis

572

3873

1.47

16.88

2.4

2.1

7.04

7.29

g/l

3.08

524

3601

Intestinal adhesions without obstruction

253

1437

1.81

16.85

3.8

2.2

7.42

7.44

g/l

0.09

228

1304

Inflammatory diseases of the central nervous system

226

1240

1.88

16.85

2.8

2.5

7.41

7.36

g/l

0.14

201

1142

Sequelae of injuries, of poisoning and of other consequences of external causes

583

4027

1.47

16.81

2.6

2.3

7.41

7.30

g/l

0.78

530

3729

Hypothyreosis and Thyroxine purchase for inclusion criteria

2333

12644

1.22

16.81

2.2

2.3

7.38

7.36

g/l

0.14

2130

11528

Other lack of coordination

229

3.25

16.80

2.0

2.7

7.09

7.30

g/l

0.50

208

Other specified/unspecified bacterial intestinal infections

204

1087

1.95

16.79

3.1

2.4

7.50

7.40

g/l

0.34

184

999

Other disorders of the musculoskeletal system and connective tissue

432

2816

1.57

16.74

2.5

2.3

7.49

7.43

g/l

0.33

406

2577

Vitamin deficiency

145

685

2.20

16.69

2.3

2.4

7.25

7.30

g/l

0.12

130

627

Vitamin deficiency, wide

145

685

2.20

16.69

2.3

2.4

7.25

7.30

g/l

0.12

130

627

Malignant neoplasm of kidney, except renal pelvis

273

1591

1.77

16.67

1.9

1.4

7.91

7.48

g/l

2.83

251

1418

Biomechanical lesions, not elsewhere classified

168

841

2.09

16.67

2.3

2.5

7.46

7.40

g/l

0.17

159

772

Other/unspecified enthesopathies of lower limb, excluding foot

181

928

2.00

16.53

2.3

2.1

7.20

7.34

g/l

0.52

168

854

Social phobias

137

630

2.21

16.53

1.9

7.16

7.21

g/l

0.11

132

599

Poisoning by medicine

434

2831

1.55

16.48

2.0

2.2

7.56

7.24

g/l

3.51

399

2648

Keratitis

884

6575

1.36

16.43

2.2

2.3

7.40

7.34

g/l

0.47

815

6020

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1123

8563

1.31

16.41

1.6

2.4

7.51

7.26

g/l

5.08

1011

7933

Nummular dermatitis

247

1406

1.81

16.37

2.4

2.5

7.32

7.40

g/l

0.34

227

1285

Cervicobrachial syndrome

504

3401

1.50

16.33

2.2

7.18

7.36

g/l

1.67

476

3099

Dermatophytosis, including avohilmo

1647

13000

1.25

16.33

2.3

7.28

7.34

g/l

0.73

1488

11937

Acute nephritic syndrome

276

2.98

16.31

2.3

2.5

7.57

7.24

g/l

0.88

254

Other disorders of bladder

359

2259

1.63

16.27

2.2

2.4

7.31

7.34

g/l

0.11

324

2049

Speech disturbances, not elsewhere classified

283

1678

1.74

16.26

1.9

2.4

7.34

7.47

g/l

0.62

247

1528

Malignant neoplasm of urinary organs

295

1769

1.72

16.22

1.8

1.4

7.93

7.50

g/l

2.90

273

1571

Cystic kidney disease

102

423

2.54

16.07

2.0

2.5

7.41

7.30

g/l

0.26

391

Other and unspecified mood [affective] disorders

135

626

2.20

16.05

1.8

2.1

7.26

7.24

g/l

0.03

127

586

Olecranon bursitis

184

962

1.98

16.03

2.6

2.3

7.28

7.31

g/l

0.08

168

892

Other and unspecified nerve root and plexus disorders, also in other diseases

518

3532

1.49

16.02

2.5

2.4

7.27

7.31

g/l

0.29

471

3262

Other diseases of oesophagus

281

1668

1.73

16.01

2.3

2.5

7.42

7.43

g/l

0.02

262

1522

Benign neoplasm: Rectum, anus and anal canal

613

4325

1.45

15.98

2.3

2.4

7.40

7.42

g/l

0.11

558

3929

Cholecystectomy

1904

13238

1.23

15.97

2.3

7.42

7.39

g/l

0.30

1740

12023

Fentanyl

292

1748

1.71

15.92

5.5

1.8

7.74

7.39

g/l

2.64

255

1555

Drug-induced polyneuropathy

123

4.19

15.84

15.1

1.5

6.89

7.54

g/l

2.05

116

Myocarditis

106

447

2.44

15.83

2.6

2.1

6.87

6.99

g/l

0.32

100

404

Benign neoplasm: Caecum

355

2250

1.63

15.76

2.8

2.4

7.44

7.45

g/l

0.04

328

2050

Lesion of lateral popliteal nerve

145

701

2.15

15.76

2.4

2.3

7.16

7.28

g/l

0.36

131

651

Invasive ventilation

221

1233

1.85

15.74

2.5

2.4

7.85

7.39

g/l

2.92

205

1130

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

734

5262

1.39

15.71

2.1

2.2

7.29

7.26

g/l

0.16

679

4910

Other bursopathies

352

2222

1.62

15.66

2.2

2.3

7.43

7.40

g/l

0.15

326

2019

Pemphigoid

114

507

2.40

15.55

1.5

2.4

7.31

7.52

g/l

0.75

107

456

Microscopic polyangiitis

4.73

15.51

1.4

2.0

8.16

7.52

g/l

1.18

Other specified/unspecified hearing loss

284

1708

1.71

15.50

2.5

2.3

7.19

7.50

g/l

2.74

271

1556

Sequelae of injuries of lower limb

238

1361

1.79

15.47

2.3

2.4

7.44

7.27

g/l

0.77

224

1264

Pollen allergy

300

1793

1.67

15.43

2.6

2.1

6.95

7.21

g/l

1.95

270

1698

Impingement syndrome of shoulder

589

4145

1.44

15.42

2.4

2.5

7.40

7.32

g/l

0.63

526

3803

Emotionally unstable personality disorder

203

1105

1.87

15.33

1.7

1.9

7.30

7.17

g/l

0.60

189

1047

Crohn disease

291

1761

1.68

15.28

1.7

2.3

7.35

7.27

g/l

0.32

274

1629

Alcohol-induced chronic pancreatitis

182

965

1.95

15.25

1.8

2.4

7.38

7.24

g/l

0.46

161

903

Benign neoplasm: Adrenal gland

245

1424

1.78

15.24

2.2

2.6

7.46

7.40

g/l

0.21

220

1308

Squamous cell neoplasms and carcinomas of the skin

326

2037

1.64

15.24

2.5

1.4

7.28

7.54

g/l

1.92

292

1780

Cystic kidney disease, including avohilmo

105

453

2.43

15.15

2.0

2.5

7.36

7.30

g/l

0.13

100

418

Aortic aneurysm

705

5036

1.40

15.15

2.3

2.4

7.25

7.29

g/l

0.24

633

4579

Ventral hernia

658

4740

1.41

15.13

2.7

2.3

7.46

7.43

g/l

0.18

609

4300

Drug-induced cataract

334

2.71

15.11

2.4

2.5

7.23

7.34

g/l

0.23

309

Macular pucker

513

3548

1.48

15.05

2.0

2.5

7.41

7.44

g/l

0.11

452

3216

Chronic viral hepatitis

112

496

2.32

15.02

2.0

1.9

7.59

7.08

g/l

2.00

103

476

Other demyelinating diseases of the central nervous system

380

2.54

15.01

1.7

2.0

6.83

7.24

g/l

1.64

361

Glucagon-like peptide-1 (GLP-1) analogues

760

5607

1.37

15.00

1.7

2.6

8.20

7.09

g/l

58.11

710

5193

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

760

5607

1.37

15.00

1.7

2.6

8.20

7.09

g/l

58.11

710

5193

Coeliac disease

296

1810

1.67

14.99

2.4

2.2

7.20

7.37

g/l

1.02

275

1659

Benign paroxysmal vertigo

824

6161

1.36

14.98

2.1

2.4

7.41

7.47

g/l

0.48

740

5581

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

403

2649

1.55

14.96

2.7

2.3

7.29

7.37

g/l

0.40

380

2439

Benign thyroid growths and nodules

880

6162

1.34

14.95

2.2

2.4

7.41

7.49

g/l

0.77

797

5543

Viral and other specified intestinal infections, including avohilmo

505

3331

1.47

14.94

2.2

2.1

7.53

7.26

g/l

3.35

483

3070

Open wound of forearm

252

1479

1.75

14.94

2.2

2.3

7.50

7.39

g/l

0.49

229

1362

Dementia in Alzheimer disease

294

3930

0.61

14.90

1.6

2.3

7.47

7.52

g/l

0.21

224

3502

Acute pancreatitis (for exclusion)

554

3885

1.45

14.90

2.0

2.3

7.52

7.37

g/l

1.24

512

3550

Cardiac arrest

166

721

2.00

14.85

2.1

2.3

7.66

7.09

g/l

3.36

150

642

Hyperhidrosis

294

2.75

14.80

2.2

2.3

6.97

7.42

g/l

1.91

269

Arthropathic psoriasis

291

1780

1.67

14.78

1.8

2.4

7.76

7.31

g/l

4.23

272

1652

Tubulo-interstitial nephritis, not specified as acute or chronic

181

966

1.93

14.77

2.7

2.1

7.50

7.35

g/l

0.61

168

881

Anosmia

143

3.53

14.73

3.5

1.3

7.09

7.26

g/l

0.24

127

Trigger finger

353

2261

1.59

14.72

1.6

2.4

7.66

7.37

g/l

2.31

328

2079

Temporomandibular joint disorders, including avohilmo

891

6525

1.33

14.66

2.2

7.11

7.32

g/l

3.91

823

6017

Cervicocranial syndrome

265

1584

1.71

14.65

1.9

2.2

7.32

7.44

g/l

0.57

246

1432

Striking against or struck by other objects

741

5452

1.37

14.64

1.9

2.3

7.25

7.28

g/l

0.16

665

5065

Speech and linguistic disorders, excluding more controls

129

570

2.16

14.56

2.1

2.3

7.36

7.39

g/l

0.06

119

521

Ptosis of eyelid

346

2221

1.60

14.51

2.5

2.4

7.34

7.49

g/l

1.13

324

2021

Hallux rigidus

355

2291

1.58

14.39

2.2

2.6

7.43

7.32

g/l

0.59

308

2085

Anterior Iridocyclitis

508

3528

1.46

14.37

2.5

2.3

7.53

7.37

g/l

1.41

471

3237

Otitis externa

560

3958

1.44

14.34

2.3

2.2

7.36

7.37

g/l

0.06

494

3657

Other localized connective tissue disorders

273

2.85

14.34

2.7

2.0

7.41

7.47

g/l

0.09

251

Ulcerative colitis, NAS

319

2010

1.62

14.28

2.0

2.3

7.26

7.30

g/l

0.13

300

1858

Acute generalized exanthematous pustulosis

134

654

2.13

14.27

4.4

2.6

7.34

7.39

g/l

0.15

126

601

Superficial injury of abdomen, lower back and pelvis

376

2460

1.55

14.26

2.1

2.2

7.26

7.39

g/l

0.77

340

2259

Postviral fatigue syndrome

5.77

14.24

1.2

2.3

6.61

6.87

g/l

0.43

Autoimmune hepatitis

4.36

14.20

1.6

2.6

7.68

7.51

g/l

0.26

Synovial cyst of popliteal space [Baker]

207

1168

1.82

14.19

2.5

2.2

7.51

7.47

g/l

0.15

191

1061

Injuries to the neck

520

3634

1.45

14.14

2.6

2.2

7.16

7.31

g/l

1.38

474

3361

Specific personality disorders

433

2920

1.50

14.10

1.8

2.2

7.28

7.22

g/l

0.31

401

2734

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

126

602

2.14

13.96

1.6

1.9

7.65

7.09

g/l

2.96

111

576

Acute and subacute iridocyclitis

474

3270

1.47

13.91

2.5

2.2

7.52

7.37

g/l

1.16

438

3000

Alcohol use disorder, ICD-based

1022

7950

1.30

13.87

1.7

2.4

7.56

7.25

g/l

7.10

927

7370

Other disorders of adrenal gland

125

601

2.16

13.82

2.6

2.5

7.41

7.37

g/l

0.09

118

564

Benign neoplasm: Rectum

544

3862

1.44

13.81

2.3

2.4

7.39

7.43

g/l

0.17

494

3510

Cluster headache, strict

365

2.49

13.76

1.7

2.8

7.20

7.33

g/l

0.31

339

Mouth breathing

962

7425

1.31

13.73

2.4

7.27

7.29

g/l

0.11

902

6880

Personal history of other diseases and conditions

194

1074

1.83

13.71

4.1

2.0

7.28

7.35

g/l

0.20

172

997

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

366

2.49

13.69

1.6

1.9

7.73

7.07

g/l

2.55

354

Unspecified urinary incontinence

262

1595

1.69

13.69

1.5

2.4

7.72

7.55

g/l

0.77

206

1434

Other hearing loss

894

6636

1.32

13.68

2.4

2.3

7.32

7.50

g/l

2.53

794

5985

Left bundle-branch block

213

1226

1.79

13.66

1.7

2.3

7.30

7.49

g/l

0.73

183

1096

Fall on same level involving ice and snow

1481

12038

1.24

13.65

2.1

2.4

7.32

7.38

g/l

0.79

1327

10996

Other and unspecified injuries of head

210

1206

1.79

13.56

1.8

2.3

7.27

7.46

g/l

0.71

183

1098

Additional codes for the location of defect, injury or illness

165

883

1.93

13.49

1.4

2.5

7.32

7.38

g/l

0.22

157

816

Acute peritonitis

189

1056

1.85

13.48

2.4

2.5

7.30

7.38

g/l

0.28

184

967

Benign neoplasm of mouth and pharynx

300

1896

1.62

13.44

3.3

2.4

7.47

7.41

g/l

0.19

271

1740

Infections with a predominantly sexual mode of transmission

526

3706

1.43

13.41

2.1

7.30

7.22

g/l

0.49

486

3461

Erosion of teeth , including avohilmo

550

3920

1.42

13.38

2.3

2.2

7.21

7.27

g/l

0.32

514

3642

Fall involving bed

125

612

2.15

13.38

2.4

2.5

7.69

7.56

g/l

0.33

108

549

Cluster headache, wide

408

2.38

13.30

1.8

2.7

7.20

7.33

g/l

0.34

377

Umbilical hernia

686

5083

1.37

13.26

2.0

2.3

7.40

7.35

g/l

0.32

641

4706

Gingival hyperplasia

107

494

2.26

13.19

3.4

2.5

7.49

7.36

g/l

0.33

458

Supplementary factors related to causes of morbidity and mortality classified elsewhere

762

5738

1.34

13.17

2.0

2.3

7.43

7.34

g/l

0.71

662

5252

Benign neoplasm: Rectosigmoid junction

142

733

2.03

13.11

2.1

2.6

7.24

7.42

g/l

0.66

127

671

Eating disorder

119

568

2.12

13.10

1.8

1.7

7.14

7.26

g/l

0.33

113

543

Psoriatic arthropathies, ICD10

267

1651

1.66

13.07

1.9

2.4

7.71

7.30

g/l

3.35

249

1532

Acute gastritis

211

1228

1.77

13.05

2.0

2.5

7.54

7.49

g/l

0.14

188

1120

Unstable angina pectoris

1090

6750

1.28

13.02

2.4

7.65

7.40

g/l

5.41

1008

6020

Other spirochaetal diseases, including avohilmo

854

6549

1.32

13.01

2.5

2.4

7.06

7.39

g/l

7.01

767

6012

Adrenocortical insufficiency

107

497

2.24

13.00

2.7

2.6

7.48

7.42

g/l

0.11

101

463

Hepatic failure, not elsewhere classified

118

571

2.16

12.95

1.8

2.7

6.89

7.31

g/l

1.36

107

523

Polycythaemia vera

111

526

2.21

12.90

2.5

1.4

6.61

7.55

g/l

7.95

103

463

Pneumonia due to Streptococcus pneumoniae

113

537

2.18

12.89

5.2

1.9

7.47

7.23

g/l

0.78

100

485

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

120

588

2.13

12.76

2.5

2.4

7.30

7.44

g/l

0.37

111

543

Other spirochaetal diseases

843

6471

1.32

12.76

2.5

2.4

7.06

7.39

g/l

7.02

757

5939

Diseases of peritoneum

282

1780

1.62

12.74

2.2

2.4

7.41

7.40

g/l

0.01

263

1618

Enteropathic arthropathies

237

2.82

12.71

1.4

2.4

7.20

7.07

g/l

0.23

223

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

444

3080

1.47

12.70

2.8

2.3

7.35

7.37

g/l

0.10

421

2827

Biological medicines for asthma

238

2.82

12.63

1.8

6.91

7.21

g/l

0.93

229

Other symptoms and signs involving the digestive system and abdomen

410

2803

1.49

12.63

2.3

2.4

7.35

7.48

g/l

0.88

356

2539

Other disorders of patella

317

2051

1.57

12.63

2.2

2.5

7.19

7.15

g/l

0.20

292

1918

Mental disorders, not otherwise specified

166

906

1.87

12.62

1.8

2.2

7.34

7.23

g/l

0.40

160

848

Mental and behavioural disorders due to sedatives or hypnotics

150

794

1.94

12.59

1.4

2.1

7.52

7.22

g/l

1.47

133

743

Background retinopathy and retinal vascular changes

316

2.58

12.58

1.8

2.8

7.45

7.44

g/l

0.02

293

Spirochaetal infections, other/unspecified, including avohilmo

841

6468

1.32

12.56

2.5

2.4

7.06

7.39

g/l

7.25

755

5935

Bacterial, viral and other infectious agents, including avohilmo

200

1157

1.77

12.54

3.3

2.3

7.17

7.28

g/l

0.44

189

1085

Artificial joint re-operation

228

1375

1.72

12.54

2.0

2.5

7.81

7.45

g/l

2.41

209

1242

Other congenital malformations, including avohilmo

254

1563

1.65

12.53

2.0

2.4

7.10

7.34

g/l

1.49

240

1451

Gonarthrosis, primary, with knee surgery

1691

10919

1.22

12.52

2.2

2.5

7.64

7.39

g/l

7.65

1527

9911

Generalized skin eruption due to drugs and medicaments

116

565

2.14

12.49

4.7

2.6

7.34

7.40

g/l

0.16

108

522

Parkinson's disease, strict definition, excluding more controls

357

2218

1.53

12.48

1.8

2.5

7.23

7.56

g/l

3.34

315

2015

Polycystic ovarian syndrome, consortium definition

1504

7034

1.23

12.47

2.0

2.2

7.52

7.44

g/l

1.05

1328

6419

Right bundle-branch block

114

552

2.15

12.46

2.7

2.3

7.37

7.41

g/l

0.08

108

494

Follicular lymphoma, hilmo

146

775

1.97

12.45

1.6

2.7

7.41

g/l

0.01

136

707

Eating disorders

160

865

1.87

12.38

2.3

1.9

7.23

7.27

g/l

0.13

151

812

Sacroiliitis, not elsewhere classified

414

2.30

12.37

2.1

1.9

7.42

7.16

g/l

0.77

387

Other abnormal uterine and vaginal bleeding

532

2727

1.42

12.36

2.1

2.2

7.59

7.60

g/l

0.05

441

2455

Malignant melanoma, including Hilmo

462

3250

1.45

12.32

2.6

1.4

7.32

7.47

g/l

1.12

411

2923

Malignant melanoma

417

2879

1.48

12.32

2.6

1.4

7.31

7.47

g/l

1.08

371

2592

Lyme disease, including avohilmo

833

6416

1.31

12.32

2.5

2.4

7.06

7.39

g/l

7.36

747

5892

Lyme disease

833

6416

1.31

12.32

2.5

2.4

7.06

7.39

g/l

7.36

747

5892

IBD patients in KELA-register

475

3352

1.43

12.30

2.2

7.20

7.28

g/l

0.44

448

3122

Excessive, frequent and irregular menstruation

756

3020

1.35

12.30

2.0

2.2

7.51

7.55

g/l

0.26

675

2738

Total colectomy

113

548

2.14

12.29

2.6

2.5

7.38

7.24

g/l

0.36

107

509

Total colectomy operation

113

548

2.14

12.29

2.6

2.5

7.38

7.24

g/l

0.36

107

509

Ovarian cyst

701

2974

1.36

12.26

2.1

2.2

7.38

7.55

g/l

1.91

645

2702

Disorders of orbit

126

637

2.05

12.25

3.4

2.5

7.78

7.44

g/l

1.15

120

588

Superficial injury of thorax

388

2643

1.49

12.25

1.6

2.3

7.43

7.39

g/l

0.17

344

2425

Retinal vascular occlusion

373

2529

1.51

12.21

2.5

2.4

7.43

7.51

g/l

0.38

340

2264

Colonic or urogenital fistula

659

4920

1.36

12.17

2.5

2.4

7.39

7.35

g/l

0.21

596

4515

Exposure to other and unspecified inanimate mechanical forces

180

1020

1.81

12.17

2.8

2.4

7.33

7.31

g/l

0.07

175

946

Clear cell adenocarcinoma of kidney

143

759

1.96

12.11

1.5

1.4

7.98

7.52

g/l

1.90

132

677

Inguinal hernia

1487

8105

1.23

12.01

2.7

2.2

7.02

7.37

g/l

13.15

1377

7412

Type of accident

710

5368

1.34

12.00

2.0

2.3

7.46

7.36

g/l

0.83

612

4924

Menorrhagia

707

2938

1.35

11.97

2.0

2.2

7.46

7.56

g/l

0.75

608

2658

Parkinson's disease, excluding more controls

376

2348

1.50

11.97

1.8

2.5

7.25

7.55

g/l

2.92

331

2135

Malignant neoplasm of other connective and soft tissue

354

2.44

11.96

4.0

1.4

7.44

7.54

g/l

0.17

319

Pain and other conditions associated with female genital organs and menstrual cycle

363

2034

1.51

11.92

2.0

2.2

7.20

7.40

g/l

1.51

326

1868

Carbimazole or st.post thyroidectomy, condition for graves disease

482

3435

1.42

11.89

2.4

2.2

7.34

7.42

g/l

0.48

443

3145

Other psoriatic arthropathies

255

1601

1.63

11.78

1.9

2.4

7.71

7.30

g/l

3.26

238

1484

Otalgia

205

1218

1.72

11.73

2.0

2.3

7.13

7.45

g/l

1.99

180

1117

Other and unspecified injuries of lower leg

176

1002

1.79

11.71

2.3

2.4

7.24

7.36

g/l

0.47

165

921

Retinal vascular disorders

375

2567

1.49

11.70

2.5

2.4

7.44

7.51

g/l

0.35

342

2299

Emphysema

229

1406

1.68

11.68

2.6

2.5

7.69

7.29

g/l

3.02

212

1271

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

531

3852

1.39

11.68

1.9

2.2

7.43

7.24

g/l

1.86

484

3600

Secondary thrombocytopenia

177

3.11

11.64

4.0

1.7

7.26

7.45

g/l

0.30

166

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

304

1987

1.55

11.63

1.9

2.3

7.60

7.21

g/l

3.81

278

1873

Suggestive for eosinophilic asthma

251

1577

1.63

11.61

2.3

7.30

7.33

g/l

0.09

240

1450

Viral and other specified intestinal infections

351

2304

1.50

11.60

2.2

2.0

7.60

7.26

g/l

3.48

333

2125

Symptoms and signs involving emotional state

322

2.44

11.44

1.7

2.1

7.66

7.39

g/l

0.75

296

Artificial opening status

165

933

1.83

11.42

3.2

2.2

7.61

7.49

g/l

0.40

154

853

Lung cancer and mesothelioma

505

3090

1.41

11.39

2.1

2.0

8.03

7.26

g/l

15.69

460

2771

Crohn's disease NAS

144

779

1.89

11.36

1.9

2.4

7.36

7.27

g/l

0.23

134

724

Other or ill-defined heart diseases

128

666

1.97

11.36

2.2

7.39

7.35

g/l

0.10

113

602

981

6690

1.28

11.35

2.3

7.57

7.51

g/l

0.43

846

5966

Carcinoma in situ of other and unspecified digestive organs

145

793

1.90

11.28

1.8

2.6

7.30

7.40

g/l

0.30

138

725

Colectomy operation

478

3441

1.42

11.28

2.7

2.4

7.57

7.44

g/l

0.92

441

3105

Cardiomyopathy, Hypertrophic obstructive

236

2.73

11.26

1.8

2.7

7.17

7.31

g/l

0.22

213

Deviated nasal septum

799

6189

1.30

11.24

2.7

2.4

7.07

7.33

g/l

4.66

738

5734

Alcohol-induced acute pancreatitis

101

488

2.15

11.16

2.1

2.6

7.54

7.17

g/l

1.12

458

Acute pharyngitis

262

1654

1.59

11.15

2.8

2.0

7.19

7.17

g/l

0.08

249

1553

Speech and linguistic disorders

130

653

1.94

11.10

2.1

2.0

7.36

7.32

g/l

0.08

120

603

Mental and behavioural disorders due to opioids

295

2.47

11.09

1.8

7.31

7.08

g/l

0.47

283

Other disorders of nervous system

195

1166

1.72

11.06

2.8

2.5

7.26

7.41

g/l

0.65

176

1073

Fracture of neck

187

1107

1.74

11.03

3.1

2.3

7.20

7.38

g/l

0.91

170

1014

Traumatic subarachnoid haemorrhage

107

530

2.09

11.03

2.4

2.5

6.98

7.55

g/l

3.18

492

Allergic contact dermatitis

281

1832

1.56

10.95

1.7

2.3

7.56

7.39

g/l

0.96

258

1682

Bullous pemphigoid

396

2.31

10.94

1.4

2.6

7.41

7.49

g/l

0.19

357

Other specified and unspecified personality disorders

174

1007

1.76

10.93

1.9

2.2

7.29

7.20

g/l

0.30

161

943

Hypothyroidism, strict autoimmune, 3 medication purchases required

2042

11687

1.18

10.90

2.1

2.3

7.42

7.37

g/l

0.67

1855

10644

Causalgia

172

3.00

10.84

1.4

2.2

7.06

7.28

g/l

0.36

166

Carcinoma in situ of skin of upper limb, including shoulder

107

539

2.11

10.82

2.6

7.28

7.55

g/l

0.88

102

479

Superficial injury of wrist and hand

429

3046

1.42

10.80

1.9

2.2

7.16

7.32

g/l

1.33

394

2818

Alcohol abuse, main dg, excluding more controls

324

2184

1.51

10.79

1.3

2.5

7.42

7.23

g/l

1.11

292

2049

Disorders of psychological development

161

843

1.79

10.77

1.9

7.32

7.28

g/l

0.10

150

785

Calculus of kidney and ureter

798

6231

1.30

10.75

2.1

2.4

7.40

7.34

g/l

0.47

732

5712

Inflammatory bowel disease, strict (require KELA)

475

3437

1.40

10.72

2.2

2.3

7.20

7.28

g/l

0.45

448

3206

Diseases of tongue

161

920

1.80

10.67

2.6

2.0

7.11

7.48

g/l

2.23

147

827

Impacted cerumen

335

2286

1.50

10.66

2.4

7.27

7.46

g/l

1.24

251

2088

Follow-up examination after treatment for malignant neoplasms

244

1553

1.60

10.64

2.5

2.2

7.65

7.46

g/l

1.03

222

1402

Bacterial, viral and other infectious agents

181

1069

1.73

10.62

3.2

2.3

7.16

7.27

g/l

0.41

170

1004

Infections with a predominantly sexual mode of transmission, including avohilmo

640

4426

1.33

10.61

2.1

2.0

7.23

7.22

g/l

0.05

594

4136

Anti-inflammatory and antirheumatic products, non-steroids

642

2411

1.35

10.57

2.6

2.3

7.36

7.28

g/l

0.51

590

2206

Other nonthrombocytopenic purpura

139

3.29

10.47

2.2

2.1

7.31

7.35

g/l

0.06

126

Respiratory disorders in diseases classified elsewhere

205

2.82

10.46

1.7

2.1

7.80

7.42

g/l

0.88

191

Diabetic retinopathy, strict definition

467

3006

1.41

10.46

1.7

2.1

8.00

7.69

g/l

3.27

426

2758

Blepharochalasis

804

6310

1.29

10.44

2.0

2.4

7.39

7.51

g/l

1.32

725

5707

Paraplegia, diplegia of upper limbs

300

2.45

10.44

2.1

2.4

7.76

7.24

g/l

1.69

277

Cryoglobulinemia

13.74

10.43

4.2

1.3

7.64

8.48

g/l

1.17

Ganglion

422

3009

1.42

10.39

2.1

2.3

7.15

7.31

g/l

1.24

381

2759

Malignant neoplasm of digestive organs, including Hilmo

1093

6502

1.25

10.35

2.1

1.4

7.57

7.48

g/l

0.93

986

5838

Suicide or other Intentional self-harm

476

3466

1.39

10.34

1.9

2.3

7.51

7.27

g/l

2.44

435

3232

MS-disease / Multiple Sclerosis

143

796

1.83

10.31

1.7

2.1

6.80

7.28

g/l

3.54

138

743

Other infective otitis externa

159

917

1.78

10.27

2.6

2.3

7.43

7.34

g/l

0.32

144

850

Disorders of myoneural junction and muscle in diseases classified elsewhere

115

3.53

10.25

1.6

2.3

7.13

7.44

g/l

0.48

107

Propionic acid derivatives

639

2411

1.34

10.22

2.4

2.3

7.34

7.28

g/l

0.37

583

2206

Carcinoma in situ of skin

272

1799

1.55

10.20

2.1

2.5

7.50

g/l

0.01

251

1625

Hyperkinetic disorders, excluding more controls

117

567

1.94

10.18

1.4

1.8

6.88

6.99

g/l

0.33

111

546

Melanocytic naevi of trunk

287

1914

1.53

10.16

2.4

7.04

7.35

g/l

2.57

271

1775

Xerosis cutis

280

2.50

10.15

1.7

2.6

6.93

7.42

g/l

1.75

256

D07AA Corticosteroids, weak (group I)

294

1965

1.51

10.12

1.8

2.3

7.45

7.32

g/l

0.64

266

1819

Other/unspecified synovitis and tenosynovitis

256

1667

1.56

10.10

1.9

2.3

7.46

7.36

g/l

0.38

236

1525

Type 1 diabetes, definitions combined

140

777

1.82

10.01

1.9

2.1

7.16

6.92

g/l

1.00

130

736

Behavioural syndromes associated with physiological disturbances and physical factors

2242

13108

1.16

9.98

2.1

2.3

7.25

7.37

g/l

2.84

2038

12013

Other orthopaedic follow-up care

148

844

1.80

9.94

1.7

2.0

7.44

7.37

g/l

0.20

136

765

Type 1 diabetes, strict (exclude DM2)

139

772

1.82

9.93

2.0

7.17

6.92

g/l

1.08

129

731

Unspecified misadventure during surgical and medical care

164

966

1.75

9.90

2.1

2.5

7.43

7.36

g/l

0.17

148

892

Abscess of anal and rectal regions

181

1090

1.69

9.90

1.4

2.2

7.42

7.28

g/l

0.50

168

1014

malignant neoplasm of male genital organs, including Hilmo

737

3427

1.31

9.85

2.2

1.4

7.35

g/l

0.01

673

3132

Other/unspecified enthesopathies, not elsewhere classified

207

1293

1.63

9.84

1.8

2.2

7.39

7.40

g/l

0.02

190

1182

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

191

1159

1.66

9.84

1.7

2.2

7.35

7.33

g/l

0.05

181

1081

Disorders of oesophagus in diseases classified elsewhere

328

2.34

9.82

4.1

2.9

7.64

7.47

g/l

0.34

296

Dermatographic urticaria

145

824

1.80

9.80

2.0

2.5

7.12

7.34

g/l

1.12

138

771

Cholecystitis

391

2789

1.43

9.78

2.2

2.3

7.61

7.42

g/l

1.43

353

2512

Exfoliative dermatitis

139

3.16

9.76

1.6

2.4

7.27

7.36

g/l

0.12

124

Superficial injury of ankle and foot

236

1520

1.57

9.75

1.8

2.3

7.34

7.28

g/l

0.21

219

1423

Superficial injury of shoulder and upper arm

286

1923

1.51

9.75

2.3

2.2

7.33

7.37

g/l

0.13

259

1779

Crohn's disease of small intestine

145

827

1.79

9.68

1.8

2.4

7.29

g/l

0.01

135

768

Benign neoplasm: Small intestine

133

745

1.86

9.68

2.3

2.5

7.23

7.45

g/l

0.90

123

682

Vascular diseases of the intestine

127

700

1.88

9.67

2.9

2.3

7.86

7.42

g/l

1.87

119

630

Sulfonylureas

1015

6541

1.25

9.64

1.8

2.5

8.16

7.26

g/l

46.62

914

5838

Other and unspecified disorders of vitreous body

1150

9262

1.23

9.62

2.4

7.17

7.44

g/l

6.61

1044

8448

Pediculosis, acariasis and other infestations, including avohilmo

325

2243

1.47

9.61

1.7

2.2

7.27

7.28

g/l

0.01

309

2090

Other/unspecified disorders of vestibular function

129

716

1.87

9.61

1.8

2.6

7.38

7.42

g/l

0.09

116

660

Allergic bronchopulmonary aspergillosis (ABPA)

8.19

9.60

2.3

2.4

8.38

7.08

g/l

1.86

Monoplegia

208

2.70

9.59

2.2

2.5

7.46

7.54

g/l

0.12

192

Other and unspecified glaucoma

224

1440

1.60

9.58

2.1

2.4

7.62

7.54

g/l

0.25

198

1287

Duodenal ulcer

304

2080

1.49

9.57

1.9

2.4

7.57

7.41

g/l

0.90

283

1888

Arterial embolism and thrombosis

169

1012

1.72

9.56

1.4

2.4

7.78

7.41

g/l

1.60

152

917

Other follicular disorders

158

927

1.74

9.55

2.4

2.3

7.49

7.26

g/l

0.93

147

866

Malignant neoplasm of bladder, including Hilmo

324

2215

1.47

9.54

2.3

1.4

7.47

7.46

g/l

0.04

288

1981

Cerebral cysts

130

722

1.84

9.52

1.6

2.4

6.74

7.31

g/l

2.68

118

669

Event of undetermined intent

138

780

1.81

9.52

2.3

7.31

7.28

g/l

0.07

130

728

Visual impairment including blindness (binocular or monocular)

197

1230

1.64

9.47

2.1

2.2

7.37

7.49

g/l

0.46

160

1107

Inflammatory diseases of female pelvic organs

1288

7311

1.21

9.41

1.8

2.3

7.43

7.45

g/l

0.16

1149

6652

Melanocytic naevi of lower limb, including hip

113

604

1.93

9.41

2.9

2.3

6.99

7.39

g/l

1.75

108

562

Attention to artificial openings

122

670

1.88

9.39

2.6

2.0

7.60

7.32

g/l

1.12

106

610

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

243

1596

1.56

9.38

2.3

2.4

7.44

7.40

g/l

0.15

215

1455

Psychotic depression

134

754

1.81

9.38

2.3

2.7

7.15

7.34

g/l

0.80

119

695

Urolithiasis

854

6842

1.26

9.35

2.1

2.4

7.40

7.34

g/l

0.47

780

6262

Other Crohn's disease

137

778

1.80

9.29

1.5

2.2

7.34

7.25

g/l

0.23

128

724

Plantar fascial fibromatosis

219

1406

1.59

9.26

2.5

2.2

7.26

7.36

g/l

0.39

203

1299

Disorders of optic nerve and visual pathways

210

1336

1.60

9.26

2.2

2.5

7.46

7.29

g/l

0.71

194

1236

Other superficial mycoses, including avohilmo

208

1321

1.60

9.18

1.9

2.3

7.21

7.30

g/l

0.30

191

1223

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

323

2251

1.45

9.14

2.3

7.24

7.27

g/l

0.09

305

2096

Malignant neoplasm of other connective and soft tissue, including Hilmo

116

633

1.89

9.11

4.4

1.4

7.44

7.52

g/l

0.16

107

567

Wet age-related macular degeneration

562

4137

1.33

9.11

2.4

2.2

7.60

7.54

g/l

0.38

484

3637

Asthma and opportunity respiratory infection

149

879

1.76

9.06

2.6

2.7

7.81

7.41

g/l

2.08

142

787

Scabies, including avohilmo

258

1722

1.52

9.05

1.7

2.3

7.19

7.24

g/l

0.24

247

1619

Bronchitis, not specified as acute or chronic

208

1328

1.60

9.05

2.1

2.4

7.07

7.32

g/l

1.24

187

1196

Dissociative [conversion] disorders

350

2.19

9.03

1.3

2.0

7.53

7.30

g/l

0.60

327

Entropion and trichiasis of eyelid

269

1822

1.51

9.03

2.3

2.5

7.57

7.50

g/l

0.23

241

1643

Conductive and sensorineural hearing loss

2115

12183

1.16

9.01

2.4

7.34

7.42

g/l

1.22

1888

11153

Ulcerative colitis (strict definition, require KELA)

333

2340

1.44

9.01

2.4

2.3

7.24

7.28

g/l

0.14

314

2181

Other specified and unspecified retinal disorders

107

572

1.94

9.00

2.6

7.34

7.46

g/l

0.33

524

Childhood asthma (age<16), excluding more controls

117

491

1.87

8.96

1.4

7.07

6.86

g/l

0.64

110

471

Psoriasis (vulgaris), strict definition

440

2.07

8.93

1.4

2.6

7.36

7.17

g/l

0.49

413

Disorders of breast

1034

7456

1.23

8.92

2.1

2.3

7.31

7.47

g/l

2.40

931

6756

Chondropathies

322

2256

1.45

8.89

2.1

2.2

7.56

7.33

g/l

1.42

288

2092

Other renal tubulo-interstitial diseases

264

2.40

8.88

1.8

2.0

7.39

7.23

g/l

0.31

248

Idiopathic pulmonary fibrosis

239

1587

1.55

8.86

2.0

2.4

8.06

7.38

g/l

6.92

222

1427

Other keratitis

248

1653

1.52

8.86

2.2

7.42

7.31

g/l

0.42

230

1525

Other and unspecified tonsillitis

525

3291

1.33

8.84

1.8

2.0

7.25

7.16

g/l

0.61

503

3103

Cluster headache, strict, including avohilmo

104

552

1.93

8.82

1.6

2.3

7.19

7.21

g/l

0.03

518

Other sleep disorders

261

1761

1.51

8.79

1.8

2.4

7.38

7.35

g/l

0.11

228

1628

Fibrosis of liver

3.55

8.78

1.5

1.8

7.29

7.28

g/l

0.01

Cluster headache, wide,, including avohilmo

110

596

1.89

8.75

1.7

2.3

7.19

7.23

g/l

0.09

102

556

Acute bronchiolitis

305

2.19

8.73

5.3

1.8

7.54

7.34

g/l

0.41

280

Palmar fascial fibromatosis [Dupuytren]

405

2965

1.39

8.72

2.2

2.4

7.36

7.35

g/l

0.04

367

2685

Unspecified/other endometriosis

151

877

1.71

8.72

1.9

2.0

7.33

7.36

g/l

0.09

136

804

Other specified/unspecified spondylopathies

385

2.14

8.68

2.9

2.0

7.62

7.41

g/l

0.60

344

Primary coxarthrosis, bilateral

835

6740

1.25

8.65

2.2

2.4

7.41

7.46

g/l

0.41

753

6047

Redundant prepuce, phimosis and paraphimosis

443

3235

1.36

8.63

1.9

2.4

7.48

7.25

g/l

1.89

417

3015

Coxarthrosis, primary, with hip surgery

1354

10610

1.19

8.60

2.2

2.4

7.46

7.45

g/l

0.11

1216

9568

Thiazolidinediones

320

2261

1.44

8.59

1.7

2.5

8.23

7.22

g/l

18.68

294

2050

Hypopituitarism

144

849

1.73

8.59

2.6

2.4

7.02

7.25

g/l

0.80

135

802

COPD, hospital admissions 1, only main diagnosis

993

7003

1.23

8.58

1.9

2.4

7.89

7.38

g/l

16.52

897

6340

Monoamine oxidase A inhibitors

273

1870

1.48

8.56

2.1

2.5

7.32

7.38

g/l

0.30

251

1718

Childhood asthma (age<16)

117

499

1.84

8.55

1.4

7.07

6.89

g/l

0.53

110

478

Carcinoma in situ of skin of trunk

119

672

1.85

8.52

3.1

2.4

7.35

7.49

g/l

0.39

112

602

Benign neoplasm: Parathyroid gland

174

2.78

8.51

2.8

2.0

7.70

7.47

g/l

0.38

164

Coronary artery bypass grafting

747

4403

1.27

8.50

1.7

2.5

7.66

7.39

g/l

3.98

683

3919

Scleritis and episcleritis

141

831

1.74

8.48

2.1

2.2

7.24

7.32

g/l

0.26

132

777

Exposure to other and unspecified animate mechanical forces

314

2.23

8.46

2.8

2.1

7.29

7.30

g/l

0.02

302

Malignant neoplasm of prostate, including Hilmo

722

3359

1.28

8.44

2.2

1.4

7.35

7.37

g/l

0.09

658

3066

Acidosis

310

2.26

8.43

1.7

2.4

7.57

7.18

g/l

0.95

284

Carrier of infectious disease

303

2.26

8.40

1.3

2.4

7.22

7.35

g/l

0.32

281

Congenital malformations and deformations of the musculoskeletal system

140

819

1.72

8.37

1.6

2.0

7.43

7.31

g/l

0.29

134

768

Anogenital herpesviral [herpes simplex] infection, including avohilmo

170

1052

1.64

8.36

2.3

2.1

6.85

7.19

g/l

2.47

158

994

Iridocyclitis in diseases classified elsewhere

254

2.39

8.31

2.0

2.3

7.44

7.40

g/l

0.06

237

Endometriosis

654

2962

1.29

8.30

1.8

2.2

7.36

7.55

g/l

2.28

598

2686

Crushed, pushed or stepped on by crowd or human stampede

130

754

1.75

8.22

2.6

2.1

7.06

7.27

g/l

0.79

121

706

Complications of cardiac and vascular prosthetic devices, implants and grafts

347

2.18

8.22

2.3

2.8

7.85

7.37

g/l

1.24

315

Cachexia

4.17

8.21

2.4

1.7

7.61

7.83

g/l

0.25

Deficiency of other B group vitamins

307

2.24

8.19

3.3

2.0

7.05

7.34

g/l

0.74

279

Disorders of magnesium metabolism

110

3.25

8.18

1.3

2.5

7.98

7.31

g/l

0.77

104

Spontaneous rupture of synovium and tendon

204

1330

1.56

8.17

1.9

2.2

7.62

7.41

g/l

1.00

183

1215

Bursitis of shoulder

320

2.20

8.15

3.1

2.3

7.40

7.47

g/l

0.12

297

Other and unspecified psoriasis

176

1112

1.62

8.13

2.0

2.5

7.54

7.36

g/l

0.65

166

1026

Lactose intolerance

353

2.13

8.12

1.6

1.7

7.12

7.24

g/l

0.23

324

Golimumab

375

2.08

8.00

1.3

1.9

7.36

7.27

g/l

0.19

360

Superficial injury of forearm

208

1367

1.54

7.98

2.2

2.3

7.35

7.37

g/l

0.05

187

1272

Adenomyosis (Endometriosis of uterus)

303

2142

1.43

7.96

2.2

2.3

7.33

7.61

g/l

2.25

281

1934

Viral warts

204

1338

1.55

7.91

1.9

2.4

7.21

7.32

g/l

0.41

194

1233

Autoimmune hyperthyroidism

128

749

1.74

7.90

2.2

2.5

7.48

7.28

g/l

0.63

122

687

Postzoster neuralgia

248

2.38

7.88

3.8

2.0

7.55

7.47

g/l

0.11

222

Chronic hepatitis, not elsewhere classified

483

1.95

7.85

1.9

2.6

7.66

7.31

g/l

0.84

453

Anogenital herpesviral [herpes simplex] infection

104

573

1.84

7.84

2.3

2.0

6.89

7.22

g/l

1.59

539

Oesophagitis

142

859

1.70

7.83

2.3

2.6

7.35

7.42

g/l

0.21

135

796

Tobacco use

124

723

1.76

7.80

1.5

2.4

7.67

7.30

g/l

1.75

119

679

Specific development disorders of speech and language

483

1.91

7.80

1.8

2.1

7.43

7.42

g/l

0.01

441

Dermatophytosis

347

2527

1.39

7.79

2.7

2.3

7.39

7.38

g/l

0.03

321

2313

Mental and behavioural disorders due to tobacco

203

1338

1.55

7.76

1.8

2.5

7.88

7.27

g/l

5.39

171

1249

Benign neoplasm: Duodenum

452

1.99

7.75

2.6

7.33

7.44

g/l

0.24

414

Hemiplegia

126

740

1.75

7.74

2.0

2.3

7.11

7.39

g/l

1.28

112

678

Obsessive-compulsive disorder

489

1.90

7.72

1.9

2.1

7.08

7.19

g/l

0.24

466

Benign neoplasm: Descending colon

204

1351

1.55

7.72

2.0

2.5

7.66

7.39

g/l

1.17

177

1244

Other benign neoplasms of skin

945

7816

1.22

7.71

3.0

2.4

7.21

7.43

g/l

3.97

843

7098

Dislocation, sprain and strain of joint and ligaments of hip

110

624

1.82

7.70

1.9

2.5

7.62

7.46

g/l

0.39

575

Melanocytic naevi

668

5325

1.27

7.69

2.6

2.3

7.11

7.37

g/l

3.71

636

4888

Other condition

316

2269

1.41

7.68

2.3

2.2

7.48

7.35

g/l

0.71

295

2093

Astigmatism

129

763

1.72

7.63

2.3

2.4

7.32

7.37

g/l

0.09

121

700

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

354

2591

1.38

7.63

2.3

7.21

7.27

g/l

0.25

335

2411

Sleep disorders

2117

12806

1.14

7.62

2.0

2.3

7.24

7.37

g/l

3.19

1925

11737

Atypical facial pain

128

759

1.73

7.61

2.0

2.4

7.20

7.36

g/l

0.58

117

694

Other and unspecified rosacea

215

1442

1.52

7.57

2.2

2.4

7.22

7.36

g/l

0.64

202

1332

Viral warts, including avohilmo

426

3213

1.34

7.52

2.1

2.2

7.09

7.31

g/l

2.18

397

2969

Panniculitis affecting regions of neck and back

461

1.94

7.52

2.0

2.2

7.35

7.31

g/l

0.08

427

Nasal polyp

468

3582

1.32

7.52

2.9

2.4

7.25

7.34

g/l

0.61

438

3288

Presence of other devices

677

5337

1.26

7.52

2.8

2.3

7.40

7.46

g/l

0.48

606

4799

Cardiac murmurs and other cardiac sounds

178

1133

1.57

7.48

2.7

2.1

7.61

7.51

g/l

0.34

166

1024

Use of anticholinesterases

786

7411

0.81

7.43

2.0

2.3

7.59

7.51

g/l

0.61

650

6620

N06DA Anticholinesterases

786

7411

0.81

7.43

2.0

2.3

7.59

7.51

g/l

0.61

650

6620

Somnolence, stupor and coma

107

608

1.81

7.41

1.6

2.7

7.51

7.47

g/l

0.08

553

Other ulcerative colitis

120

704

1.74

7.39

1.4

2.4

7.51

7.28

g/l

0.74

113

654

Smoking dependency

203

1353

1.53

7.39

1.8

2.5

7.88

7.28

g/l

5.21

171

1263

Testicular dysfunction

457

1.93

7.36

1.6

2.5

7.23

7.06

g/l

0.31

429

Tinnitus

574

4525

1.28

7.34

2.3

2.4

7.19

7.41

g/l

2.50

531

4164

Periapical abscess

1059

8891

1.20

7.34

2.2

2.4

7.43

7.30

g/l

1.74

977

8214

Necrosis of pulp, including avohilmo

1241

10426

1.18

7.34

2.3

7.29

7.28

g/l

0.08

1162

9640

Rosacea

288

2056

1.42

7.28

2.1

2.3

7.20

7.35

g/l

0.77

271

1895

malignant neoplasm of male genital organs

703

3391

1.26

7.27

2.2

1.4

7.36

7.35

g/l

0.02

642

3098

Complications of genitourinary prosthetic devices, implants and grafts

370

2.05

7.25

1.8

2.1

7.44

7.40

g/l

0.06

335

Other obstructive and reflux uropathy

466

1.91

7.25

1.9

2.1

7.65

7.31

g/l

1.45

432

Bell's palsy

271

1918

1.43

7.21

2.3

7.25

7.39

g/l

0.69

245

1752

Thrombotic microangiopathy

3.57

7.20

3.8

1.5

7.06

7.35

g/l

0.32

Organic, including symptomatic, mental disorders

1546

9404

1.17

7.18

2.2

2.4

7.56

7.45

g/l

1.80

1332

8519

Other disorders of iris and ciliary body

421

1.97

7.14

2.1

2.6

7.58

7.35

g/l

0.67

385

Varicose veins

1561

10206

1.16

7.14

2.4

2.3

7.44

7.42

g/l

0.23

1409

9255

Nontoxic goitre/thyroid nodule

724

5883

1.24

7.11

2.2

2.3

7.40

7.53

g/l

1.29

659

5304

Visual field defects

219

1496

1.49

7.11

2.2

7.36

7.43

g/l

0.23

198

1367

Paget disease

3.49

7.03

2.5

1.3

6.98

7.58

g/l

1.37

Hepatocellular carcinoma, including Hilmo

452

1.92

7.02

2.5

1.4

7.59

7.47

g/l

0.27

399

Congenital malformations of the circulatory system

275

1901

1.42

7.02

1.8

2.3

6.89

7.35

g/l

4.43

254

1762

Other secondary coxarthrosis

524

1.85

7.01

1.6

2.4

7.74

7.36

g/l

1.12

484

Open wound of abdomen, lower back and pelvis

346

2.05

7.01

1.9

2.5

7.57

7.15

g/l

1.33

327

Arthropathy in hypersensitivity reactions classified elsewhere

15.21

6.97

1.6

1.2

7.20

7.78

g/l

—

Follicular cysts of skin and subcutaneous tissue

426

3255

1.32

6.96

2.5

2.3

7.40

7.34

g/l

0.26

396

2999

Alzheimer’s disease (Late onset), excluding more controls

426

2098

1.34

6.95

2.0

2.5

7.49

7.59

g/l

0.50

365

1890

Disorders of speech understanding and production

394

1.96

6.92

1.8

2.3

7.57

7.47

g/l

0.16

355

Malignant neoplasm of mesothelium and soft tissue

107

622

1.77

6.91

3.5

1.4

7.73

7.49

g/l

0.56

553

Portal vein thrombosis

217

2.36

6.91

2.1

2.5

7.14

7.25

g/l

0.14

204

Malignant melanoma of skin

296

2146

1.40

6.89

2.6

1.4

7.21

7.47

g/l

1.93

264

1938

Melanoma in situ

138

861

1.65

6.88

2.3

2.6

7.44

7.39

g/l

0.11

117

781

Extreme obesity with alveolar hypoventilation

107

623

1.77

6.88

2.1

2.7

8.10

7.20

g/l

7.52

570

Autonomic disorders

329

2.08

6.88

1.9

2.4

7.01

7.37

g/l

0.90

302

Thyrotoxicosis with diffuse goitre

285

2052

1.41

6.86

2.2

2.3

7.45

7.40

g/l

0.19

265

1888

Malignant melanoma of skin, including Hilmo

353

2633

1.36

6.86

2.5

1.4

7.24

7.46

g/l

1.94

317

2375

Thyrotoxicosis with toxic multinodular goitre

170

1113

1.57

6.84

1.8

2.3

7.54

g/l

0.02

151

999

Other and unspecified vascular occlusions

268

1916

1.43

6.84

2.4

7.53

7.50

g/l

0.07

244

1723

Abnormal blood-pressure reading, without diagnosis

108

630

1.75

6.84

2.2

2.3

7.38

7.41

g/l

0.07

101

569

Other and specified injuries of hip and thigh

345

2.05

6.78

1.6

2.3

7.38

7.48

g/l

0.18

316

Arthropathy in ulcerative colitis

157

2.61

6.78

1.5

1.9

7.13

7.20

g/l

0.10

150

Ulcerative colitis (strict definition, all Crohn cases excluded)

277

1989

1.41

6.77

2.6

2.3

7.16

7.28

g/l

0.59

260

1855

Unspecified lump in breast

349

2603

1.36

6.77

1.9

2.3

7.36

7.54

g/l

1.22

318

2353

Degenerative macular diseases

336

2496

1.37

6.77

2.1

2.4

7.50

7.51

g/l

0.02

304

2233

severe traumatic brain injury, does not include concussion

599

4801

1.26

6.71

2.3

7.29

7.43

g/l

1.25

523

4337

Postmenopausal bleeding

642

2684

1.26

6.71

2.2

2.3

7.54

7.63

g/l

0.73

573

2417

Malignant neoplasm of prostate

695

3323

1.25

6.70

2.2

1.4

7.35

7.37

g/l

0.09

634

3032

Fracture at wrist and hand level

733

5977

1.23

6.70

2.4

2.3

7.25

7.32

g/l

0.48

663

5508

Lactose intolerance, other/unspecified

318

2.07

6.70

1.6

1.7

7.18

7.23

g/l

0.08

293

Hyperaldosteronism

431

1.92

6.69

3.2

2.6

7.63

7.45

g/l

0.42

398

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

131

811

1.66

6.68

2.0

1.4

7.56

7.53

g/l

0.07

115

713

Other symptoms and signs involving general sensations and perceptions

107

628

1.75

6.67

2.2

2.6

7.08

7.51

g/l

2.03

574

Drug-induced hypoglycaemia without coma

214

2.34

6.67

2.2

2.4

7.72

7.28

g/l

0.82

196

Chondrocostal junction syndrome [Tietze]

547

1.80

6.65

2.3

2.2

7.41

7.49

g/l

0.18

499

Procreative management

577

3777

1.27

6.65

1.9

2.2

7.04

7.31

g/l

3.50

550

3518

Achilles tendinitis

223

1547

1.46

6.65

2.6

2.2

7.37

7.31

g/l

0.22

204

1438

Combinations of oral blood glucose lowering drugs

730

5985

1.23

6.63

1.8

2.6

8.03

7.16

g/l

31.89

682

5476

Sudden idiopathic hearing loss

260

1859

1.42

6.62

2.1

2.3

7.23

7.46

g/l

1.47

228

1709

Sensorineural hearing loss

2012

11866

1.14

6.59

2.4

7.35

7.43

g/l

1.35

1793

10847

Benign neoplasm: Other and unspecified parts of mouth

536

1.81

6.55

3.0

2.6

7.72

7.40

g/l

0.77

493

Postprocedural disorders of digestive system, not elsewhere classified

506

1.83

6.55

1.8

2.6

7.65

7.38

g/l

0.69

466

Hydrocele

292

2131

1.39

6.54

2.3

2.5

7.00

7.34

g/l

3.38

270

1958

Thyroiditis

157

1019

1.57

6.52

2.2

2.4

7.49

7.40

g/l

0.26

141

939

Orchitis and epididymitis

221

1539

1.46

6.49

2.0

2.4

7.21

7.26

g/l

0.18

205

1412

Other aneurysm

150

967

1.59

6.48

2.2

2.5

7.61

7.32

g/l

1.15

143

886

Alcohol abuse, main dg

324

2406

1.36

6.47

1.3

2.3

7.42

7.26

g/l

0.93

292

2249

Other noninflammatory disorders of vulva and perineum

194

1317

1.49

6.47

2.0

2.3

7.45

7.50

g/l

0.18

175

1200

Crohn's disease of large intestine

104

611

1.74

6.43

1.6

2.3

7.20

7.25

g/l

0.11

567

Alzheimer disease, excluding more controls

478

2409

1.30

6.40

2.0

2.5

7.51

7.58

g/l

0.33

408

2182

Orthopaedic devices associated with adverse incidents

341

2.04

6.37

1.4

2.2

7.32

7.53

g/l

0.46

310

Open wound of hip and thigh

394

1.93

6.36

1.3

2.4

6.85

7.16

g/l

0.92

375

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

163

1074

1.55

6.36

3.6

1.4

7.65

7.49

g/l

0.49

150

952

Other and/or unspecified nontoxic goitre

205

1417

1.47

6.32

2.3

7.31

7.50

g/l

1.01

191

1289

Urethral stricture

155

1014

1.56

6.27

2.1

2.5

7.48

7.26

g/l

0.96

140

926

Ulcerative enterocolitis

354

1.97

6.26

1.9

2.3

7.47

7.23

g/l

0.54

329

Other and unspecified bullous disorders

164

2.52

6.26

3.1

2.2

7.14

7.43

g/l

0.57

150

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

189

1289

1.49

6.25

2.1

2.4

7.65

7.40

g/l

1.13

172

1179

Use of donepezil

416

5087

0.77

6.24

1.7

2.2

7.74

7.55

g/l

1.23

339

4489

Later onset COPD

869

5843

1.21

6.23

1.7

2.4

7.88

7.39

g/l

12.52

779

5233

Insomnia

2037

12594

1.13

6.21

2.0

2.3

7.23

7.37

g/l

3.10

1853

11545

Lichen simplex chronicus

478

1.83

6.19

2.5

2.8

7.73

7.37

g/l

0.94

441

Injury of eye and orbit

283

2073

1.38

6.18

1.9

2.2

7.20

7.28

g/l

0.29

257

1940

Other epidermal thickening

115

704

1.67

6.16

1.9

2.5

7.06

7.39

g/l

1.60

104

646

Other otitis externa (chronic)

157

1034

1.55

6.14

2.5

7.56

7.35

g/l

0.68

131

955

Assault

208

1445

1.45

6.14

1.9

2.1

7.29

7.17

g/l

0.42

191

1376

Malignant neoplasm of breast, ER-positive, including Hilmo

684

4160

1.23

6.10

2.1

1.4

7.63

7.54

g/l

0.65

599

3722

Left ventricular outflow tract obstruction (LVOTO), broad definition

202

1400

1.46

6.10

1.8

2.4

6.96

7.25

g/l

1.39

189

1312

Use of antiglaucoma preparations and miotics

227

1612

1.44

6.09

2.2

2.4

7.67

7.52

g/l

0.62

198

1431

Malignant neoplasm of breast, HER-positive

682

4154

1.23

6.07

2.1

1.4

7.63

7.54

g/l

0.63

597

3717

Amenorrhoea

567

1.73

6.07

1.9

2.1

6.99

7.28

g/l

1.00

531

Alzheimer’s disease (Early onset)

850

0.45

6.05

1.2

2.1

7.71

7.60

g/l

0.12

757

Other disorders of optic [2nd] nerve and visual pathways

146

950

1.57

6.04

2.3

2.5

7.49

7.32

g/l

0.53

133

875

Injury of muscle and tendon at hip and thigh level

222

1569

1.44

6.04

2.0

2.4

7.14

7.31

g/l

0.78

206

1471

Retinal detachment with retinal break

337

2551

1.34

6.02

2.9

2.4

7.33

7.39

g/l

0.29

304

2328

Disorders of ocular muscles, binocular movement, accommodation and refraction

981

8256

1.18

6.02

2.1

2.3

7.20

7.32

g/l

1.58

910

7582

Aortic valve malfunction, age under 60 years

193

1332

1.47

5.98

1.9

2.3

6.91

7.25

g/l

1.96

180

1250

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

127

801

1.61

5.97

1.7

2.2

7.36

7.33

g/l

0.06

121

742

Leisure time condition

413

3213

1.30

5.97

1.7

2.2

7.43

g/l

0.01

337

2939

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

229

2.18

5.96

1.6

1.8

7.36

7.20

g/l

0.19

218

Complications of other internal prosthetic devices, implants and grafts

114

704

1.66

5.94

2.7

2.3

7.40

7.49

g/l

0.18

108

637

Bicipital tendinitis

114

703

1.66

5.94

2.0

2.4

7.25

7.33

g/l

0.20

108

660

Paralytic ileus

100

597

1.72

5.93

3.8

2.3

7.76

7.35

g/l

1.35

541

Diabetic maculopathy

319

2266

1.35

5.92

1.5

2.1

8.15

7.70

g/l

4.75

296

2071

Seborrhoeic dermatitis

232

1660

1.42

5.91

2.4

7.37

7.39

g/l

0.05

210

1521

Other misadventures during surgical and medical care

363

1.94

5.90

1.8

2.8

8.21

7.29

g/l

3.40

335

Nonsuppurative otitis media, including avohilmo

538

3726

1.26

5.90

2.2

2.1

7.34

g/l

0.01

509

3452

Irregular menses

813

5092

1.20

5.89

2.1

2.2

7.36

7.35

g/l

0.11

749

4715

Other salmonella infections

515

1.77

5.89

2.8

2.2

7.46

7.29

g/l

0.34

473

Type 1 diabetes, strict definition

490

1.77

5.83

1.5

1.7

7.18

6.82

g/l

1.35

472

UC patients in KELA-register (code 208), prior to 1994

106

648

1.68

5.76

2.4

2.6

7.08

7.35

g/l

1.09

100

602

Injuries to the wrist and hand

2402

14344

1.11

5.76

2.2

2.3

7.30

7.36

g/l

0.98

2206

13135

Episcleritis

111

685

1.65

5.75

2.1

2.2

7.26

7.31

g/l

0.10

105

644

Excessive earwax

1640

13135

1.14

5.75

2.5

2.4

7.27

7.41

g/l

2.91

1450

11989

Otitis externa, unspecified

232

1669

1.41

5.71

2.1

2.3

7.27

7.35

g/l

0.31

213

1540

Pulmonary oedema

297

2.03

5.71

2.8

2.5

7.98

7.55

g/l

0.88

265

Gluteal tendinitis

102

618

1.69

5.70

2.0

2.3

7.60

7.35

g/l

0.76

571

Disorders of parathyroid gland, other and/or unspecified

117

2.77

5.70

1.5

1.8

7.58

g/l

0.01

109

Alcohol dependence

615

5037

1.23

5.69

1.6

2.5

7.54

7.22

g/l

4.71

552

4688

Glucosamine medication

1310

9116

1.16

5.66

2.3

2.4

7.47

7.49

g/l

0.21

1180

8172

Other disorders of penis

220

1572

1.42

5.63

1.7

2.5

6.99

7.26

g/l

1.53

199

1449

Infective dermatitis

254

1862

1.38

5.61

1.7

2.4

7.57

7.37

g/l

1.17

230

1714

Other disorders of pigmentation

114

715

1.63

5.59

3.0

2.2

7.05

7.44

g/l

1.67

108

651

Cholangitis (primary sclerosing, PSC)

154

1033

1.52

5.58

1.9

2.4

7.64

7.39

g/l

0.99

141

944

Other, unspecified and serous retinal detachments

502

1.76

5.58

2.2

2.7

7.59

7.41

g/l

0.44

463

Other deformities of toe(s)

502

1.76

5.55

2.4

2.3

7.40

7.32

g/l

0.15

453

Brachial plexus disorders

158

1064

1.50

5.54

2.4

6.94

7.23

g/l

1.63

151

1008

Other congenital malformations of skin, including avohilmo

154

1033

1.51

5.53

1.9

2.3

7.15

7.34

g/l

0.71

143

955

Burns and corrosions

265

1960

1.37

5.50

2.0

2.2

7.48

7.28

g/l

1.08

245

1828

Benign neoplasm of major salivary glands

239

1743

1.39

5.50

1.9

2.4

7.47

7.44

g/l

0.09

220

1591

Premature rupture of membranes

134

1447

0.65

5.50

1.9

2.0

6.79

7.19

g/l

2.26

126

1371

Malignant neoplasm, without specification of site, including Hilmo

120

764

1.60

5.50

2.9

1.4

7.85

7.55

g/l

1.10

110

668

Chronic iridocyclitis

112

702

1.63

5.49

2.1

2.4

7.57

7.34

g/l

0.76

106

644

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

645

5328

1.22

5.47

2.5

2.3

7.34

7.31

g/l

0.15

591

4923

Malignant neoplasm of breast, including Hilmo

837

4510

1.20

5.47

2.1

1.4

7.56

7.50

g/l

0.44

742

4057

Malignant neoplasm of breast, HER2-negative, including Hilmo

837

4511

1.20

5.46

2.1

1.4

7.55

7.50

g/l

0.40

742

4058

Other and unspecified nonorganic psychotic disorders

318

2419

1.33

5.43

1.7

2.3

7.37

7.22

g/l

0.86

289

2268

Pustulosis palmaris et plantaris

103

635

1.66

5.43

2.2

2.4

7.99

7.38

g/l

3.98

593

Excessive attrition of teeth

1280

11067

1.15

5.42

2.4

2.3

7.17

7.32

g/l

2.64

1180

10231

Benign neoplasm of urinary organs

127

824

1.58

5.41

1.9

2.6

7.42

7.41

g/l

0.03

119

754

Impotence

142

944

1.54

5.40

1.9

2.4

7.06

7.24

g/l

0.73

129

863

Malignant neoplasm of colon, including Hilmo

458

3643

1.27

5.39

2.6

1.4

7.64

7.50

g/l

0.98

411

3254

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

411

3196

1.28

5.38

2.1

7.09

7.25

g/l

1.17

382

2973

Acute laryngitis and tracheitis

159

1060

1.49

5.38

1.6

1.9

7.32

7.27

g/l

0.13

147

990

665

5159

1.22

5.34

2.2

7.58

7.54

g/l

0.20

573

4562

Hordeolum and other deep inflammation of eyelid

130

849

1.56

5.33

2.5

2.6

7.17

7.34

g/l

0.56

114

792

Seborrhoeic keratosis

644

5342

1.22

5.31

2.5

2.3

7.19

7.44

g/l

3.47

591

4820

Postprocedural musculoskeletal disorders, not elsewhere classified

189

1335

1.44

5.29

2.8

2.4

7.49

7.45

g/l

0.13

178

1217

Other other unspecified disorders of the circulatory system

571

1.69

5.28

2.1

2.5

7.64

7.37

g/l

0.71

521

Pneumothorax

169

1169

1.47

5.27

2.5

2.3

7.43

7.30

g/l

0.49

157

1077

Other salmonella infections, including avohilmo

586

1.67

5.25

2.7

2.3

7.50

7.33

g/l

0.39

541

Early complications of trauma

102

633

1.65

5.23

2.7

2.4

7.55

7.29

g/l

0.89

590

!Aliquae complicationes praecoces traumatis

102

633

1.65

5.23

2.7

2.4

7.55

7.29

g/l

0.89

590

Other and unspecified trigeminal disorders

184

2.26

5.21

1.9

2.0

6.94

7.21

g/l

0.52

170

Moderate visual impairment, binocular

505

1.73

5.20

1.7

2.1

7.54

7.66

g/l

0.25

453

Disorders of tooth development and eruption

284

1734

1.34

5.20

1.9

2.1

7.38

7.33

g/l

0.19

261

1595

Postprocedural disorders of nervous system

112

710

1.60

5.20

2.3

2.0

6.95

7.32

g/l

1.84

104

670

Recurrent dislocation and subluxation of joint

102

632

1.63

5.19

1.9

2.3

7.03

7.06

g/l

0.05

600

Ulcer of oesophagus

172

1200

1.46

5.15

2.3

2.6

7.40

7.44

g/l

0.13

154

1098

Other specified/unspecified disorders of bone/cartilage

358

1.87

5.14

2.8

2.1

6.93

7.27

g/l

0.98

338

Malignant neoplasm of breast, HER2-negative

821

4475

1.19

5.13

2.1

1.4

7.56

7.50

g/l

0.44

726

4022

Postpartum haemorrhage

184

2135

0.71

5.12

1.9

2.1

6.93

7.19

g/l

2.00

170

2009

Tongue abnormality

153

1046

1.49

5.11

2.7

2.4

7.11

7.43

g/l

1.70

139

952

Injury of muscle and tendon at lower leg level

334

2587

1.31

5.08

2.5

7.29

7.26

g/l

0.10

316

2414

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

120

777

1.56

5.08

1.9

2.3

7.08

g/l

0.01

105

730

Malignant neoplasm of breast

821

4481

1.19

5.05

2.1

1.4

7.56

7.50

g/l

0.46

726

4028

Benign neoplasm: salivary glands, exclude unknown (D119)

213

1549

1.40

5.03

1.9

2.4

7.46

7.42

g/l

0.13

196

1419

Retinal breaks without detachment

391

3095

1.28

5.03

2.4

7.11

7.38

g/l

2.14

351

2841

Familial hypercholesterolemia, with ischemic heart disease

260

1954

1.35

5.00

2.0

2.4

7.75

7.41

g/l

2.31

233

1739

Colitis, primary sclerosing, strict definition

100

2.71

4.99

2.7

2.4

7.18

7.17

g/l

0.01

Monocytic leukaemia

3.52

4.99

3.6

1.4

6.83

7.64

g/l

0.72

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

204

1275

1.40

4.99

1.4

1.6

7.07

7.04

g/l

0.12

192

1216

Ulcerative proctitis

118

766

1.56

4.99

1.4

2.2

7.30

7.28

g/l

0.05

109

709

Malignant neoplasm, without specification of site

503

1.71

4.98

2.8

1.4

7.89

7.59

g/l

0.84

437

Diffuse brain injury

398

1.79

4.95

2.5

2.0

7.49

7.45

g/l

0.06

373

Other retinal artery occlusion

401

1.81

4.93

2.1

2.8

7.47

7.52

g/l

0.07

366

Colitis, primary sclerosing

131

2.45

4.90

2.5

2.1

7.16

7.28

g/l

0.16

125

Inflammatory disease of uterus

226

1662

1.37

4.90

1.8

2.2

7.27

7.41

g/l

0.68

203

1538

Nail disorders

177

1252

1.43

4.89

1.9

2.3

7.23

7.34

g/l

0.39

164

1158

Colorectal cancer, including Hilmo

654

5100

1.20

4.88

2.5

1.4

7.52

7.49

g/l

0.18

587

4551

Post-traumatic wound infection, not elsewhere classified

364

1.83

4.88

2.4

2.5

7.56

7.20

g/l

1.06

338

Spontaneous abortion

585

4728

0.82

4.86

2.0

2.3

7.31

7.38

g/l

0.59

548

4333

Pustular psoriasis

110

709

1.59

4.86

2.2

2.3

7.98

7.39

g/l

4.06

103

656

Use of memantine

638

6123

0.83

4.85

1.9

2.3

7.61

7.53

g/l

0.50

509

5439

Use of other anti-dementia drugs

638

6123

0.83

4.85

1.9

2.3

7.61

7.53

g/l

0.50

509

5439

Benign neoplasm: Pituitary gland, craniopharyngeal duct

113

733

1.57

4.83

2.8

2.5

7.14

7.29

g/l

0.42

105

678

Drug-induced neutropenia

173

1225

1.44

4.81

3.5

2.5

7.47

7.37

g/l

0.28

168

1128

Flat foot [pes planus] (acquired)

186

1332

1.41

4.78

1.8

2.6

7.52

7.30

g/l

1.00

167

1220

Oesophageal obstruction

587

1.64

4.78

3.1

2.7

7.42

7.41

g/l

0.02

535

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

139

2.37

4.76

5.0

1.9

7.00

7.22

g/l

0.39

130

Central retinal artery occlusion

391

1.80

4.74

3.6

2.5

7.38

7.48

g/l

0.22

353

Nonsuppurative otitis media

354

2409

1.28

4.74

2.0

2.1

7.35

7.32

g/l

0.14

333

2223

Asthma mixed form (mode), excluding more controls

547

1.65

4.73

2.0

1.6

7.26

g/l

0.00

486

Other obstetric conditions, not elsewhere classified

319

1548

1.31

4.71

1.6

1.8

6.89

7.05

g/l

1.11

302

1480

Dystonia

121

803

1.54

4.68

1.3

2.5

7.07

7.37

g/l

1.35

112

744

Nontoxic multinodular goitre

465

3786

1.24

4.68

2.1

2.4

7.41

7.56

g/l

1.06

413

3411

Atrophic disorders of skin

335

2627

1.29

4.66

2.1

2.2

7.52

7.47

g/l

0.22

309

2383

Type 1 diabetes, strict definition, subgroup 1

448

1.71

4.66

1.4

1.6

7.30

6.80

g/l

1.97

431

Crohn disease (strict definition, require KELA, min 2 HDR)

110

715

1.56

4.64

1.9

2.2

7.04

7.27

g/l

0.79

102

666

Salpingitis and oophoritis

346

2726

1.28

4.63

1.8

2.5

7.63

7.46

g/l

1.04

316

2498

Other blood glucose lowering drugs, excl. Insulins

405

3254

1.26

4.63

1.8

2.4

8.18

7.26

g/l

21.06

374

2918

Crohn disease (strict definition, require KELA)

112

732

1.55

4.61

1.9

2.2

7.03

7.27

g/l

0.86

104

683

Epiphora

357

1.82

4.61

2.3

2.4

7.40

7.46

g/l

0.09

326

Other arterial embolism and thrombosis

462

1.71

4.59

1.4

2.5

7.68

7.42

g/l

0.51

419

Other disorders of cornea

225

1676

1.36

4.59

2.0

2.3

7.32

7.42

g/l

0.38

208

1535

Complications of labour and delivery

895

5770

0.86

4.59

2.5

2.2

7.32

7.43

g/l

1.27

837

5260

Lagophthalmos

202

2.13

4.58

2.0

2.2

7.79

7.44

g/l

0.53

186

Benign neoplasm of middle ear and respiratory system

187

1354

1.40

4.58

2.5

2.4

7.31

7.40

g/l

0.25

175

1242

Disorders of optic nerve, not elsewhere classified

329

1.86

4.57

2.5

2.7

7.55

7.41

g/l

0.21

303

Convalescence

112

735

1.55

4.56

2.1

7.21

7.35

g/l

0.49

671

Dislocation, sprain and strain of joints and ligaments at neck level

263

2004

1.32

4.53

2.2

2.3

7.19

7.25

g/l

0.21

245

1874

Corneal scars and opacities

403

1.76

4.53

2.8

2.6

7.75

7.41

g/l

0.65

370

Other and unspecified follicular disorders

532

1.65

4.52

3.0

2.4

7.34

7.24

g/l

0.22

502

Burns and corrosions of external body surface, specified by site

205

1509

1.37

4.49

2.1

2.3

7.45

7.29

g/l

0.64

187

1410

Spasmodic torticollis

435

1.72

4.46

1.4

2.1

7.23

7.45

g/l

0.69

407

Disorders of synovium and tendon in diseases classified elsewhere

266

1.93

4.45

1.8

2.1

7.42

7.37

g/l

0.09

247

Lichen planus, including avohilmo

449

3665

1.24

4.44

2.5

2.3

7.33

7.44

g/l

0.74

413

3338

Acute suppurative otitis media

350

2582

1.27

4.41

3.0

2.1

7.30

7.19

g/l

0.58

327

2421

Benign neoplasm: Liver/bile ducts

347

1.80

4.39

2.2

2.0

7.30

7.38

g/l

0.17

328

Other and unspecified mononeuropathies, also in other diseases

422

1.73

4.39

2.0

2.3

7.33

7.35

g/l

0.04

385

Other predominantly sexually transmitted diseases, not elsewhere classified

239

1805

1.33

4.38

2.2

7.12

7.20

g/l

0.39

219

1700

Single delivery by forceps and vacuum extractor

836

0.63

4.38

1.6

6.89

7.25

g/l

1.56

789

Status post-ami

706

4551

1.19

4.37

1.7

2.4

7.77

7.39

g/l

6.32

634

4049

Lichen ruber planus, wide definition including periferal and oral lichen planus

529

4396

1.21

4.37

2.4

7.33

7.44

g/l

0.91

485

4010

Benign neoplasm: Parotid gland

189

1383

1.39

4.37

2.0

2.4

7.48

7.40

g/l

0.20

175

1270

Other noninflammatory disorders of vagina

158

1120

1.43

4.36

2.3

7.46

7.53

g/l

0.19

141

1014

Other noninflammatory disorders of uterus, except cervix

486

2658

1.23

4.35

2.4

2.3

7.57

7.64

g/l

0.42

435

2390

Lateral epicondylitis

242

1836

1.33

4.33

1.8

2.3

7.32

7.30

g/l

0.05

223

1699

Retinal haemorrhage

440

1.71

4.32

4.0

2.7

7.22

7.57

g/l

0.92

401

Senility

126

2.37

4.32

1.7

2.0

7.13

8.02

g/l

1.12

114

Other neurotic disorders

106

697

1.55

4.32

1.6

2.6

7.29

7.37

g/l

0.21

635

Subacute thyroiditis

508

1.65

4.31

2.6

2.3

7.56

7.43

g/l

0.23

468

Triptan medication for migraine, min. 3 purchases

928

6014

1.16

4.31

2.2

7.01

7.30

g/l

7.18

871

5594

Other lesions of median nerve

425

1.72

4.30

1.2

2.3

7.77

7.51

g/l

0.53

380

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

303

1478

1.30

4.29

1.5

1.8

6.87

7.03

g/l

1.09

287

1415

Lichen planus

310

2438

1.29

4.29

2.8

2.3

7.32

7.47

g/l

1.05

284

2217

Secondary parkinsonism, excluding more controls

335

1.80

4.27

2.9

2.1

7.21

7.59

g/l

1.04

309

Hyperfunction of pituitary gland

516

1.63

4.27

2.7

2.0

7.07

7.34

g/l

0.91

486

Contact with heat and hot substances

102

667

1.55

4.24

1.9

2.3

7.51

7.34

g/l

0.34

621

Viral infections of the central nervous system

140

977

1.45

4.23

2.3

7.33

7.36

g/l

0.07

127

900

Benign neoplasm: Spinal meninges

175

2.16

4.21

1.4

2.0

7.20

7.54

g/l

0.36

158

Disorders of refraction and accommodation

511

4226

1.21

4.21

2.0

2.2

7.19

7.33

g/l

1.13

474

3915

Corns and callosities

152

1079

1.43

4.21

2.4

2.3

7.41

7.43

g/l

0.05

139

992

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

117

789

1.50

4.20

1.9

2.3

7.07

7.26

g/l

0.65

109

734

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

158

1130

1.42

4.20

1.9

1.4

7.56

7.47

g/l

0.23

140

1000

Benign neoplasm: Kidney

584

1.60

4.18

2.1

2.7

7.35

7.41

g/l

0.13

536

All dysplastic lesions of the cervix uteri, vagina or vulva

415

3292

1.24

4.17

2.2

2.0

7.30

7.26

g/l

0.24

383

3060

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

282

3594

0.78

4.17

1.8

1.5

7.83

7.45

g/l

3.17

259

3235

Benign neoplasm of meninges

254

1956

1.32

4.17

1.9

2.4

7.23

7.51

g/l

1.68

225

1771

Status epilepticus

490

1.64

4.14

1.6

2.6

7.26

7.45

g/l

0.43

445

Meralgia paraesthetica

483

1.65

4.13

1.4

2.4

7.25

7.31

g/l

0.12

447

Malignant neoplasm of head and neck, including Hilmo

221

1671

1.34

4.11

2.7

1.4

7.29

7.46

g/l

0.80

204

1490

Arterial embolism and thrombosis of lower extremity artery

610

1.58

4.11

1.4

2.6

7.79

7.38

g/l

1.36

554

Maternal care for other conditions predominantly related to pregnancy

254

1903

1.31

4.10

2.0

7.08

7.12

g/l

0.18

243

1805

Uterine polyps

575

2812

1.20

4.07

1.9

2.3

7.44

7.58

g/l

1.19

517

2543

Campylobacter enteritis

356

1.75

4.04

2.1

2.4

7.23

7.34

g/l

0.25

329

Contusion of other and unspecified parts of foot

555

1.59

4.03

2.0

2.3

7.21

7.29

g/l

0.20

521

Ectropion of eyelid

116

792

1.50

4.01

1.6

2.5

7.84

7.54

g/l

0.96

100

702

Malignant neoplasm of bladder

165

1198

1.40

4.00

1.9

1.4

7.62

7.46

g/l

0.61

148

1055

Burns and corrosions of multiple and unspecified body regions

262

1.88

3.97

1.9

2.7

7.84

7.21

g/l

1.54

248

Congenital iodine-deficiency syndrome/hypothyroidism

458

1.66

3.97

3.2

2.0

7.61

7.52

g/l

0.13

415

Disorder of external ear, unspecified

489

1.63

3.95

2.7

2.6

7.42

7.35

g/l

0.15

455

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

584

4060

1.19

3.93

2.2

1.4

7.96

7.48

g/l

7.48

534

3639

Acne, including avohilmo

224

1373

1.33

3.92

1.7

1.8

7.15

7.11

g/l

0.17

212

1295

Benign neoplasm: Liver

300

1.81

3.92

2.2

2.1

7.30

7.32

g/l

0.02

284

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

267

2082

1.29

3.91

2.1

7.09

7.18

g/l

0.41

245

1964

Benign neoplasm: Skin of ear and external auricular canal

100

666

1.54

3.91

2.4

7.10

7.42

g/l

1.07

607

Viral infections of the central nervous system, including avohilmo

149

1068

1.41

3.91

2.2

2.4

7.36

7.37

g/l

0.02

135

985

Other disorders of bone density and structure

301

1.80

3.86

1.9

2.1

7.27

7.26

g/l

0.02

283

Malnutrition

317

1.79

3.85

1.7

2.1

7.14

7.56

g/l

0.92

286

Carcinoma in situ of skin of ear and external auricular canal

304

1.82

3.83

1.8

2.4

6.99

7.33

g/l

0.82

267

Haemangioma and lymphangioma, any site

190

1422

1.35

3.82

2.7

2.4

7.39

7.36

g/l

0.08

178

1311

Benign neoplasm of eye and adnexa

250

1946

1.30

3.81

1.8

2.4

7.24

7.45

g/l

1.24

223

1782

Dissection of aorta

542

1.59

3.81

2.2

2.6

7.04

7.31

g/l

0.71

496

Other female pelvic inflammatory diseases

311

2485

1.26

3.79

1.7

2.4

7.63

7.50

g/l

0.59

258

2264

Allergic contact dermatitis due to drugs in contact with skin

319

1.77

3.77

2.2

2.1

7.94

7.40

g/l

1.40

298

Malignant neoplasm of digestive organs

929

6234

1.15

3.77

2.2

1.4

7.55

7.49

g/l

0.51

832

5590

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

536

4521

1.19

3.77

1.8

2.3

7.26

7.28

g/l

0.11

492

4203

Acquired absence of limb

142

2.21

3.76

2.4

1.8

8.20

7.33

g/l

1.76

132

Pre-eclampsia or eclampsia

338

2727

1.25

3.75

2.4

2.2

7.38

7.33

g/l

0.24

316

2524

Complications peculiar to reattachment and amputation

2.55

3.75

1.9

2.6

8.29

7.36

g/l

1.51

Sequelae of injuries of neck and trunk

395

1.68

3.74

3.2

2.6

7.31

7.25

g/l

0.11

368

Single spontaneous delivery

666

4101

0.85

3.73

2.6

2.1

7.52

7.59

g/l

0.50

613

3658

Congenital malformations of cardiac septa

108

712

1.49

3.73

1.6

2.3

6.85

7.33

g/l

2.17

664

Benign neoplasm: Skin of eyelid, including canthus

372

3044

1.23

3.69

3.2

2.3

7.27

7.47

g/l

1.67

331

2767

Pneumonitis due to solids and liquids

204

1554

1.33

3.67

2.2

7.60

7.42

g/l

0.85

172

1406

Polyp of the female genital tract

595

2856

1.19

3.67

1.9

2.2

7.46

7.58

g/l

0.92

541

2581

Pre-eclampsia or poor fetal growth

420

3458

1.21

3.65

2.3

2.1

7.25

7.28

g/l

0.16

393

3216

Focal epilepsy, strict definition

428

3551

1.21

3.65

2.0

2.3

7.22

7.40

g/l

1.42

379

3248

Malignant neoplasm of colon

365

2983

1.24

3.65

2.8

1.4

7.59

7.53

g/l

0.25

329

2652

Pedestrian injured in transport accident

143

1033

1.40

3.62

1.7

2.3

7.43

7.37

g/l

0.16

131

952

Amyloidosis of skin

7.27

3.61

3.0

1.1

6.38

8.10

g/l

—

Assault by bodily force

109

749

1.47

3.60

1.9

2.2

7.20

7.17

g/l

0.07

101

717

Nonspecific lymphadenitis

107

734

1.48

3.60

1.8

2.2

7.34

7.29

g/l

0.10

101

688

Haemangioma, any site

178

1334

1.35

3.58

2.5

7.43

7.35

g/l

0.26

166

1228

Disturbance of activity and attention

112

754

1.46

3.58

1.4

1.6

6.85

7.06

g/l

0.73

106

725

Degeneration of nervous system due to alcohol

340

1.73

3.57

1.2

2.7

7.24

7.27

g/l

0.07

314

Procedures for purposes other than remedying health state

309

1.76

3.57

1.9

1.7

6.97

7.34

g/l

1.08

290

Other disorders of Eustachian tube

424

1.64

3.56

1.6

2.3

7.03

7.41

g/l

1.03

394

conjunctival haemorrhage

187

1415

1.34

3.55

2.4

2.3

7.25

7.44

g/l

0.89

172

1291

Focal epilepsy

453

3788

1.20

3.55

2.0

2.3

7.26

7.39

g/l

0.93

402

3465

Other facial nerve disorders

378

1.68

3.54

2.1

7.08

7.30

g/l

0.43

346

Contusion of toe(s) without damage to nail

272

1.80

3.54

1.2

2.5

7.16

7.26

g/l

0.17

261

Crohn disease (strict definition, all UC cases excluded)

582

1.53

3.54

1.7

2.4

7.17

7.26

g/l

0.22

543

Other congenital malformations of the digestive system, including avohilmo

586

1.53

3.52

1.5

2.5

7.20

7.35

g/l

0.39

541

HSIL lesion of the cervix uteri, vagina or vulva

270

2140

1.27

3.52

2.1

2.0

7.38

7.26

g/l

0.64

246

1994

Sixth [abducent] nerve palsy

537

1.56

3.51

2.6

7.52

7.40

g/l

0.28

486

Viral encephalitis, not elsewhere classified/unspecified

274

1.80

3.50

3.3

2.4

7.44

7.31

g/l

0.20

252

Delivery

672

4103

0.86

3.49

2.5

2.1

7.52

7.59

g/l

0.46

621

3660

Other disorders of the genitourinary system

304

2452

1.25

3.48

2.2

2.3

7.56

7.52

g/l

0.13

277

2209

Benign neoplasm: Pancreas

507

1.58

3.48

2.5

2.8

7.40

7.42

g/l

0.04

463

Vascular dementia

271

2080

1.27

3.47

2.6

2.3

7.68

7.53

g/l

0.68

230

1842

Degeneration of the brain due to alcohol

343

1.71

3.47

1.2

2.7

7.24

7.31

g/l

0.15

316

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

5.66

3.45

2.8

1.1

6.27

8.20

g/l

—

Sequelae of injuries of head

103

708

1.48

3.45

2.7

2.4

7.49

7.24

g/l

0.71

657

Malignant neoplasm of liver and intrahepatic bile ducts

491

1.58

3.45

1.9

1.4

7.70

7.44

g/l

0.52

437

Hyperkinetic disorders

117

800

1.43

3.44

1.4

1.6

6.88

7.04

g/l

0.53

111

767

Acute alcohol intoxication, ICD10

401

3333

1.21

3.39

1.4

2.4

7.43

7.24

g/l

1.42

364

3118

120

1668

0.71

3.39

1.3

2.3

7.10

7.35

g/l

0.74

1526

Other and unspecified mononeuropathies of upper limb

375

1.66

3.39

1.6

2.4

6.92

7.26

g/l

0.82

353

Medial epicondylitis

447

1.59

3.32

1.4

2.2

7.33

7.40

g/l

0.12

421

Use of rivastigmine

320

3892

0.81

3.31

2.4

2.3

7.45

7.57

g/l

0.60

269

3429

Other problems related to primary support group, including family circumstances

142

1010

1.38

3.31

1.8

2.1

7.27

7.26

g/l

0.04

132

951

Melanoma in situ of trunk

273

1.79

3.29

2.3

2.7

6.98

7.33

g/l

0.86

250

Chorioretinal inflammation

410

1.62

3.28

1.6

2.2

7.21

7.36

g/l

0.30

382

Vulvovaginal ulceration/inflammation in other diseases

106

740

1.45

3.27

1.8

2.3

7.30

7.39

g/l

0.24

693

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

171

1292

1.34

3.27

2.2

2.4

7.38

7.45

g/l

0.22

155

1185

Paralytic strabismus

163

1226

1.35

3.26

2.1

2.4

7.52

7.42

g/l

0.30

149

1126

Postpartum hemorraghe, parous women as controls

184

2006

0.76

3.25

1.9

2.1

6.93

7.14

g/l

1.44

170

1903

Macular cyst

572

1.52

3.25

2.3

2.7

7.36

7.49

g/l

0.29

524

Reduction defects of unspecified limb

9.30

3.24

1.0

6.35

7.76

g/l

—

Inflammatory diseases of prostate (prostatitis)

288

2330

1.25

3.23

2.1

2.5

7.11

7.30

g/l

1.25

270

2153

Strabismus

503

4273

1.18

3.22

2.2

2.3

7.21

7.37

g/l

1.37

465

3925

Schizophrenia or delusion, excluding more controls

520

4383

1.18

3.22

2.0

2.4

7.48

7.30

g/l

1.64

466

4069

Prepatellar bursitis

620

1.49

3.22

2.5

2.3

7.09

7.28

g/l

0.48

572

Brain meningioma, including Hilmo

113

804

1.43

3.19

2.3

1.4

7.30

7.55

g/l

0.87

104

706

Malignant neoplasm of small intestine, including Hilmo

477

1.56

3.19

2.1

1.4

7.41

7.50

g/l

0.19

425

Trigeminal neuralgia

125

905

1.40

3.18

2.4

2.3

7.54

7.37

g/l

0.56

116

829

Hereditary angioödema type 1

6.90

3.18

10.1

1.0

6.29

8.02

g/l

—

Other and unspecified disorders of skin and subcutaneous tissue

138

1016

1.38

3.18

1.8

2.4

7.41

7.38

g/l

0.05

111

932

Alzheimer’s disease (Atypical or mixed)

208

2610

0.78

3.16

1.8

2.2

7.53

7.56

g/l

0.08

174

2288

Injury of nerves and spinal cord at neck level

321

1.69

3.16

2.6

2.8

6.91

7.30

g/l

1.13

294

Residual foreign body in soft tissue

622

1.48

3.16

2.0

2.4

7.10

7.36

g/l

0.79

583

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

283

1.74

3.16

3.3

2.4

7.44

7.30

g/l

0.21

261

Congenital malformations of heart and great arteries

214

1624

1.29

3.16

2.1

2.3

6.85

7.34

g/l

3.98

195

1509

Appendectomy

1315

11347

1.11

3.15

2.4

2.3

7.32

7.31

g/l

0.08

1209

10473

Other and unspecified mononeuropathies of lower limb

407

1.61

3.14

1.7

2.1

7.29

7.36

g/l

0.12

373

Haemorrhagic disorder due to circulating anticoagulants

247

1.81

3.14

1.9

2.4

7.57

7.51

g/l

0.07

222

Polypectomy (DHB20)

144

1070

1.36

3.13

2.7

2.4

7.25

7.36

g/l

0.36

136

992

Melanocytic naevi of upper limb, including shoulder

314

1.69

3.13

1.9

2.3

6.87

7.35

g/l

1.35

295

Physiological and behavioural disorders associated with sexual development and orientation

8.12

3.12

1.0

5.8

5.97

6.31

g/l

—

Asthma mixed form (mode)

607

1.48

3.12

2.0

1.7

7.26

7.29

g/l

0.08

542

Acute lymphadenitis

665

1.46

3.11

2.6

2.4

7.58

7.30

g/l

0.83

618

Alzheimer disease

802

6483

0.88

3.11

1.9

2.3

7.62

7.52

g/l

0.89

673

5761

Corneal ulcer

362

3009

1.21

3.10

2.3

2.2

7.51

7.34

g/l

1.13

335

2769

Endocrine disorders, other/unspecified

246

0.36

3.10

1.4

2.2

7.51

7.42

g/l

—

233

Sequelae of injuries of upper limb

188

1453

1.31

3.09

2.6

2.5

7.42

7.31

g/l

0.33

170

1347

Malignant neoplasm of head and neck

179

1375

1.32

3.08

2.1

1.4

7.34

7.45

g/l

0.35

166

1228

Postpartum hemorraghe, all women as controls

184

2317

0.77

3.08

1.9

2.0

6.93

7.16

g/l

1.69

170

2195

Maternal care related to the fetus and amniotic cavity and possible delivery problems

487

3352

0.85

3.07

2.6

2.1

7.14

7.30

g/l

1.40

463

3119

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

175

1.92

3.04

2.6

2.2

7.05

7.35

g/l

0.46

166

Arthropathy in Crohn disease

114

2.18

3.01

1.0

2.3

7.35

7.24

g/l

0.09

109

Focal brain injury

127

931

1.38

3.00

2.1

2.4

7.45

7.42

g/l

0.08

108

860

Medical abortion

1239

6058

1.11

3.00

1.8

2.4

7.51

7.45

g/l

0.55

1112

5472

Palindromic rheumatism

121

2.14

2.99

1.4

1.9

7.91

7.03

g/l

1.38

111

Noninflammatory disorders of female genital tract

691

3022

1.15

2.99

2.3

2.2

7.48

7.55

g/l

0.41

626

2740

Myocardial infarction, with ST-elevation

441

3749

1.19

2.98

1.8

2.3

7.79

7.38

g/l

5.66

406

3375

Conductive hearing loss, unspecified

170

1304

1.32

2.98

2.2

2.3

7.49

7.42

g/l

0.21

156

1201

Graves disease, strict definition

182

1408

1.30

2.98

2.5

2.2

7.38

7.37

g/l

0.04

167

1307

Brain meningioma

109

782

1.42

2.97

2.3

1.4

7.29

7.55

g/l

0.89

100

687

Ingrowing nail

689

1.44

2.97

2.1

2.4

7.20

7.30

g/l

0.26

639

Schizophrenia

179

2302

0.77

2.96

2.4

2.3

7.61

7.24

g/l

2.49

159

2148

Other diseases of gallbladder

106

758

1.42

2.95

2.6

2.5

7.29

7.45

g/l

0.46

685

Graves ophthalmopathy, strict

305

1.68

2.93

1.1

2.0

7.81

7.49

g/l

0.74

285

Recurrent and persistent haematuria

109

2.19

2.92

1.3

2.5

7.02

7.41

g/l

0.59

101

Tracheo-bronchomalasia

4.24

2.92

1.7

3.8

7.48

7.03

g/l

—

Benign neoplasm: Cerebral meninges

225

1796

1.27

2.91

2.0

2.4

7.19

7.53

g/l

2.24

203

1632

Other disorders of conjunctiva

336

2796

1.21

2.90

2.7

2.3

7.32

7.49

g/l

1.06

311

2545

Leiomyoma of uterus

1271

6464

1.11

2.89

2.3

2.2

7.51

7.46

g/l

0.40

1131

5854

Other peripheral vertigo

213

1690

1.28

2.89

1.8

2.5

7.37

7.44

g/l

0.28

190

1546

Lung diseases due to external agents

340

2835

1.21

2.87

2.8

2.3

7.65

7.40

g/l

2.08

297

2564

Other and unspecified acute skin changes due to ultraviolet radiation

393

1.59

2.87

2.1

2.3

6.99

7.50

g/l

2.12

355

Benign neoplasm of breast

243

1958

1.25

2.87

2.2

7.35

7.56

g/l

1.31

217

1765

Dislocation of lens

239

1.76

2.85

2.7

2.5

7.69

7.56

g/l

0.18

225

Congenital obstruction of the pelviureteric junction

2.25

2.84

3.3

2.4

7.39

7.52

g/l

0.11

Other puerperal infections

537

1.48

2.83

1.7

6.95

7.25

g/l

0.99

515

Benign neoplasm: Prostate

118

2.15

2.83

3.7

3.0

7.14

7.31

g/l

0.19

104

Other factor of the environment

159

1.94

2.82

3.5

1.9

7.51

7.37

g/l

0.16

149

Examination and encounter for administrative purposes

156

1193

1.32

2.81

2.5

2.3

7.46

7.38

g/l

0.26

146

1097

Ventricular septal defect, a heart condition

158

1.92

2.81

1.5

1.8

6.75

7.39

g/l

1.42

150

Benign neoplasm: Larynx

492

1.51

2.80

2.5

2.6

7.17

7.30

g/l

0.25

452

Benign neoplasm of other and unspecified intrathoracic organs

160

1.95

2.79

2.8

2.2

7.59

7.42

g/l

0.18

147

Atopic conjunctivitis

499

1.50

2.79

1.5

2.0

7.27

7.44

g/l

0.38

465

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

279

2286

1.23

2.79

2.1

2.2

7.26

7.39

g/l

0.67

259

2102

Malignant neoplasm of oral cavity, including Hilmo

657

1.44

2.78

2.3

1.4

7.34

7.49

g/l

0.38

586

Other diseases of spinal cord

420

1.55

2.77

2.6

2.7

7.55

7.32

g/l

0.48

390

Ulcerative rectosigmoiditis

144

1091

1.33

2.77

1.9

2.4

7.16

7.28

g/l

0.35

131

1021

Pre-eclampsia

295

2434

1.22

2.76

2.6

2.2

7.37

7.31

g/l

0.23

273

2256

Vertigo of central origin

257

1.72

2.75

2.0

2.7

7.32

7.54

g/l

0.57

232

HSIL lesion of the cervix uteri

224

1795

1.25

2.75

1.9

2.1

7.30

7.20

g/l

0.44

207

1685

Malignant neoplasm of endocrine gland, including Hilmo

154

1180

1.32

2.75

2.7

1.4

7.30

7.46

g/l

0.55

142

1054

Thyroiditis, unspecified

197

1.82

2.74

1.3

1.8

7.17

7.41

g/l

0.31

184

All dysplastic lesions of the cervix uteri

329

2700

1.20

2.74

2.1

7.25

7.20

g/l

0.20

307

2527

Non-small cell lung cancer, including Hilmo

355

2800

1.20

2.73

2.0

1.4

8.07

7.48

g/l

7.01

323

2501

Proteinuria and renal glomerular damage; focal glomerulonephritis

4.66

2.72

1.3

3.0

8.30

7.84

g/l

—

Laparoscopic right hemicolectomy

150

1150

1.33

2.72

2.4

2.5

7.44

7.47

g/l

0.07

130

1042

Vascular dementia (subcortical)

101

729

1.41

2.72

3.3

2.2

7.61

7.62

g/l

0.02

647

Hereditary sideroblastic anaemia

2.82

2.71

2.8

1.5

7.55

7.52

g/l

0.02

Colorectal cancer

558

4668

1.15

2.70

2.7

1.4

7.51

7.49

g/l

0.11

501

4158

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

6.59

2.69

1.0

6.07

8.72

g/l

—

Foreign body entering into or through eye or natural orifice

147

1123

1.32

2.69

2.6

2.3

7.26

7.28

g/l

0.04

133

1051

Alzheimer’s disease (Early onset), excluding more controls

610

0.60

2.68

1.2

2.2

7.71

7.59

g/l

0.13

545

Blindness, monocular

141

1.99

2.68

4.3

2.0

7.14

7.52

g/l

0.55

131

Lifestyle-related condition

148

1.95

2.67

3.6

1.9

7.50

7.32

g/l

0.20

137

Abnormal spermatozoa

216

2672

0.80

2.65

2.0

2.5

7.29

7.26

g/l

0.11

198

2453

Other drug-induced secondary parkinsonism

156

1.93

2.65

2.3

7.15

7.57

g/l

0.66

145

Delivery, wide proxy

561

3414

0.87

2.65

2.4

2.0

7.54

7.64

g/l

0.76

514

3005

Triptan medication for migraine, single purchase ok

1430

8883

1.09

2.63

2.2

2.3

7.09

7.34

g/l

7.48

1333

8206

Migraine, single triptan purchase ok & required. ICD-code if available is included

1430

8883

1.09

2.63

2.2

2.3

7.09

7.34

g/l

7.48

1333

8206

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

113

834

1.37

2.63

1.7

1.4

7.63

7.51

g/l

0.25

733

Unspecific neurodegenerative disorder

1060

7995

0.90

2.63

2.0

2.4

7.56

7.49

g/l

0.59

875

7188

Granuloma annulare

200

1.80

2.62

1.9

1.8

7.29

7.50

g/l

0.45

187

Seminoma of testis, including Hilmo

2.36

2.62

1.6

1.4

6.96

6.93

g/l

0.03

Moyamoya

7.81

2.61

1.2

1.0

5.92

6.64

g/l

—

Pyoderma

253

1.70

2.61

1.9

2.3

7.49

7.34

g/l

0.19

237

Osteochondrodysplasia with defects of growth of tubular bones and spine

5.84

2.60

1.0

1.2

8.48

6.82

g/l

—

Chromophobe cell carcinoma of kidney

2.39

2.59

2.3

1.2

6.79

7.35

g/l

0.66

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.98

2.59

11.9

1.1

7.20

8.10

g/l

—

Diseases of appendix

1577

13016

1.09

2.58

2.6

2.3

7.25

7.32

g/l

0.96

1446

11989

Other acquired deformities of musculoskeletal system and connective tissue

651

1.42

2.57

2.4

2.3

7.58

7.35

g/l

0.56

601

Other changes in lacrimal passages

4.23

2.56

2.9

1.6

7.34

7.94

g/l

—

Chondromalacia

380

1.56

2.56

1.5

2.2

7.72

7.35

g/l

0.65

363

Use of disulfiram, acamprosate or naltrexone

151

1167

1.31

2.55

1.6

2.3

7.53

7.18

g/l

1.97

135

1099

Melanoma in situ of other and unspecified parts of face

249

1.71

2.53

2.2

2.6

7.13

7.56

g/l

0.91

226

Meningitis

669

1.41

2.53

3.1

2.3

7.27

7.33

g/l

0.14

622

Bitten or struck by other mammals

189

1503

1.27

2.53

3.0

2.4

7.35

7.28

g/l

0.26

179

1395

Injuries involving multiple body regions

486

1.48

2.53

2.3

7.45

7.29

g/l

0.34

453

Acute alcohol intoxication

537

4698

1.15

2.52

1.5

2.5

7.49

7.22

g/l

3.23

485

4358

Septal defects

672

1.40

2.51

1.7

2.3

6.81

7.32

g/l

2.18

627

Benign neoplasm: Choroid

156

1217

1.30

2.50

1.7

2.6

7.11

7.41

g/l

1.52

137

1113

Malignant neoplasm of pancreas

1227

0.72

2.49

1.7

1.4

7.45

7.53

g/l

0.16

1088

Other maternal disorders predominantly related to pregnancy

759

5315

0.89

2.48

2.3

7.39

7.34

g/l

0.34

709

4908

Myopia

189

1507

1.26

2.48

2.0

2.3

7.14

7.29

g/l

0.67

179

1407

Alkalosis

3.57

2.46

2.0

2.6

6.93

7.57

g/l

—

Ménière disease

210

1701

1.25

2.44

1.9

2.5

7.44

7.45

g/l

0.04

191

1552

Malignant neoplasm of thymus, including Hilmo

2.55

2.44

4.7

1.2

7.41

7.46

g/l

0.03

Convergent concomitant strabismus

589

1.42

2.44

2.3

2.2

7.19

7.30

g/l

0.24

548

Contact with and exposure to communicable diseases

385

3277

1.17

2.44

2.2

2.1

7.02

7.16

g/l

1.09

374

3084

Respiratory tuberculosis, confirmed

274

1.64

2.43

1.8

2.4

7.91

7.43

g/l

0.91

247

Systemic sclerosis,strict definition

125

1.99

2.42

1.4

1.8

7.16

7.54

g/l

0.61

118

Unspecified mental disorder

738

6601

1.12

2.41

2.0

2.3

7.29

7.30

g/l

0.05

680

6082

Car occupant injured in other and unspecified transport accidents

317

2673

1.19

2.41

2.0

2.2

7.26

7.31

g/l

0.23

290

2478

Respiratory tuberculosis, confirmed, including avohilmo

283

1.63

2.40

1.9

2.4

7.91

7.41

g/l

1.01

255

Other and unspecified primary disorders of muscles

2.17

2.39

1.4

2.6

7.57

7.15

g/l

0.70

Acute appendicitis

1442

12358

1.09

2.39

2.6

2.3

7.25

7.31

g/l

0.78

1328

11398

Congenital varicose veins

2.93

2.39

2.4

2.1

7.19

7.53

g/l

0.32

Malignant neoplasm of small intestine

347

1.56

2.38

2.5

1.4

7.21

7.55

g/l

0.94

309

Corneal degeneration

276

1.64

2.38

1.4

2.4

7.51

7.48

g/l

0.03

253

Hepatocellular carcinoma

347

1.56

2.38

2.2

1.4

7.70

7.42

g/l

0.51

305

Focal epilepsy, mode (most common among epilepsy diagnosis)

389

3341

1.17

2.37

2.1

2.3

7.18

7.39

g/l

1.61

340

3059

Dentofacial anomalies [including malocclusion]

1347

9701

1.09

2.37

2.3

7.16

7.33

g/l

3.67

1238

8966

Presbycusis

402

3424

1.17

2.36

2.5

2.2

7.47

7.59

g/l

0.79

345

3040

Other and unspecified abdominal hernia

680

1.39

2.35

1.6

2.1

7.41

7.52

g/l

0.22

623

Explicit viral Sepsis

6.79

2.34

1.2

1.0

7.34

7.63

g/l

—

Explicit viral Sepsis, including avohilmo

6.56

2.32

1.2

1.0

7.34

7.63

g/l

—

Acute appendicitis, no complications

1064

9664

1.10

2.30

2.7

2.3

7.19

7.28

g/l

0.94

986

8960

Appendicitis, broad definition

1552

12917

1.08

2.30

2.6

2.3

7.24

7.32

g/l

1.08

1425

11901

Effects of foreign body entering through natural orifice

468

4087

1.15

2.29

2.3

2.4

7.29

7.27

g/l

0.09

428

3795

Disorders of lacrimal system and orbit in diseases classified elsewhere

342

1.55

2.29

1.1

2.0

7.74

7.45

g/l

0.66

320

Neovascular glaucoma

683

1.38

2.29

2.4

2.3

7.69

7.38

g/l

1.15

620

Dronedarone medication

465

1.47

2.29

2.3

2.6

7.48

g/l

0.01

413

hereditary angioödema type 3

6.24

2.29

1.0

7.22

7.06

g/l

—

Malignant neoplasm of thyroid gland, including Hilmo

135

1046

1.30

2.28

2.6

1.4

7.27

7.46

g/l

0.59

123

934

Open wound of wrist and hand

903

7916

1.11

2.27

2.4

2.3

7.36

7.27

g/l

0.75

840

7334

Other acute skin changes due to ultraviolet radiation

532

1.43

2.27

2.0

2.3

7.11

7.47

g/l

1.36

487

Injury of other and unspecified intrathoracic organs

134

1039

1.30

2.27

1.9

2.3

7.30

7.34

g/l

0.10

125

954

Pedal cyclist injured in noncollision transport accidents

205

1670

1.24

2.26

1.8

2.3

6.94

7.34

g/l

3.05

186

1555

Hypertrophic disorders of skin

666

1.38

2.26

2.5

2.2

7.15

7.37

g/l

0.57

621

Carcinoma in situ of other and unspecified sites

106

798

1.35

2.26

2.9

2.5

7.32

7.36

g/l

0.07

732

Perforation of tympanic membrane

198

1609

1.24

2.25

2.3

7.21

7.42

g/l

1.17

180

1470

Graves ophthalmopathy

344

1.54

2.24

1.1

2.0

7.74

7.42

g/l

0.78

320

Varicose veins of other sites

124

953

1.32

2.24

2.7

2.3

6.82

7.28

g/l

2.21

108

882

Glaucoma secondary to other eye disorders

686

1.38

2.24

2.4

2.6

7.69

7.41

g/l

1.01

622

Inguinal or femoral hernia, bilateral

251

2092

1.21

2.23

2.7

2.4

7.05

7.35

g/l

2.37

225

1913

Inguinal hernia, bilateral

247

2056

1.21

2.23

2.7

2.4

7.04

7.35

g/l

2.44

221

1879

Vascular dementia (undefined)

109

816

1.34

2.23

2.1

7.87

7.63

g/l

0.58

716

Alport

4.66

2.21

1.5

3.8

7.50

7.24

g/l

—

Burn and corrosion of wrist and hand

426

1.47

2.21

1.6

2.3

7.27

7.14

g/l

0.25

401

Nontoxic single thyroid nodule

149

1177

1.28

2.19

2.4

2.3

7.19

7.46

g/l

1.33

140

1078

Carcinoma in situ, bladder

725

1.36

2.18

3.1

2.6

7.26

7.34

g/l

0.15

666

Contact with other and unspecified heat and hot substances

2.17

2.18

4.9

1.9

7.99

7.16

g/l

0.81

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

110

834

1.33

2.18

2.1

2.4

7.16

7.21

g/l

0.14

105

790

Diseases of middle ear and mastoid

1067

7979

1.09

2.17

2.5

2.2

7.27

7.30

g/l

0.21

995

7339

Use of galantamine

140

1769

0.78

2.16

1.6

2.4

7.65

7.54

g/l

0.33

108

1559

Other disorders of breast

243

2025

1.21

2.15

2.4

2.3

7.01

7.49

g/l

4.70

213

1848

Abdominal aortic aneurysm (AAA)

243

2010

1.21

2.15

1.8

2.3

7.63

7.31

g/l

2.22

217

1794

Non-small cell lung cancer, adenocarcinoma

143

1129

1.28

2.13

1.8

1.4

8.00

7.48

g/l

2.52

129

1000

Benign lipomatous neoplasm

641

5746

1.12

2.11

2.5

2.4

7.36

7.38

g/l

0.10

592

5250

Otitis media, unspecified

143

1037

1.28

2.10

2.8

2.1

7.17

7.36

g/l

0.79

138

963

Follow-up care involving plastic surgery

506

1.42

2.10

1.7

2.0

7.22

7.31

g/l

0.18

466

Maternal care for known or suspected abnormality of pelvic organs

217

1771

0.82

2.08

2.7

2.1

7.06

7.21

g/l

0.74

204

1666

Felty syndrome

2.15

2.08

1.7

2.2

6.89

7.54

g/l

0.93

Respiratory tuberculosis, bacteriologically and histologically confirmed

286

1.57

2.08

1.8

2.5

7.91

7.41

g/l

0.99

257

Malignant neoplasm of stomach, including Hilmo

125

974

1.30

2.06

1.3

1.4

7.67

7.48

g/l

0.69

114

855

Acute nasopharyngitis (common cold)

192

1558

1.23

2.06

1.9

2.1

7.08

7.22

g/l

0.55

181

1463

Benign neoplasm: Skin of other and unspecified parts of face

235

1964

1.21

2.06

3.5

2.4

7.22

7.45

g/l

1.30

209

1790

Atrial septal defect

389

1.47

2.05

1.9

2.1

7.07

7.36

g/l

0.69

363

Other and unspecified disorders of orbit

2.24

2.04

1.5

2.6

7.59

7.34

g/l

0.24

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

128

1003

1.29

2.02

2.4

1.4

7.46

7.48

g/l

0.05

115

893

Hypertrophic scar

603

1.37

2.02

2.6

2.2

7.12

7.42

g/l

0.77

560

Abrasion of teeth

740

6702

1.11

2.01

2.5

2.4

7.12

7.37

g/l

4.00

680

6154

Cysts of oral region, not elsewhere classified

113

873

1.31

2.01

3.0

2.4

7.36

7.28

g/l

0.22

103

809

Pilonidal cyst

115

889

1.30

2.00

2.0

2.1

7.40

7.13

g/l

1.12

107

846

Other strabismus

366

3166

1.16

1.98

2.2

2.3

7.06

7.37

g/l

3.29

340

2920

Schizoaffective disorder

117

909

1.30

1.98

1.8

2.3

7.60

7.26

g/l

1.57

107

854

All dysplastic lesions of the vagina

339

1.50

1.95

2.4

2.0

7.28

7.49

g/l

0.39

319

Malignant neoplasm of endocrine gland

129

1018

1.28

1.94

2.2

1.4

7.22

7.46

g/l

0.94

121

910

Suppurative and unspecified otitis media

540

4261

1.13

1.94

2.8

2.1

7.31

7.28

g/l

0.19

508

3952

Fall on and from ladder

162

1316

1.24

1.92

3.4

2.5

7.08

7.32

g/l

1.04

149

1215

Tuberculosis, IBD comorbidity

158

1280

1.25

1.92

2.2

7.66

7.45

g/l

0.81

137

1149

Malignant neoplasm of bronchus and lung, including Hilmo

500

3706

1.13

1.90

2.1

1.5

8.02

7.48

g/l

8.42

456

3315

Pleural plaque without asbestos

760

1.33

1.90

2.0

2.5

7.94

7.43

g/l

1.78

684

Contraceptive management

522

4092

0.89

1.89

2.3

2.2

7.05

7.26

g/l

2.28

488

3852

Benign neoplasm: Other parts of oropharynx

137

1.81

1.88

3.2

1.8

7.00

7.42

g/l

0.70

128

Recurrent dislocation of patella

333

1.48

1.87

1.5

2.0

7.49

7.08

g/l

1.39

319

Carcinoma in situ of skin of lip

2.32

1.86

1.2

1.4

7.43

7.75

g/l

0.24

Other disorders of skin and subcutaneous tissue related to radiation

3.30

1.86

1.1

7.64

7.99

g/l

—

Oral lichen planus

452

1.42

1.86

2.7

2.4

7.37

7.42

g/l

0.10

418

Contact with other hot metals

183

1.67

1.85

1.5

2.4

7.84

7.20

g/l

0.87

169

Hereditary lymphedema, including avohilmo

2.96

1.85

1.0

1.6

6.76

7.63

g/l

—

Other specified disorders of external ear

623

1.35

1.85

2.0

2.6

7.36

7.33

g/l

0.05

579

Other acquired deformities of ankle and foot

101

1.94

1.85

1.6

2.2

7.91

7.27

g/l

0.47

Alzheimer disease, including avohilmo

947

7119

0.92

1.84

2.0

2.3

7.61

7.51

g/l

1.01

796

6352

Endometriosis of pelvic peritoneum

241

1853

1.19

1.83

1.5

2.3

7.24

7.43

g/l

1.13

219

1697

Congenital malformations of genital organs

112

870

1.29

1.82

1.7

2.0

7.09

7.33

g/l

0.92

105

822

Use of peginterferon beta-1a

2.85

1.82

1.9

1.3

6.30

7.08

g/l

—

Use of levodopa decarboxylase inhibitor

357

3125

1.15

1.81

2.0

2.4

7.13

7.47

g/l

3.64

314

2806

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

539

4686

1.12

1.80

3.0

1.4

8.12

7.47

g/l

10.35

491

4229

Occupational exposure to risk-factors

522

0.64

1.80

3.4

2.7

7.00

7.19

g/l

0.29

487

Other sideroblastic anaemias

2.34

1.79

1.2

1.4

7.05

7.78

g/l

0.79

Malignant neoplasm of stomach

107

835

1.29

1.79

1.3

1.4

7.62

7.53

g/l

0.26

736

Other disorders of male genital organs

489

1.39

1.77

1.6

2.5

7.29

7.16

g/l

0.26

452

Foreign body in alimentary tract

106

828

1.29

1.77

1.6

2.4

7.56

7.34

g/l

0.78

760

Embedded teeth, including avohilmo

756

1.30

1.77

2.6

1.9

7.07

7.26

g/l

0.52

713

Glaucoma suspect

768

8384

0.91

1.76

2.3

2.4

7.43

7.46

g/l

0.19

695

7561

Tuberculosis, wide, including avohilmo

166

1367

1.23

1.75

2.2

2.4

7.66

7.46

g/l

0.78

144

1228

Amblyopia ex anopsia

456

1.40

1.75

1.4

2.1

7.53

7.41

g/l

0.19

427

Chalazion

211

1777

1.20

1.74

3.1

2.4

7.19

7.38

g/l

1.01

192

1641

Benign mammary dysplasia

287

2480

1.16

1.74

2.6

2.3

7.45

7.59

g/l

0.80

257

2230

Other intracranial haemorrhages

561

1.36

1.73

2.1

2.5

7.34

7.43

g/l

0.17

505

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

694

0.70

1.72

1.9

2.2

7.17

7.51

g/l

1.02

643

Benign neoplasm: other/unspecified salivary gland

434

1.41

1.71

1.5

2.4

7.47

7.52

g/l

0.08

394

Malignant neoplasm of oral cavity

510

1.37

1.71

2.0

1.4

7.42

7.52

g/l

0.19

454

Myositis ossificans

2.70

1.69

2.1

2.5

7.17

7.44

g/l

—

Oral lichen planus, including avohilmo , including avohilmo

147

1201

1.24

1.69

2.5

7.32

7.41

g/l

0.29

133

1103

Colorectal neuroendocrine tumor and carcinoma

165

1.67

1.68

4.4

1.3

6.82

7.47

g/l

2.02

150

Parkinson's disease, including avohilmo

401

3557

1.13

1.68

1.8

2.4

7.25

7.47

g/l

1.94

351

3200

Benign neoplasm: Skin of trunk

633

1.33

1.68

2.9

2.4

6.95

7.36

g/l

1.56

587

Other diseases of peritoneum

712

1.31

1.68

1.7

2.5

7.70

7.42

g/l

0.66

652

Injury of muscle and tendon at shoulder and upper arm level

832

7659

1.09

1.67

2.3

2.4

7.40

7.34

g/l

0.38

763

7066

Mixed conductive and sensorineural hearing loss

286

2481

1.16

1.67

2.5

2.3

7.52

g/l

0.01

250

2256

Other diseases of biliary tract

195

1640

1.20

1.66

2.3

2.4

7.43

7.48

g/l

0.15

177

1489

Other contact dermatitis

136

1103

1.24

1.66

1.8

2.5

7.28

7.38

g/l

0.36

118

1013

Maze procedure for atrial fibrillation

2.05

1.65

1.3

1.9

6.89

7.54

g/l

0.32

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

268

2315

1.17

1.65

2.6

2.3

7.35

7.36

g/l

0.02

245

2142

Benign neoplasm: Endocrine pancreas

106

1.86

1.64

1.8

2.4

6.87

7.55

g/l

1.61

100

Colon adenocarcinoma

274

2372

1.16

1.64

2.8

1.4

7.54

7.51

g/l

0.11

243

2102

Dislocation, sprain and strain of joints and ligaments of knee

1143

9624

1.08

1.64

1.9

2.4

7.24

7.26

g/l

0.20

1046

8932

Cytomegaloviral hepatitis

2.63

1.63

1.9

2.3

6.79

7.77

g/l

—

Malignant neoplasm of hypopharynx, including Hilmo

1.97

1.63

4.1

1.2

7.71

7.54

g/l

0.16

Neuroendocrine tumor and carcinoma of rectum

2.30

1.61

4.6

1.1

6.80

7.61

g/l

1.15

Tuberculosis, wide

162

1344

1.22

1.61

2.2

2.4

7.65

7.46

g/l

0.71

140

1207

Malignant neoplasm of ureter, including Hilmo

129

1.76

1.61

2.4

1.4

7.79

7.40

g/l

0.61

115

Renal cell carcinoma of kidney

490

1.36

1.61

2.2

1.5

7.70

7.45

g/l

0.38

428

Other and unspecified intracranial injuries

430

1.39

1.61

1.9

2.4

7.45

7.34

g/l

0.20

393

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

447

1.38

1.61

1.6

2.3

6.77

7.29

g/l

1.93

416

Benign neoplasm: Heart

2.22

1.61

1.5

1.9

8.23

7.17

g/l

0.88

Other and unspecified degenerative diseases of nervous system

526

1.35

1.60

2.1

2.5

7.41

7.49

g/l

0.15

477

Papillary adenocarcinoma of thyroid gland

708

1.30

1.60

1.9

1.4

7.12

7.40

g/l

1.01

639

Transient global amnesia

153

1843

0.82

1.59

2.6

2.4

7.26

7.53

g/l

1.32

132

1692

Oligomenorrhoea

355

1.42

1.58

1.8

2.3

7.49

7.44

g/l

0.07

327

Glaucoma-related operations

139

1141

1.23

1.57

2.6

2.5

7.44

7.51

g/l

0.17

125

1019

Vasomotor rhinitis (mode)

140

1149

1.23

1.56

2.2

2.6

7.13

7.36

g/l

0.97

123

1055

Tonsillectomy and adenotomy

689

5238

0.91

1.56

1.9

2.1

7.17

g/l

0.02

642

4921

Benign neoplasm of male genital organs

332

1.44

1.56

2.6

2.7

6.98

7.17

g/l

0.33

305

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

2.26

1.55

1.2

7.37

7.49

g/l

0.06

Disorders of endocrine glands in diseases classified elsewhere

3.52

1.55

1.0

1.1

6.78

7.63

g/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

492

3675

1.12

1.55

2.1

1.5

7.99

7.48

g/l

7.29

445

3296

Macular hole

142

1170

1.23

1.55

1.9

2.6

7.56

7.49

g/l

0.23

127

1064

Other specified and unspecified disorders of lens

170

1.64

1.54

1.5

2.6

6.82

7.69

g/l

2.25

155

Pregnancy, childbirth and the puerperium

507

2937

0.90

1.54

1.9

2.1

7.63

g/l

0.03

458

2561

Lesion of radial nerve

511

1.35

1.54

2.2

2.3

7.42

7.32

g/l

0.18

473

Parkinson's disease, strict definition

357

3166

1.14

1.53

1.8

2.4

7.23

7.46

g/l

1.99

315

2853

Maternal care for (suspected) damage to fetus from alcohol

2.95

1.52

1.2

1.4

7.57

6.89

g/l

—

Caught, crushed, jammed or pinched in or between objects

616

1.31

1.52

1.5

2.4

7.08

7.19

g/l

0.24

579

Transient acantholytic dermatosis [Grover]

2.56

1.52

1.2

2.3

7.36

7.17

g/l

—

Erectile dysfunction

189

1604

1.19

1.50

2.4

7.20

7.33

g/l

0.52

175

1462

Calculus of lower urinary tract

119

966

1.25

1.50

2.2

2.6

7.50

7.34

g/l

0.47

107

885

Separation of retinal layers (serosa)

601

1.31

1.49

2.3

2.5

7.25

7.32

g/l

0.12

560

Non-small cell lung cancer, squamous, helper endpoint

970

0.77

1.49

1.8

2.4

8.28

7.39

g/l

4.20

873

Contact with other hot fluids

334

1.42

1.49

1.5

2.3

7.18

7.24

g/l

0.07

316

Other or unspecified paralytic strabismus

1.89

1.49

1.1

2.6

7.27

7.18

g/l

0.08

HSIL lesion of the vulva

252

1.50

1.48

3.8

2.1

7.96

7.59

g/l

0.60

235

Vascular dementia (other)

125

1.73

1.48

1.7

2.4

7.56

7.59

g/l

0.03

111

Chronic postrheumatic arthropathy [Jaccoud]

3.34

1.47

2.2

1.9

7.98

7.56

g/l

—

Generalized epilepsy, strict definition

203

1.55

1.47

1.7

2.2

6.85

7.19

g/l

0.67

194

Pedal cyclist injured in transport accident

406

3635

1.12

1.47

2.1

2.3

7.19

7.35

g/l

1.19

371

3369

Long labour

221

2175

0.86

1.46

2.4

2.1

7.10

7.20

g/l

0.46

210

2043

Malignant neoplasm of thyroid gland

117

950

1.24

1.46

2.2

1.4

7.17

7.48

g/l

1.21

109

851

Seminoma of testis

2.01

1.45

1.8

1.4

6.86

6.95

g/l

0.08

Other and unspecified injuries of shoulder and upper arm

430

1.36

1.45

1.9

2.5

7.70

7.35

g/l

0.74

397

Secondary parkinsonism+Parkinsonism in other disease

457

1.35

1.44

2.9

2.6

7.23

7.37

g/l

0.29

417

Benign neoplasm: Lip

329

1.42

1.44

3.6

2.2

7.63

7.33

g/l

0.47

298

Maternal care for other known or suspected fetal problems

164

1225

0.84

1.43

1.5

1.9

6.94

7.08

g/l

0.56

158

1167

Lichen sclerosus et atrophicus

226

1954

1.16

1.42

2.2

7.51

7.52

g/l

0.04

204

1753

Alcohol withdrawal state with delirium

133

1099

1.22

1.42

1.3

2.3

7.44

7.28

g/l

0.44

111

1025

Other articular cartilage disorders

296

1.44

1.42

2.2

2.3

7.39

7.14

g/l

0.46

272

Disturbances of smell and taste

651

1.29

1.41

3.4

2.8

6.97

7.43

g/l

1.47

601

Benign neoplasm: Orbit, unspecified

1.86

1.41

3.3

2.2

7.29

7.38

g/l

0.07

Any dementia, excluding more controls

1008

6458

1.08

1.41

2.2

2.5

7.56

7.47

g/l

0.82

862

5804

Fibrosis and sclerosis of liver

3.25

1.41

1.4

1.5

7.34

7.62

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

161

1356

1.20

1.41

2.0

2.5

7.32

7.35

g/l

0.06

148

1247

Malignant neoplasm of nasopharynx

2.29

1.40

1.2

6.89

7.34

g/l

—

Hereditary corneal dystrophies

617

1.30

1.40

1.8

2.6

7.59

7.44

g/l

0.32

562

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.90

1.40

1.7

2.2

7.24

7.41

g/l

0.14

Endometriosis ASRM stages 1,2

250

2179

1.15

1.40

1.5

2.1

7.28

7.37

g/l

0.39

226

2019

Benign neoplasm of bone and articular cartilage

140

1164

1.21

1.40

1.8

2.4

7.01

7.32

g/l

1.90

121

1081

Cerebral aneurysm, nonruptured

172

1458

1.19

1.39

1.9

2.4

7.37

7.42

g/l

0.13

156

1345

Lack of expected normal physiological development

2.26

1.39

1.0

1.1

7.18

7.43

g/l

—

Varus deformity, not elsewhere classified

135

1.66

1.38

1.4

2.5

7.54

7.21

g/l

0.41

125

Alzheimer’s disease, strict definition

626

5496

0.91

1.38

1.9

2.3

7.59

7.53

g/l

0.31

528

4869

Discharge from other and unspecified firearms

0.00

1.37

0.0

2.3

—

7.09

—

Benign lipomatous neoplasm of other sites/unspecified

184

1573

1.18

1.36

2.9

2.3

7.40

7.45

g/l

0.13

175

1433

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

110

895

1.24

1.36

2.1

2.3

7.16

7.31

g/l

0.46

105

844

Dislocation, sprain and strain of joints and ligaments of head

435

1.34

1.35

1.8

1.9

7.24

7.32

g/l

0.13

404

Other fall from one level to another

411

3701

1.11

1.35

2.3

7.31

7.32

g/l

0.05

380

3424

Glaucoma

1465

11772

1.06

1.35

2.3

2.4

7.42

7.45

g/l

0.33

1312

10639

Disorders of globe

419

1.36

1.35

2.7

2.6

7.60

7.42

g/l

0.34

383

All dysplastic lesions of the vulva

602

1.29

1.35

2.5

2.3

7.71

7.53

g/l

0.42

560

Benign neoplasm: Long bones of lower limb

384

1.37

1.35

1.8

2.1

7.18

7.20

g/l

0.03

362

Secondary parkinsonism

446

1.34

1.33

2.9

2.5

7.21

7.40

g/l

0.43

406

Other acantholytic disorders

2.12

1.33

1.4

2.6

7.15

7.25

g/l

0.06

Deep bite

149

1099

1.20

1.31

2.4

2.3

7.28

7.34

g/l

0.17

135

1031

Small plaque parapsoriasis

2.14

1.30

1.9

2.0

7.36

7.66

g/l

—

Endometriosis of ovary

278

2310

1.14

1.30

1.8

2.2

7.30

7.55

g/l

1.86

247

2105

Outcome of delivery

168

872

1.19

1.30

1.8

1.9

6.90

7.23

g/l

2.14

162

833

Tooth eruption problems

130

1043

1.21

1.30

2.3

1.8

7.17

7.23

g/l

0.13

123

983

Endometriosis diagnosis and infertility diagnosis occurring together

131

1091

1.21

1.29

1.6

2.3

7.32

7.27

g/l

0.12

118

1028

Struck by thrown, projected or falling objec

632

1.28

1.29

1.5

2.5

7.21

7.22

g/l

0.00

595

Single delivery by caesarean section

162

1090

0.85

1.28

2.2

1.6

7.19

7.27

g/l

0.26

154

1033

Whooping cough, including avohilmo

138

1.61

1.27

1.4

2.3

6.39

7.16

g/l

1.63

133

Disorders of eyelid in diseases classified elsewhere

458

1.32

1.27

1.2

2.6

7.45

7.43

g/l

0.03

422

Reduction defects of lower limb, including avohilmo

2.30

1.26

3.3

3.4

7.30

7.44

g/l

—

Gestational diabetes (for exclusion)

314

2424

0.89

1.26

1.8

2.0

7.29

7.07

g/l

1.52

294

2306

Vascular dementia (mixed)

383

1.35

1.23

2.4

2.1

7.66

7.55

g/l

0.17

341

LSIL lesion of the vagina

180

1.52

1.23

1.2

1.8

7.27

7.45

g/l

0.19

172

Benign neoplasm of brain and other parts of central nervous system

121

1008

1.21

1.23

2.2

2.5

7.24

7.37

g/l

0.37

102

926

Radial styloid tenosynovitis [de Quervain]

664

1.26

1.22

2.6

2.3

7.42

7.37

g/l

0.10

622

Aneurysms, operations, SAH

349

3141

1.12

1.22

2.0

2.3

7.43

7.41

g/l

0.07

308

2870

Dysplasia of cervi uteri

342

2156

1.12

1.21

2.2

2.1

7.32

7.42

g/l

0.56

310

1968

Undefined dementia

226

2372

0.87

1.20

2.1

2.2

7.67

7.56

g/l

0.40

194

2062

Hypertrophy of breast in women and men

319

2858

1.12

1.20

1.9

2.3

7.39

7.35

g/l

0.14

293

2638

Pleural plaque

237

2089

1.14

1.20

2.2

2.3

7.58

7.35

g/l

1.18

212

1881

Calcaneal spur

157

1.55

1.19

1.9

1.8

7.28

7.50

g/l

0.41

145

Parkinson's disease

376

3405

1.11

1.19

1.8

2.3

7.25

7.47

g/l

1.87

331

3069

Tuberculosis of other organs, strict, including avohilmo

412

1.33

1.18

2.7

2.5

7.68

7.61

g/l

0.10

369

Tuberculosis of other organs, strict

404

1.33

1.17

2.7

2.5

7.72

7.58

g/l

0.22

361

Peritonsillar abscess

320

2874

1.12

1.16

3.1

2.2

7.36

7.25

g/l

0.59

301

2670

Tuberculosis of other organs

344

1.36

1.15

2.7

2.4

7.72

7.60

g/l

0.15

308

Ductal carcinoma of pancreas

114

0.43

1.15

1.0

1.2

7.88

7.40

g/l

—

Obstructed labour due to malposition and malpresentation of fetus

195

2066

0.87

1.13

1.6

2.0

7.10

7.18

g/l

0.41

188

1954

Ovarian dysfunction, other/unspecified

2.00

1.13

2.7

2.2

7.24

7.59

g/l

—

Pathological resorption of teeth

521

1.28

1.12

1.1

2.5

7.26

7.30

g/l

0.07

489

Other benign neoplasm of uterus: Corpus uteri

112

1.64

1.11

4.1

2.1

6.52

7.52

g/l

2.02

105

Other vitreous opacities

674

1.24

1.11

3.2

2.6

7.09

7.38

g/l

1.17

623

Other appendicitis

144

1231

1.18

1.11

3.2

2.4

7.22

7.34

g/l

0.39

128

1148

Gonococcal infection, including avohilmo

433

1.30

1.11

2.1

1.9

7.72

7.31

g/l

0.95

405

Malignant neoplasm of other and unspecified urinary organs

2.02

1.11

1.0

1.3

7.10

7.44

g/l

—

Non-small cell lung cancer

228

1993

1.14

1.10

1.8

1.4

8.17

7.47

g/l

6.21

206

1762

Vertical strabismus

478

1.29

1.10

1.9

2.5

7.19

7.35

g/l

0.39

443

Labour and delivery complicated by fetal stress [distress]

168

1264

0.86

1.10

1.7

1.8

7.04

7.01

g/l

0.08

162

1203

Malignant neoplasm of nasal cavity and sinuses

1.73

1.10

5.5

1.3

6.34

7.61

g/l

4.07

Vestibular neuronitis

176

1531

1.16

1.09

2.3

2.5

7.39

7.37

g/l

0.05

160

1406

Bacterial meningitis

470

1.29

1.09

3.8

2.5

7.27

7.25

g/l

0.04

437

Abscess of Bartholin gland

278

1.38

1.09

3.2

2.1

7.52

7.51

g/l

0.01

262

Foreign body or object entering through skin

794

1.22

1.08

3.0

2.4

7.02

7.28

g/l

1.00

744

105

874

1.20

1.07

2.0

2.4

7.26

7.55

g/l

1.13

758

Arthropod-borne viral fevers and viral haemorrhagic fevers

132

1543

0.85

1.06

3.3

2.4

7.23

7.36

g/l

0.43

123

1428

Dementia, including avohilmo

1316

8536

1.05

1.06

2.1

2.4

7.55

7.48

g/l

0.79

1111

7700

Unattended death

151

0.52

1.05

4.5

1.8

7.23

7.31

g/l

—

136

Wilms' tumor, including Hilmo

1.73

1.04

1.0

1.2

8.30

7.52

g/l

0.91

Severe visual impairment, monocular

155

1.51

1.03

1.3

2.5

7.47

7.52

g/l

0.05

144

Accidental poisoning by and exposure to alcohol

177

0.56

1.02

1.7

2.6

7.02

7.13

g/l

—

167

Antepartum haemorrhage, not elsewhere classified

699

1.22

1.01

2.4

2.0

6.89

7.15

g/l

0.92

666

LSIL lesion of the cervix uteri, vagina or vulva

181

1587

1.14

1.01

2.7

2.2

7.20

7.29

g/l

0.34

168

1480

Burn and corrosion of trunk

387

1.30

1.01

1.3

2.6

7.90

7.26

g/l

1.26

362

Typhoid and paratyphoid fevers, including avohilmo

1.75

1.01

1.2

1.4

7.65

7.32

g/l

0.28

Pregnancy with abortive outcome

1237

6121

1.05

1.00

2.0

2.3

7.58

7.46

g/l

1.51

1118

5517

Malignant neoplasm of other and ill-defined sites, including Hilmo

232

1.40

0.99

1.3

7.73

7.64

g/l

0.10

203

Foreign body in respiratory tract

711

1.22

0.99

2.6

2.4

7.10

7.36

g/l

0.72

656

Malignant neoplasm of hypopharynx

1.91

0.99

1.0

1.2

8.25

7.41

g/l

—

Other complications of labour and delivery, not elsewhere classified

676

0.80

0.99

1.5

1.6

6.72

7.05

g/l

1.63

644

Malignant neoplasm of nasopharynx, including Hilmo

1.90

0.98

1.2

1.3

6.80

7.33

g/l

—

Perforation of oesophagus

1.70

0.97

1.1

2.3

7.39

7.37

g/l

0.02

Unspecified dementia

225

2255

0.89

0.95

2.1

2.3

7.69

7.52

g/l

0.70

193

1992

Benign neoplasm: Scrotum

1.88

0.94

1.3

7.25

7.22

g/l

—

Exposure to other specified electric current

220

0.63

0.92

2.3

2.1

7.15

7.28

g/l

0.14

209

Malignant neoplasm of ovary, including Hilmo

982

0.83

0.91

3.0

1.4

7.45

7.60

g/l

0.36

873

Female infertility

403

2220

1.09

0.91

2.0

2.2

7.41

7.42

g/l

0.03

375

2039

Interstitial cystitis (chronic), drug-induced

1.97

0.90

1.1

1.7

7.13

7.88

g/l

—

Degenerative diseases of the nervous system

939

7113

0.95

0.90

1.9

2.3

7.56

7.51

g/l

0.40

796

6354

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.65

0.90

1.8

2.2

7.24

7.34

g/l

0.06

Other nonscarring hair loss

119

1.53

0.89

1.5

2.3

7.66

7.45

g/l

0.15

112

Viral haemorrhagic fevers, not elsewhere classified/unspecified

105

1227

0.85

0.89

3.1

2.3

6.94

7.33

g/l

2.08

1142

Gonococcal infection

422

1.27

0.88

2.2

1.9

7.86

7.32

g/l

1.36

395

Other osteochondropathies

102

868

1.18

0.88

2.5

2.2

7.59

7.36

g/l

0.70

809

2.05

0.88

6.2

3.0

7.65

6.71

g/l

—

Unequal limb length (acquired)

1.88

0.88

2.6

7.55

7.08

g/l

—

Acute poliomyelitis, including avohilmo

192

0.62

0.88

1.6

2.1

7.59

7.46

g/l

0.10

176

Necrobiosis lipoidica, not elsewhere classified

1.70

0.87

3.3

2.3

7.57

7.43

g/l

0.10

Eustachian salpingitis and obstruction

814

1.18

0.87

2.3

2.1

7.26

7.15

g/l

0.25

765

Dengue, including avohilmo

2.01

0.86

4.8

1.5

8.02

7.98

g/l

—

Ill-defined and unknown causes of mortality

184

2063

0.89

0.86

2.3

7.79

7.47

g/l

1.33

162

1851

Acute poliomyelitis

191

0.62

0.86

1.6

2.1

7.59

7.46

g/l

0.11

175

Other mental disorders due to brain damage and dysfunction and to physical disease

284

2590

1.10

0.86

2.7

2.3

7.46

7.47

g/l

0.02

243

2342

Erythema intertrigo

380

1.28

0.85

2.4

2.8

7.49

7.37

g/l

0.22

350

Anomalies of pupillary function

248

1.34

0.84

2.6

2.2

7.27

7.31

g/l

0.04

233

False labour

257

1760

0.90

0.84

1.8

2.0

6.91

7.18

g/l

2.55

251

1676

Pedal cyclist injured in other and unspecified transport accidents

189

1688

1.12

0.84

2.3

7.43

7.34

g/l

0.31

173

1562

Carcinoma in situ of breast, lobular

105

1.56

0.84

4.1

2.3

7.17

7.67

g/l

0.70

100

Contact with machinery

165

1858

0.88

0.83

2.2

2.3

7.11

7.26

g/l

0.58

151

1728

Whooping cough

1.76

0.83

1.0

3.3

6.39

6.92

g/l

—

Contact urticaria

1.92

0.83

1.7

1.4

7.88

7.70

g/l

—

Heterophoria

116

1004

1.16

0.82

2.8

2.4

6.97

7.39

g/l

2.40

111

932

Universal erythroderma, KELA reimbursement

189

1.39

0.82

1.4

2.4

7.24

7.34

g/l

0.10

175

Specific developmental disorder of motor function

1.89

0.82

1.0

2.3

7.63

7.30

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

138

1214

1.14

0.80

1.8

2.2

7.74

7.40

g/l

1.50

131

1120

Aggressive periodontitis

322

1.29

0.79

2.3

2.5

7.48

7.34

g/l

0.19

300

Hypertrophy of breast

261

2381

1.10

0.79

1.5

2.3

7.37

7.39

g/l

0.06

239

2197

Superficial injuries involving multiple body regions

331

1.28

0.78

3.0

2.3

6.89

7.25

g/l

0.92

311

LSIL lesion of the cervix uteri

129

1131

1.14

0.78

2.8

2.3

7.14

7.27

g/l

0.45

120

1072

Pregnancy hypertension

581

4884

1.06

0.78

2.4

2.2

7.38

7.32

g/l

0.44

549

4503

Reduction defects of lower limb

2.24

0.77

4.4

2.7

7.54

7.33

g/l

—

Thromboangiitis obliterans

1.75

0.77

1.1

2.7

6.77

7.44

g/l

—

Divergent concomitant strabismus

113

983

1.15

0.77

2.0

2.3

7.07

7.32

g/l

1.03

106

909

Erosion and ectropion of cervix uteri

459

1.23

0.76

3.1

2.2

8.03

7.65

g/l

1.04

415

Acute appendicitis, with complications

378

3512

1.08

0.76

2.4

2.3

7.40

7.33

g/l

0.32

342

3244

Abnormal findings in secretions and smears from cervix uteri vagina vulva

756

5277

1.06

0.75

2.2

7.26

7.37

g/l

1.01

701

4843

Postmenopausal atrophic vaginitis

521

2662

1.07

0.74

2.4

2.3

7.27

7.62

g/l

5.50

473

2406

Gastrointestinal stromal tumor and sarcoma

176

1.38

0.74

1.2

1.4

7.34

7.47

g/l

0.10

158

Burn and corrosion confined to eye and adnexa

254

1.31

0.74

2.3

2.4

7.78

7.11

g/l

1.08

244

Other chromosome abnormalities, not elsewhere classified

2.03

0.73

1.2

2.9

6.18

7.37

g/l

—

Other benign neoplasms of connective and other soft tissue

175

1573

1.12

0.73

2.7

2.4

7.33

7.38

g/l

0.15

158

1444

Pedestrian injured in collision with car, pick-up truck or van

326

1.27

0.73

1.6

2.3

7.29

7.40

g/l

0.16

301

Right side

101

1.53

0.72

1.4

1.7

7.79

7.55

g/l

0.41

Fractures involving multiple body regions

1.98

0.72

1.6

1.2

8.54

7.65

g/l

—

Anomalies of dental arch relationship, including avohilmo

267

2217

1.09

0.71

2.2

2.3

7.24

7.29

g/l

0.17

238

2074

Colorectal adenocarcinoma

439

4063

1.07

0.70

2.6

1.4

7.50

7.49

g/l

0.03

386

3629

Frontotemporal dementia

102

1.51

0.69

2.2

1.9

7.79

7.46

g/l

—

Gender identity disorders

1.53

0.68

1.0

2.0

7.38

7.06

g/l

—

Malignant neoplasm of bronchus and lung

415

3248

1.07

0.68

1.9

1.5

8.07

7.49

g/l

7.90

374

2904

Dementia due to Parkinson's disease

517

0.80

0.68

1.3

2.4

6.91

7.50

g/l

1.34

464

Acute drug-induced interstitial lung disorder

128

1.43

0.67

9.0

2.0

7.19

7.47

g/l

0.33

118

Hypermetropia

109

957

1.14

0.67

2.2

2.3

7.42

7.39

g/l

0.07

883

Postpartum haemorrhage due to retained placenta

1004

0.86

0.67

2.0

1.9

6.90

7.12

g/l

0.83

958

Lesion of sciatic nerve

765

0.84

0.66

1.3

2.4

7.38

7.45

g/l

0.14

682

Injury of muscle and tendon at wrist and hand level

240

2206

1.09

0.66

2.0

2.4

7.40

7.34

g/l

0.23

228

2041

Von Willebrand disease

137

1.40

0.65

2.4

2.1

6.77

7.44

g/l

1.01

130

Persistent delusional disorders

107

1213

0.88

0.65

2.2

2.4

7.58

7.40

g/l

0.56

1106

Other and unspecified disease of Bartholin gland

441

1.21

0.65

1.9

2.4

7.70

7.52

g/l

0.39

407

L01XE Protein kinase inhibitors

109

962

1.14

0.65

3.0

2.6

7.81

7.40

g/l

1.21

103

888

Alzheimer’s disease (Late onset)

600

5198

0.95

0.64

1.9

2.3

7.60

7.54

g/l

0.41

504

4595

Unspecified jaundice

803

1.15

0.64

1.6

2.4

7.01

7.40

g/l

1.32

729

Complications predominantly related to the puerperium

336

3134

1.07

0.64

2.1

2.2

7.27

7.30

g/l

0.13

318

2914

Convergence insufficiency and excess

121

1.42

0.63

1.3

1.9

6.97

7.31

g/l

0.54

114

Other congenital malformations of respiratory system

1.72

0.62

1.0

1.5

9.64

7.53

g/l

—

Excessive vomiting in pregnancy

814

1.15

0.62

2.1

2.3

7.15

7.34

g/l

0.55

766

Tetralogy of Fallot, a congenital heart defect.

1.69

0.62

1.6

2.4

6.70

7.77

g/l

—

Malignant neoplasm of pancreas, including Hilmo

140

1554

0.90

0.61

2.1

1.4

7.54

7.50

g/l

0.08

127

1387

Congenital malformations of eye, ear, face and neck

656

1.16

0.61

3.3

2.2

6.95

7.29

g/l

1.03

609

Disorder of visual pathways, unspecified

0.00

0.61

0.0

1.6

—

7.43

—

Acute and transient psychotic disorders

174

1584

1.10

0.60

2.2

2.3

7.47

7.30

g/l

0.72

156

1478

Cervical polyps

166

1509

1.10

0.60

2.1

2.3

7.31

7.52

g/l

1.15

158

1366

Infliximab

157

1.35

0.59

1.2

1.8

7.27

7.04

g/l

0.24

151

Mental retardation, excluding more controls

306

1.23

0.59

1.7

2.4

7.44

7.27

g/l

0.29

283

Female infertility, cervical, vaginal, other or unspecified origin

362

2168

1.07

0.59

2.1

2.2

7.40

g/l

0.03

338

1990

Short Achilles tendon (acquired)

332

0.78

0.59

2.7

2.5

7.18

7.44

g/l

0.47

310

Nontoxic diffuse goitre

502

1.18

0.58

3.0

2.3

7.49

7.47

g/l

0.03

455

Myocardial infarction, unclassifiable

487

4587

0.95

0.58

1.8

2.2

7.65

7.47

g/l

1.46

435

4082

Communicating hydrocephalus

328

1.23

0.58

1.5

2.7

7.41

7.46

g/l

0.04

300

Malignant neoplasm of adrenal gland, including Hilmo

1.50

0.58

2.3

1.2

7.78

7.33

g/l

0.39

Embolic stroke

857

1.14

0.58

1.9

2.5

7.43

7.46

g/l

0.06

780

Dementia in other diseases classified elsewhere

101

896

1.13

0.58

1.6

2.4

7.13

7.44

g/l

1.03

811

Fistulae involving female genital tract

256

1.26

0.58

2.1

2.2

8.45

7.49

g/l

1.56

233

Malignant neoplasm of eye and adnexa

115

1.41

0.58

1.8

1.2

7.61

7.44

g/l

0.16

100

ILD medications: nintedanib

0.57

1.0

1.5

8.02

7.29

g/l

—

Intermittent heterotropia

566

1.17

0.57

2.0

2.2

6.75

7.37

g/l

2.64

525

Motor disorders

1.71

0.57

1.0

2.2

7.63

7.37

g/l

—

Prolapse and hernia of ovary and fallopian tube

693

1.15

0.56

1.8

2.1

7.75

7.81

g/l

0.13

594

Frontotemporal dementia, wide, incl. Pick's disease

116

1.41

0.56

2.1

1.9

7.78

7.42

g/l

0.26

105

Kela-code for severe mental illness

623

5951

1.05

0.55

2.0

2.3

7.31

g/l

0.04

570

5481

Benign neoplasm of other and unspecified female genital organs

687

0.85

0.55

1.9

2.4

7.62

7.58

g/l

0.06

626

Benign neoplasm: Short bones of lower limb

124

0.64

0.55

1.5

2.5

6.85

7.37

g/l

—

118

Sequelae of infectious and parasitic diseases

121

1088

1.12

0.55

2.9

2.2

7.75

7.38

g/l

1.29

113

996

Malignant neoplasm of rectosigmoid junction, including Hilmo

450

1.19

0.55

2.5

1.4

7.49

7.56

g/l

0.10

401

Malignant neoplasm of breast, ER-negative, including Hilmo

392

3462

1.06

0.54

2.0

1.4

7.55

7.61

g/l

0.26

348

3067

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

1.57

0.54

1.0

1.6

7.88

7.70

g/l

—

Toxic effects of substances chiefly nonmedicinal as to source

147

1613

0.91

0.53

1.6

2.3

7.11

7.32

g/l

0.86

135

1499

Supervision of high-risk pregnancy

209

1158

1.09

0.53

1.8

1.9

7.00

7.28

g/l

1.97

198

1102

Other ill-defined and unspecified causes of mortality

173

1882

0.92

0.53

2.2

2.4

7.84

7.48

g/l

1.61

152

1687

Drug-induced tremor

100

1.42

0.53

1.4

2.4

7.24

7.38

g/l

0.20

Pterygium

508

1.17

0.52

2.3

2.6

7.17

7.34

g/l

0.29

468

Hydatidiform mole

146

0.68

0.52

6.5

2.1

6.78

7.39

g/l

—

139

Presbyopia

123

1111

1.11

0.52

1.5

2.4

6.96

7.30

g/l

1.32

114

1048

Burns and corrosions confined to eye and internal organs

305

1.22

0.52

2.5

2.3

7.73

7.13

g/l

1.03

290

Morphin

342

1.21

0.52

1.7

1.8

7.44

7.40

g/l

0.04

306

Use of dimethyl fumarate

1.40

0.51

1.0

2.4

5.94

6.81

g/l

—

Use of rasagiline

455

1.17

0.50

1.5

2.8

6.89

7.41

g/l

2.13

415

Anisometropia and aniseikonia

436

1.18

0.50

2.7

2.4

7.18

7.42

g/l

0.59

402

Congenital malformations of breast, including avohilmo

136

1.33

0.49

1.5

2.1

6.70

7.24

g/l

1.07

131

Diabetes mellitus in pregnancy

276

1871

0.94

0.49

1.5

2.0

7.39

7.05

g/l

2.85

261

1782

Retained placenta and membranes, without haemorrhage

147

1603

0.91

0.48

2.6

2.2

7.35

7.42

g/l

0.23

139

1485

L02BX Other hormone antagonists and related agents

111

1224

0.90

0.48

1.8

2.6

8.32

7.29

g/l

3.86

1121

Carcinoma in situ of cervix uteri

104

937

1.11

0.48

2.0

7.30

7.31

g/l

0.00

881

Malignant neoplasm of palate

1.46

0.47

2.4

1.1

7.40

7.34

g/l

—

Poor fetal growth

881

1.11

0.47

1.7

1.9

6.76

7.12

g/l

1.76

840

Oral leukoplakia, including avohilmo

430

1.17

0.47

1.6

2.4

7.43

7.35

g/l

0.09

399

Neuroendocrine tumor and carcinoma of stomach

1.46

0.46

1.9

1.2

8.24

7.61

g/l

0.77

Benign neoplasm: Conjunctiva

496

1.16

0.46

1.4

2.6

7.49

7.43

g/l

0.09

462

Valgus deformity, not elsewhere classified

1.44

0.46

1.1

1.9

7.88

7.24

g/l

1.31

Congenital malformations of breast

129

1.33

0.46

1.5

1.6

6.72

7.24

g/l

0.96

124

Schizophrenia or delusion

520

4978

1.05

0.46

2.0

2.2

7.48

7.30

g/l

1.59

466

4604

Abnormalities of forces of labour

113

1026

1.10

0.46

1.7

2.1

7.12

7.24

g/l

0.41

107

983

Otosclerosis

139

1276

1.09

0.45

2.0

2.6

7.41

7.38

g/l

0.06

124

1171

Benign neoplasm of ovary

318

3009

1.06

0.45

2.3

7.55

g/l

0.01

293

2709

Persons encountering health services in circumstances related to reproduction

899

6225

0.97

0.45

2.2

2.3

7.05

7.31

g/l

5.01

845

5808

Maltreatment syndromes

450

1.16

0.45

2.3

1.9

7.07

7.19

g/l

0.27

429

Complications following abortion and ectopic and molar pregnancy

554

1.14

0.44

1.5

2.6

7.23

7.49

g/l

0.62

510

Open bite that required surgery (Lefort1 or BSSO)

1.46

0.44

1.0

1.8

6.63

7.11

g/l

—

Primary amenorrhea

1.62

0.43

2.0

1.5

6.28

6.95

g/l

—

Malignant neoplasm of renal pelvis

1.40

0.43

1.2

1.3

8.40

7.54

g/l

0.57

Premature separation of placenta [abruptio placentae]

196

0.76

0.43

1.5

2.1

6.92

7.35

g/l

0.58

189

Lesion of plantar nerve

109

993

1.10

0.43

2.3

7.38

7.44

g/l

0.15

899

Respiratory tuberculosis, confirmed and not-confirmed

105

955

1.10

0.43

2.1

2.5

7.67

7.41

g/l

0.77

857

Respiratory tuberculosis

105

955

1.10

0.43

2.1

2.5

7.67

7.41

g/l

0.77

857

Malignant neoplasm of nasal cavity and middle ear

1.45

0.42

5.5

1.3

6.13

7.51

g/l

—

Postpartum care and examination

673

0.90

0.42

1.8

1.6

7.02

7.23

g/l

0.72

638

Non-allergic asthma

142

1309

1.09

0.42

2.2

2.4

7.41

g/l

0.01

132

1202

Other congenital malformations of spinal cord

0.00

0.42

0.0

1.1

—

7.73

—

Infections of breast associated with childbirth

295

1.19

0.42

1.3

1.7

6.89

7.39

g/l

1.27

284

Ectopic pregnancy

212

2260

0.94

0.41

1.7

2.4

7.51

7.35

g/l

0.66

195

2109

Malignant neoplasm of accessory sinuses, including Hilmo

1.37

0.41

4.5

1.3

7.17

7.56

g/l

—

Schizophrenia, schizotypal and delusional disorders

523

5024

1.04

0.41

2.1

2.2

7.48

7.30

g/l

1.72

469

4649

Other congenital musculoskeletal deformities, including avohilmo

0.00

0.41

0.0

1.0

—

7.59

—

Malignant neoplasm of other and ill-defined digestive organs

114

1.33

0.41

1.3

8.51

7.70

g/l

1.04

102

Benign neoplasm: Pineal gland

0.00

0.41

0.0

1.6

—

6.89

—

Obstetric embolism

0.00

0.40

0.0

1.1

—

8.16

—

Malignant neoplasm of vulva, including Hilmo

205

1.23

0.40

2.5

1.5

7.24

7.74

g/l

1.18

180

Other benign neoplasm of uterus: Other parts/unspecified

788

1.11

0.40

3.0

2.2

7.84

7.78

g/l

0.14

683

Benign leiomyoma with endometriosis

296

2810

1.06

0.40

2.2

2.4

7.53

7.55

g/l

0.08

262

2537

malignant neoplasm of female genital organs

258

2666

0.94

0.39

2.0

1.4

7.76

7.63

g/l

0.48

232

2343

Mental and behavioural disorders due to use of volatile solvents

0.00

0.39

0.0

3.2

—

6.77

—

Infections of genitourinary tract in pregnancy

106

1156

0.91

0.38

2.5

2.2

7.30

7.42

g/l

0.36

1067

Sequelae of infectious and parasitic diseases, including avohilmo

122

1125

1.09

0.38

2.9

2.2

7.74

7.38

g/l

1.24

114

1028

Pre-eclampsia superimposed on chronic hypertension

1.40

0.38

1.0

1.4

7.44

6.88

g/l

—

Serous carcinoma of ovary

113

0.70

0.38

2.0

1.5

7.29

7.73

g/l

—

100

Cyst of Bartholin Gland

439

1.14

0.38

2.4

2.2

7.38

7.44

g/l

0.10

413

Other benign neoplasms of uterus

109

1003

1.09

0.37

3.1

2.2

7.65

7.73

g/l

0.18

881

Spinal instabilities

346

1.16

0.37

1.3

2.0

7.09

7.30

g/l

0.35

325

Embedded and impacted teeth

252

1936

1.06

0.36

2.0

7.03

7.14

g/l

0.44

240

1832

Crossbite

562

1.12

0.36

1.4

2.1

7.20

7.23

g/l

0.05

538

Other congenital malformations of limb(s)

1.44

0.35

1.0

1.9

8.05

7.17

g/l

—

Fitting and adjustment of external prosthetic device

1.38

0.35

1.5

1.3

7.60

7.45

g/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

181

1.22

0.35

2.0

2.1

7.49

7.30

g/l

0.14

168

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

669

5620

1.03

0.34

2.3

2.2

7.44

7.34

g/l

0.89

631

5157

Simple and mucopurulent chronic bronchitis

671

1.11

0.34

1.8

2.4

7.86

7.35

g/l

1.28

598

Malignant neoplasm of rectum, including Hilmo

233

2211

1.06

0.34

2.7

1.4

7.35

7.48

g/l

0.69

208

1973

Endometriosis of intestine

118

1.28

0.33

1.0

2.7

7.83

7.25

g/l

1.04

112

L02BB Anti-androgens

194

2051

0.94

0.33

1.9

2.4

7.64

7.31

g/l

1.60

174

1844

Other noninflammatory disorders of cervix uteri

810

1.09

0.31

2.7

2.3

7.69

7.61

g/l

0.18

725

Stenosis and insufficiency of lacrimal passages

177

1672

1.06

0.31

2.2

2.5

7.41

7.53

g/l

0.42

155

1518

Non-small cell lung cancer, adenocarcinoma, helper endpoint

143

1344

1.07

0.30

1.8

2.5

8.00

7.43

g/l

2.96

129

1224

Cervical root disorders

1.32

0.30

1.0

1.9

7.01

7.44

g/l

0.59

Other disorders of binocular vision

111

1.27

0.30

5.6

2.3

6.45

7.23

g/l

2.19

106

Tuberculosis

121

1131

1.07

0.30

2.0

2.4

7.73

7.44

g/l

0.97

108

1009

Antenatal screening

230

1225

1.05

0.29

2.0

1.9

7.07

7.29

g/l

1.29

225

1168

Kela-code for behavioural disturbances in mental retardation

110

0.72

0.29

1.6

1.9

7.24

7.26

g/l

—

104

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

1.24

0.29

3.6

1.2

6.94

7.57

g/l

—

Mental retardation

342

1.13

0.28

1.7

2.1

7.44

7.29

g/l

0.25

322

Any dementia

1097

7427

1.02

0.28

2.2

2.4

7.58

7.50

g/l

0.85

933

6649

Ethmoidectomy

211

2011

1.05

0.28

2.8

2.3

7.14

7.33

g/l

0.89

195

1871

Pneumoconiosis due to dust containing silica

1.27

0.28

2.4

2.6

7.88

7.29

g/l

—

malignant neoplasm of female genital organs, including Hilmo

318

2915

1.04

0.28

2.3

1.4

7.78

7.63

g/l

0.77

286

2567

Normal-pressure hydrocephalus

979

0.93

0.28

2.5

2.4

7.64

7.48

g/l

0.33

878

Circumscribed brain atrophy

375

1.13

0.27

1.8

2.7

7.31

7.51

g/l

0.39

342

Motorcycle rider injured in noncollision transport accidents

280

1.15

0.27

1.7

2.0

6.73

7.05

g/l

0.66

267

Other specified and unspecified strabismus

131

1.23

0.27

1.9

2.3

7.88

7.20

g/l

0.51

121

Other bursal cyst

206

1.17

0.26

2.2

2.1

6.68

7.40

g/l

1.62

190

Carcinoma in situ of middle ear and respiratory system

0.67

0.26

2.8

2.0

6.10

7.31

g/l

—

Malignant neoplasm of gallbladder

1.24

0.26

1.2

1.1

7.71

7.57

g/l

—

Hydrocephalus

134

1417

0.94

0.25

2.2

2.5

7.52

7.51

g/l

0.02

114

1276

Malignant neoplasm of eye, brain and central nervous system

588

1.09

0.25

1.8

1.4

7.41

7.39

g/l

0.04

530

Female genital prolapse

519

2804

1.03

0.25

2.2

7.54

7.60

g/l

0.38

470

2530

Benign neoplasm: Short bones of upper limb

198

1.17

0.25

1.7

2.2

6.64

7.32

g/l

1.98

187

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

179

1875

0.95

0.25

2.8

1.4

7.42

7.48

g/l

0.21

156

1679

Disorders of acoustic nerve

436

1.11

0.24

3.2

2.5

7.42

7.48

g/l

0.09

399

Viral infections of central nervous system, not elsewhere classified/unspecified

133

1.21

0.24

1.6

2.3

7.12

7.44

g/l

0.41

125

Mucinous and mucinous cystic tumor, including Hilmo

0.73

0.24

7.8

1.4

8.20

7.65

g/l

—

Chronic suppurative otitis media, including avohilmo

122

1152

1.06

0.24

1.6

2.4

7.22

7.40

g/l

0.60

115

1057

Chronic myringitis

0.70

0.24

3.2

1.9

6.95

7.47

g/l

—

Other and unspecified heterotropia

1.37

0.24

1.8

1.1

7.08

7.46

g/l

—

Foreign body on external eye

233

2239

1.04

0.24

2.4

2.3

7.24

g/l

0.00

215

2101

Use of levodopa decarbox-comt-inhibitor

609

0.92

0.23

1.1

2.7

6.89

7.43

g/l

1.66

556

Androgenic alopecia

106

1.23

0.23

1.1

2.1

7.25

7.49

g/l

0.22

101

Endometriosis ASRM stages 3,4

357

3460

1.03

0.23

1.8

2.2

7.29

7.49

g/l

1.67

319

3142

Dementia due to Parkinsons disease, excluding more controls

380

1.11

0.23

1.3

2.6

6.91

7.50

g/l

1.33

346

Impacted teeth

160

1308

1.05

0.23

1.6

1.8

7.10

g/l

0.02

153

1237

Melanocytic naevi, other sites/unspecified

127

1204

1.06

0.23

1.9

2.4

7.31

g/l

0.01

122

1117

Family history of certain disabilities and chronic diseases leading to disablement

457

1.10

0.23

1.6

2.0

7.08

7.31

g/l

0.47

427

Mental retardation, wide definition

377

1.11

0.23

1.7

2.1

7.38

7.32

g/l

0.10

354

Dementia

1201

8074

1.02

0.22

2.1

2.4

7.57

7.47

g/l

1.10

1010

7271

Tooth agenesis EXCLUDE clefts and syndromes

231

0.86

0.22

1.2

1.7

6.64

7.28

g/l

1.27

226

Plasmodium vivax malaria

0.00

0.22

0.0

1.1

—

7.29

—

Plasmodium vivax malaria, including avohilmo

0.00

0.22

0.0

1.1

—

7.29

—

Neurological devices associated with adverse incidents

0.00

0.22

0.0

1.0

—

7.30

—

Myiasis

0.00

0.22

0.0

5.0

—

7.31

—

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.22

0.0

1.8

—

7.43

—

Pseudohypoparathyroidism

0.00

0.22

0.0

1.0

—

7.26

—

Glanders and melioidosis, including avohilmo

0.00

0.22

0.0

1.0

—

7.77

—

Glanders and melioidosis

0.00

0.22

0.0

1.0

—

7.77

—

Congenital heart conduction disorder

0.00

0.21

0.0

1.0

—

7.20

—

Supernumerary ureter

0.00

0.21

0.0

1.0

—

8.01

—

Pinta [carate], including avohilmo

0.00

0.21

0.0

1.0

—

8.07

—

Contact with other specified venomous animals

1.24

0.21

1.1

2.7

6.07

7.47

g/l

3.01

Complications of anaesthesia during pregnancy

0.00

0.21

0.0

1.1

—

6.76

—

Ascariasis, including avohilmo

0.00

0.21

0.0

1.3

—

7.80

—

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.0

—

7.57

—

Underdevelopment of the second kidney

0.00

0.21

0.0

4.5

—

7.47

—

Inflammatory disease of cervix uteri

108

1022

1.06

0.21

1.4

2.3

7.42

7.56

g/l

0.40

930

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

0.21

0.0

1.0

—

6.95

—

Birth injury to peripheral nervous system

0.00

0.21

0.0

4.5

—

6.78

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

7.85

—

Postpartum haemorrhage due to anatomy

636

0.93

0.20

1.8

1.7

6.86

7.04

g/l

0.68

609

Other menopausal disorders

475

2581

1.03

0.20

2.4

2.3

7.13

7.57

g/l

7.01

441

2355

Unicornuate uterus

0.00

0.20

0.0

1.1

—

6.80

—

Mild mental retardation

239

0.88

0.19

1.9

2.2

7.60

7.17

g/l

0.72

228

Malignant neoplasm of other and unspecified parts of mouth

1.23

0.19

1.8

1.3

7.21

7.64

g/l

0.41

Other obstructed labour

901

0.94

0.19

1.9

2.3

7.60

7.37

g/l

0.80

849

Premenstrual syndrome

109

1.20

0.18

1.2

2.4

6.42

7.25

g/l

2.87

104

Colon adenocarcinoma, helper endpoint

274

2822

0.97

0.18

2.8

2.4

7.54

7.46

g/l

0.36

243

2548

Benign neoplasm of thyroid gland

517

0.93

0.17

2.3

2.4

7.31

7.43

g/l

0.18

479

Obstructed labour due to maternal pelvic abnormality

214

2210

0.97

0.17

2.2

2.3

7.37

7.45

g/l

0.35

197

2035

Alcoholic cardiomyopathy

1.23

0.17

1.3

2.7

6.89

7.34

g/l

—

Senile degeneration of the brain, not elsewhere classified

0.74

0.17

1.2

2.2

6.48

7.51

g/l

—

Other/unspecified mastoiditis and related conditions

0.71

0.17

1.8

2.1

7.26

7.41

g/l

—

Calcific tendinitis of shoulder

777

1.06

0.17

2.6

2.3

7.31

7.32

g/l

0.01

727

Primary open-angle glaucoma, strict

650

6371

1.02

0.17

2.2

2.3

7.50

7.51

g/l

0.08

574

5669

Prophylactic surgery

1.16

0.16

5.4

1.3

6.29

7.24

g/l

—

Malignant neoplasm of breast, HER-negative

354

3320

1.02

0.16

2.0

1.4

7.58

7.62

g/l

0.15

312

2933

Use of ropinirole

613

1.06

0.16

2.0

2.8

7.27

7.38

g/l

0.18

563

Osteitis due to dental implant

130

1.16

0.16

3.4

1.9

7.53

7.56

g/l

0.03

118

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS